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Abstract 
Palladium-Catalyzed Carbon-Hydrogen Bond Functionalization 
Utilizing an Exo-Directing Strategy 
Zhi Ren, Ph.D 
The University of Texas at Austin, 2016 
Supervisor:  Guangbin Dong 
Transition metal catalyzed functionalization of carbon-hydrogen bonds (C−H 
bonds) has become an exponentially growing field. Particularly, Pd-catalyzed methods 
with various directing groups (DGs) have been developed for site selectivity. In addition, 
the use of an oxime as a DG proved to be an efficient and removable DG. However, 
alcohol-based directing strategies are still rare and underdeveloped. The research and 
development in this dissertation mainly focused on the utilization of masked alcohols as 
DGs for late stage diversification. With an exo-directing strategy, the syntheses of 
chemically differentiated vicinal diols and 2-hydroxyalkylphenol derivatives were 
achieved. Through a series of studies on cyclopalladation of methine groups, the first 
direct C−H activation complex was prepared and characterized. Additionally, a 
comprehensive introduction of TM-catalyzed alkylation of aromatic C−H bonds with 
simple olefins was illustrated. 
vii 
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 1 
CHAPTER 1:  PALLADIUM-CATALYZED C−H 
FUNCTIONALIZATION OF OXIMES 
1.1 Introduction 
Transition metals catalyzed carbon-hydrogen bond functionalization (C−H 
functionalization) represents the one of the challenging yet fruitful fields.
1
 In particularly, 
many novel transformations using palladium catalysis have been developed.
2
 To achieve 
the high site-selectivity, directing groups (DGs) was introduced and applied as a strategy 
to overcome the wide existence of C−H bonds in organic molecules.3 Among various 
DGs, such as pyridine and oxazoline, using oxime groups as DGs are demonstrated to 
possess synthetic advantages, as oxime DGs can be removed or transformed into other 
function groups.
4
 
The first C−H cyclopalladation with oximes was documented in 1970 (Scheme 
1.1.1).
5
 Using Li2PdCl2 with NaOAc in acetic acid at room temperature, the ortho 
aromatic C−H bonds was successfully activated to give a 5-membered palladacycle. The 
NaOAc was found to be crucial for the C−H activation step to occur, which could be 
explained by the mechanism that was now known as the concerted metalation-
deprotonation (CMD) pathway.  
Scheme 1.1.1. First cyclopalladation with aromatic oximes. 
 
 2 
In general, the sp
2
 nitrogen-centered ligands are known to form two types of 
metalation: an endo-directing mode in which the C=N double bond is inside of the 
palladacycle, and exo-directing mode in which C=N double bond is outside of the 
palladacycle (Scheme 1.1.2).
6
 The endo-directing mode is favored over exo-directing 
mode when both activation modes are possible, and even the sp
2
-exo C−H bond is less 
competitive than sp
3
-endo C−H bond, which has been known as endo effect.7 
Scheme 1.1.2. endo-Directing vs. exo-directing strategy. 
 
Using oximes as DGs in C−H functionalization, three different types of C−H 
bonds can be activated: 1) the C−H bond on the nitrogen side, 2) the C−H bond on the 
oxygen side, and 3) the sp
2
 C−H bond on the carbon-nitrogen double bond. Therefore, in 
this review, the transformations are divided into the three corresponding parts: endo-
mode, exo-mode, and the other types of reactions as shown in corresponding Type A, B, 
 3 
or C in Scheme 1.1.2. The reactions involving in situ cleavage of N−O bond of oximes 
for heterocycle synthesis are not reviewed in this chapter.
8
 
Scheme 1.1.3. Three types of C−H functionalization of oximes. 
 
 
 
 
  
 4 
1.2 Pd-Catalyzed C−H Functionalization via an Endo-Directing Strategy  
1.2.1 FUNCTIONALIZATION OF SP
3
 C−H BONDS 
The first seminal work in Pd-catalyzed sp
3
 C−H acetoxylation with endo oxime 
DG (Type A) was developed by Sanford and co-workers in 2004 (Scheme 1.2.1).
9
 The 
oxime substrates are prepared by condensation between parent ketones and O-
methylhydroxylamine. In the help of the oxime sp
2
 nitrogen, Pd catalyst can selectively 
activate the C−H bond at the -position of the parent ketones to give the five-membered 
palladacycle, which could be further oxidized by the oxidant, PhI(OAc)2, to give 
actoxylation product in good yield. The C−H bonds at both methyl and cyclic methylene 
group were successfully oxidized under the optimal condition. When cyclic methylene 
substrate was applied (e.g. trans-decline O-methyl oxime), the C−H oxidation occurred 
diastereoselectively at the equatorial position. 
Scheme 1.2.1. Pd-catalyzed sp
3
 C−H acetoxylation. 
 
However, the further transformations for the C−H functionalization products with 
O-methyl oxime DG were found to be problematic, as the -hydroxyl ketone derivatives 
 5 
tend to give elimination products under strong acidic conditions. In 2010, Sanford and 
co-worker developed a transformable DG, which can be removed within two steps in 
one-pot to solve this problem (Scheme 1.2.2).
10
  
Scheme 1.2.2. Pd-catalyzed sp
3
 C−H oxidation with transformable DG. 
 
Scheme 1.2.3. NaNO3 as catalytic co-oxidant in aerobic C−H oxygenation. 
 
In 2012, the further studies by Sanford group led to the discovery of NaNO3 or 
NaNO2, as catalytic co-oxidant, which enabled the aerobic C−H oxygenation (Scheme 
1.2.3).
11
 According to the preliminary mechanistic studies, NO was proposed to be the 
key intermediate in this NOx redox co-catalyst system, in which NO could be oxidized to 
NO2 by oxygen, and NO2 could oxidize Pd(II) to Pd(III). 
 6 
In 2006, Che and Yu co-team developed the Pd-catalyzed C−H amidation of 
oximes with nitrene insertion (Scheme 1.2.4).
12
 The sp
3
 C−H functionalization selectively 
occurs at -position of parent oxime to give amidation products in good to excellent 
yields. The nitrene was demonstrated to be generated in situ by reacting the primary 
amides or sulfonamides with K2S2O8. However, the nature of the reactive nitrene species 
that inserted into the palladacycle during the reaction is still uncertain. The similar 
transformation with Ir catalysis and TsN3 as nitrene precursor was achieved by Chang’s 
group in 2014.
13
 
Scheme 1.2.4. Pd-catalyzed sp
3
 C−H amidation with nitrene. 
 
In 2016, Chen's group demonstrated the arylation of O-methyl oxime substrates 
with diaryliodonium salts (Scheme 1.2.5).
14
 The optimized condition requires a super-
stoichiometric amount of silver salt to give the desired products in good to excellent 
yields with various diaryliodonium salts. The counterion of diaryliodonium salts was also 
found to be critical, and the OTf salt gave the best result. The proposed palladation 
intermediate was isolated and offered the desired product under the standard condition. 
Scheme 1.2.5. Pd-catalyzed arylation with diaryliodonium salts. 
 7 
 
Before the transformable DG was introduced, the O-methyl oxime DG cannot be 
easily removed. Therefore, the applications need to use stoichiometric Pd in total 
synthesis with oxime as DG (Scheme 1.2.6). In 2005, the Oltra and Cueva team applied 
the -oxygenation in the total synthesis of Rostratone, and toward Aphidicolin and 
Pyripyropene A with Pb(OAc)4 as an oxidant in two separate steps.
15
 In 2007, the Parra 
and co-workers followed the stoichiometric Pd C−H oxidation in the partial synthesis of 
hyptatic acid A.
16
 
The development of removable DG for C−H functionalization enables the 
applications of catalytic Pd in the total synthesis of natural products (Scheme 1.2.7). In 
2004, Sorensen and co-workers synthesize Jiadifenolide with the transformable DG.
17
 
Later in 2015, Johnson and co-worker prepared the intermediated for the synthesis of 
Paspaline
18
, and Trotta group and Li group applied O-methyl oxime DG in the 
preparation of Oridamycin B
19
. 
  
 8 
Scheme 1.2.6. Total synthesis of natural products with stoichiometric Pd. 
 
  
 9 
Scheme 1.2.7. Total synthesis of natural products with catalytic Pd. 
 
1.2.2 FUNCTIONALIZATION OF SP
2
 C−H BONDS 
The first Pd-catalyzed oxygenation of the aromatic C−H bond using oxime as DG 
was demonstrated by Sanford's group in 2006 (Scheme 1.2.8).
20
 The substrate scope of 
this method was tested by applying various substituted substrates with different electronic 
properties under the optimal condition. Among many oxidants tested, the inexpensive and 
environmental-friendly oxidant, Oxone, was found to give the acetoxylated products in 
moderate to good yields, which is comparable to using PhI(OAc)2 as the oxidant. The 
C−H methoxylation reaction was also discovered using MeOH as solvent and Oxone as 
oxidant under carefully regulated temperature to avoid the formation of Pd black.  
 10 
Scheme 1.2.8. Pd-catalyzed sp
2
 C−H acetoxylation and methoxylation. 
 
In 2012, Bolm and co-workers applied the Pd-catalyzed C−H functionalization to 
the oxidation of ortho-aromatic C−H bond in [2.2]paracyclophane oxime derivatives 
(Scheme 1.2.9).
21
 The [2.2]paracyclophane and its derivatives have significant 
applications in the material science and asymmetric synthesis as ligands or catalysts.  
Scheme 1.2.9. Application in acetoxylation of [2.2]paracyclophane oximes with Pd 
catalysis. 
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In 2015, Jiao's group developed the Pd-catalyzed C−H hydroxylation of aromatic 
C−H bonds using O-methyl oxime as a DG (Scheme 1.2.10).22 With PPh3 or DEAD as 
ligand and Oxone as the oxidant, the ortho selective C−H hydroxylation offers the phenol 
products in good to excellent yields. Through oxygen isotope labeling experiments, the 
incoming oxygen atom of the hydroxyl group was proposed to be transferred from the 
Oxone. The key intermediate for Zaltoprofen synthesis was prepared to demonstrate the 
application potential of this method.  
Scheme 1.2.10. Pd-catalyzed sp
2
 C−H hydroxylation and application in Zaltoprofen 
synthesis. 
 
In 2006, the Che and Yu co-team developed the Pd-catalyzed amidation reaction 
of aromatic C−H bonds using oxime DGs (1.2.11).12 Comparing to the sp3 C−H 
functionalization, the aromatic C−H amidation can undergo with the less acidic primary 
amides, such as acetamide, to provide the acetylaniline derivatives in good to excellent 
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yields. The pathway for this reaction was proposed to give the palladation first and then 
nitrene insertion to give the final product. To clarify the nature of the nitrene species 
during the insertion step, the further mechanistic studies are still in demand.  
Scheme 1.2.11. Pd-catalyzed sp
2
 C−H amidation. 
 
In 2008, Yu's group demonstrated the Pd-catalyzed ethoxycarbonylation of 
aromatic C−H bonds (Scheme 1.2.12).23 Using DEAD as the source of the acyl group and 
K2S2O8 as the oxidant, the aromatic ethyl esters were obtained in acceptable to moderate 
yields. The mechanistic studies suggest that this reaction may involve a radical pathway 
as the DEAD can thermally decompose to ethoxycarbonyl radical, and the addition of the 
radical scavenger dramatically decreases the yield. However, the detailed mechanism for 
the radical insertion into the palladacycle requires more comprehensive examination. 
Since the reaction is conducted under the strong oxidative condition, the Pd(IV) pathway 
could be an alternative pathway for the formation of C-C bond.  
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Scheme 1.2.12. Pd-catalyzed sp
2
 C−H ethoxycarbonylation. 
 
In 2010, the Shi's group demonstrated the arylation of oximes with aryl boronic 
acids (Scheme 1.2.13).
24
 In the help of copper salt, 1,4-benzoquinone, 2,6-
methoxypyridine, and 3Ǻ molecular sieves, the Pd-catalyzed ortho-arylation reaction 
give the biaryl products in moderate to good yields. Under the arylation condition, the 1-
tetralone oxime gave the product in good yield, while the more strained 1-indanone 
oxime did not offer the desired biaryl product. The role of the copper salt was proposed 
to be the terminal oxidant for regenerating Pd(II) from Pd(0) with the assistance of 1,4-
benzoquinone. The base, 2,6-methoxypyridine, is used to neutralize the strong acid, 
HOTf, generated through the reaction to avoid the acid mediated cyclization to give the 
fluorenone derivatives.  
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Scheme 1.2.13. Pd-catalyzed sp
2
 C−H arylation. 
 
1.3 Pd-Catalyzed C−H Functionalization via an Endo-Directing Strategy  
1.3.1 FUNCTIONALIZATION OF SP
3
 C−H BONDS 
As demonstrated in the previous sections, the traditional endo-DGs played a 
significant role in Pd-catalyzed C−H functionalization. However, it is difficult to 
rationalize the application of such strategy in free alcohols or masked alcohols 
functionalization. On the other hand, the prevalence of hydroxyl groups in natural 
products and bioactive compounds demands methodologies to functionalize the -
position preferably in late stage. Therefore, the development of a new directing strategy 
is required to solve this scientific problem, and will have a significant impact on the 
synthesis of bioactive compounds for pharmaceutical studies. As demonstrated in this 
section, the exo-directing strategy (Type B) exhibits an exclusive advantage in the 
functionalization of masked alcohols. 
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In 2012, Dong and co-workers first utilized the exo-directing strategy (Type B) in 
Pd-catalyzed C−H functionalization of the oxime masked alcohols to synthesize 
chemically differentiated 1,2-diols (Scheme 1.3.1).
25
 Through the appropriate design of 
the DG, the palladation occurred selectively at the -position of the original hydroxyl 
group via an exo-directing mode, and after the oxidation to give the acetate protected 1,2-
diols. Under the reaction condition, not only the regular methyl and cyclic methylene 
C−H bonds, but also the bridgehead methine C−H bonds were oxidized in good to 
excellent yields. The DG and acetate group can be removed under orthogonal conditions 
to give a chemically differentiated 1,2-diols, which could work as valuable building 
blocks for pharmaceutical industrial and academic research. 
Scheme 1.3.1. Pd-catalyzed sp
3
 C−H acetoxylation for 1,2-diol synthesis. 
 
Surprisingly, when the menthol derived oxime substrate was submitted to the Pd-
catalyzed condition, an oxidative rearrangement product was obtained as a single 
diastereomer (Figure 1.1). The structure of the product is a 1,3-diol derivative containing 
a 5-membered ring, which was confirmed by X-ray crystallography. 
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Figure 1.1. Pd-catalyzed sp
3
 C−H oxidative rearrangement. 
 
Scheme 1.3.2. Pd-catalyzed sp
3
 C−H sulfonyloxylation for diverse functionalization. 
 
In 2015, the same group developed the Pd-catalyzed C−H sulfonyloxylation at the 
-position of alcohols (Scheme 1.3.2).26 In general, the OTs group is considered as an 
excellent leaving group while a terrible nucleophile under most conditions. Therefore, 
enabling HOTs as a nucleophile has a great advantage to introduce a good leaving group 
for the rapid diversification of drug molecules in late stage. The optimal condition 
involves an electrophilic fluorination reagent, NFSI, as the oxidant, and HOTs as a 
nucleophile to give the products in good to excellent yields. Many interesting functional 
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groups including olefins, amines, arenes and heterocycles were tolerated. The steroid 
intermediate, 2H-pregnanediol oxime, was used to demonstrate the late-stage 
diversification of the product through SN2 reaction with various nucleophiles including 
nucleophiles based on carbon, oxygen, sulfur, phosphine, and halogens. When menthol 
derived oxime substrate was used, the fluorinated product was obtained. 
Scheme 1.3.3. Pd-catalyzed sp
3
 C−H for the synthesis of the cyclic ether. 
 
In the same year, Dong' s group demonstrated a Pd-catalyzed dehydrogenative 
cyclization for the synthesis of cyclic ether (Scheme 1.3.3).
27
 The primary, secondary, 
and tertiary free alcohols all worked under the optimized condition to give the cyclic 
ethers in good to excellent yields. The oxidative cyclization occurs through the tethered 
free hydroxyl group attacking the C-Pd bond via SN2 reaction to form four- to seven-
membered rings. The fused four-and six-membered oxetane product demonstrates the 
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potential application in the bioactive compound syntheses, e.g. paclitaxel. Many types of 
functional groups are tolerated, including amides, carbamates, cyclobutane, and arenes.  
1.3.2 FUNCTIONALIZATION OF SP
2
 C−H BONDS 
Comparing to the functionalization of sp
3
 C−H bonds, sp2 C−H functionalization 
with exo-directing strategy goes through a six-membered exo-palladacycle. Differed from 
the C=N double bond in the endo-directing mode, the C−O single bond in exo-DGs can 
freely rotate. This unique feature allows the multiple C−H bonds functionalization under 
Pd-catalyzed conditions, which is another consideration when applying these methods. 
Figure 1.2. One example using oxime DG in aromatic C−H oxidation. 
 
In 2008, Sanford group conducted a series of experiments to compare the 
directing ability among various functional groups and reported a single example using 
oxime in directed aromatic C−H oxidation (Figure 1.2).28 This seminal work provides 
moderate yield, due to the relatively low efficiency of the DG. Therefore, a better DG is 
still needed for higher reactivity and turnover numbers. 
The Pd-catalyzed oxygenation of aromatic C−H bonds was developed by Dong 
group in 2015 (Scheme 1.3.4).
29
 As the wide existence of 2-hydroxyalkylphenol 
derivatives in the natural products and drugs, the rapid and straightforward synthetic 
methods are required. For practical purpose, high catalyst turnover numbers are favored 
for the application. By adopting the 2,6-dimethoxyoxime as DG, 1700 TON was 
achieved for each oxidation with 0.1 mol % Pd(OAc)2, attribute to the extra stability 
provided by the weak coordination of methoxy groups. To take the advantage of benzylic 
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oximes, the DG can be removed through either C−O or N−O cleavage to offer versatility 
for different synthetic purposes. 
Scheme 1.3.4. Pd-catalyzed sp
2
 C−H acetoxylation. 
 
In 2015, Zhao's group demonstrated the ortho-olefination of aromatic C−H bond 
via oxidative Heck reaction (Scheme 1.3.5).
30
 As the lack of additional coordination from 
the DG, an extra amino acid was required to facilitate the C−H activation step.31  In the 
present of stoichiometric silver acetate, the olefination products were obtained in 
moderate to good yields. As demonstrated by the application in the total synthesis of 3-
deoxyisoochacinic acid, the DG was removed using the expensive and super-
stoichiometric reagent, Mo(CO)6, because the newly generated alkenes cannot be 
tolerated under the reductive condition.  
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Scheme 1.3.5. Pd-catalyzed sp
2
 C−H olefination with acrylate derivatives. 
 
Scheme 1.3.6. Pd-catalyzed sp
2
 C−H arylation with aryl boronic acid pinacol esters. 
 
In the same year, Zhao and co-workers developed a C−H arylation reaction with 
aryl boronic acid pinacol esters as coupling partners (Scheme 1.3.6).
32
 By using the 
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similar combination of amino acid ligand, Ag2CO3, and KBF4, the C−H arylation gives 
ortho-arylation products in good yields. The scope of the substrate for this transformation 
is demonstrated by various substituted aromatic oximes with aryl boronic acid pinacol 
esters with different electronic properties. The amino acid ligand was known to promote 
the C−H activation while the Ag2CO3 was proposed to be the oxidant to regenerate the 
Pd(II) catalyst. However, the detailed role of KBF4 salt is still unclear. 
1.4 Other Pd-Catalyzed Functionalization of Oximes C−H Bonds 
Pd-catalyzed functionalization of the imine C−H bond at aldoxime undergoes a 
different mechanistic pathway, which is known as insertion/elimination pathway. Unlike 
the Type A and Type B reactions (endo/exo-directed C−H functionalization), Type C 
reaction did not go through C–H activation of the imine hydrogen. Instead, the imine 
hydrogen was removed by -hydride elimination to regenerate the Pd catalysis. These 
methods were applied to prepare heterocycles and fluorenone. 
In 2007, Tanaka, Ohno, and co-workers developed a Pd-catalyzed synthesis of 
heterocycles via Heck-type cyclization of oxime ethers (Scheme 1.4.1).
33
 The reaction 
was discovered during the investigations toward the cyclization of allene with additional 
double bonds. An unexpected Pd-catalyzed C−H functionalization of aldoxime with 
iodobenzene occurred and gave the pyrrolidine derivative. This reaction was further 
extended into the intramolecular fashion to prepare 3-indolinone or 3-benzofuranone 
oxime analogs in moderate to good yields. The inconsistency of E/Z ratio in starting 
materials and products suggests an insertion/elimination mechanism for cyclization 
reaction. 
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Scheme 1.4.1. Pd-catalyzed synthesis of heterocycles via Heck-type cyclization of oxime 
ethers. 
 
 
Scheme 1.4.2. Pd-catalyzed cyclization for the synthesis of heterocyclic oximes with 
tethered vinyl iodide. 
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In 2011, Tong' group extended the Pd-catalyzed cyclization for heterocyclic 
oximes synthesis with tethered vinyl iodide moiety (Scheme 1.4.2).
34
 With PPh3 as ligand 
and stoichiometric silver salt, the Heck-type cyclization with different tether length to 
give heterocyclic products in moderate yields. Since the desired product can be obtained 
with catalyst turnover by solely using K2CO3, the role of silver was suggested as a base.  
Scheme 1.4.3. Pd-catalyzed synthesis of fluorenone via dual C−H functionalization. 
 
 
In 2008, Cheng's group demonstrated a Pd-catalyzed synthesis of 9-fluorenone 
through dual C−H functionalization of O-methyl oximes with aryl iodides (Scheme 
1.4.3).
35
 The reaction proceeded through the ortho C−H arylation at the aldoximes, and 
the Heck-type cyclization to form the 5-membered ring and through acid prompted 
hydrolysis to give 9-fluorenone derivatives in good yields. The process was supported by 
using the biaryl intermediate under the reaction condition to give the desired product in 
good yields. Silver salt was proposed to contribute as the halides scavenger to facilitate 
the reductive elimination and the oxidant to regenerate Pd(II) from Pd(0). 
 24 
1.5 Conclusion 
The directing strategy is still widely deployed in the field of C−H 
functionalization for site selectivity. Utilizing oxime group as DG in different modes has 
been proven to provide novel and efficient transformations in Pd-catalyzed C−H 
functionalization. Up to date, the methods using C−H functionalization to form C−O, 
C−N, C−C bonds have been developed and described. For the development of the DG 
point of view, the removability becomes an important concern in the perspective of the 
application. As the weakness of the N−O bond in oxime substrates, there are many ways 
has been demonstrated to achieve the cleavage of the oxime DG.  
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CHAPTER 2:  PALLADIUM-CATALYZED FUNCTIONALIZATION 
OF UNACTIVATED ALIPHATIC C−H BONDS OF MASKED 
ALCOHOLS VIA EXO-DIRECTING GROUPS 
2.1 Introduction 
Transition metal catalyzed C−H functionalization has been rapid growth in the 
past two decades.
1
 Many novel transformations have been realized to provide building 
blocks and applied to natural products.
2
 Since the chemo- and site-selectivity is one of the 
challenges for developing the predictable and reliable transformations, different groups 
have solved this problem in their ways. For the metal carbenoid insertion reaction, both 
the substrate and catalyst-controlled C−H functionalization reactions have been 
developed by Davies’ group.3 The Hartwig group demonstrated to utilize the sterical 
effect of substrates to control the chemo- and regioselectivity in borylation and silylation 
of arenes and alkanes.
4
 Besides the substrate or ligand-controlled examples, Sanford,
5
 
Daugulis
6
 and Yu
7
 have developed various types of directing groups (DGs) for the C−H 
functionalization. 
Scheme 2.1. Pd-catalyzed C−H functionalization of ketone oximes. 
 
Pd-catalyzed C−H functionalization and carbon-heteroatom bond formation have 
been demonstrated as an efficient method to change the oxidation state of organic 
molecules.
8
 To achieve high site selectivity, the oxime as endo-DGs was established and 
studied by Sanford’s group.9 However, the functionalization of alcohols or masked 
alcohols to synthesis 1,2-diols has not been realized before.
10
 Our group has utilized an 
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exo-directing strategy to achieve the C−H functionalization for C-O bonds formation to 
synthesize 1,2-diols.  
2.2 Background 
There are only a few methods have been developed for the unactivated sp
3
 C−H 
functionalization of alcohols or masked alcohols.
11
 In 2010, Du Bois and co-workers 
realized the Rh-catalyzed 1,2- or 1,3- amino alcohols synthesis through carbamate- or 
sulfamate-tethered nitrene insertion.
12
 In 2008, Baran’s group developed a four-step 
one-pot radical process to prepare 1,3-diols inspired by Hofmann-Lőffler type reaction.13 
In 2012, Hartwig’s work on 1,3-diols synthesis from mono alcohols using Ir-catalyst with 
silicon as a temporary functional group.
14
 However, there is no 1,2-diols synthesis via 
C−H functionalization has been demonstrated before.  
Scheme 2.2. Alcohol or masked-alcohol directed C−H bond functionalization. 
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As demonstrated in chapter 1, there are many examples of using oximes as endo-
DGs for sp
3
 C−H oxygenation of parent ketones. However, it is difficult to rationalize the 
endo-directing strategy in the functionalization of alcohols or masked alcohols. 
Therefore, a new strategy is demanded the synthesis of 1,2-diol moieties, which is 
common in natural products, such as Taxol, Picato, and Bryostatin 7 (Figure 2.1).
15
  
Figure 2.1. Representing natural products containing 1,2-diol moieties. 
 
Figure 2.2. endo-Directing vs. exo-directing. 
 
Considering C−H bonds that at the -position of alcohol is more electron-poor 
than the ones at -position, because of the inductive effect of the oxygen atom. This 
electron distribution makes the transition metal-oxo species prefer to insertion of the C−H 
bonds at the-position.16 Another consideration is the removability of DGs after the 
reaction to recover the free hydroxyl group. We hypothesize that with appropriate oxime 
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as DG, the C−H functionalization of -position of masked alcohols could be realized by 
new exo-directing strategy (Figure 2.2). 
2.3 Reaction Development and Scope 
The design of exo-DG encounters the problem that the formation of endo-
metallocycle is much favored compared to exo-metallocycle.
17
 This endo-effect suggests 
that all the possible endo C−H activation sites need to be blocked on the new DG for the 
exo-metallation.
18
 Therefore, we decided to employ 2,6-dimethoxyaldhyde oxime as DG 
for the formation of a 5-membered exo-metallocycle. 
Scheme 2.3. endo-Effect using oxazoline as a DG. 
 
 
Figure 2.3. exo-Directing strategy with Pd catalysis. 
 
 
To test this hypothesis, oxime masked 2-butanol was prepared and applied to the 
reaction as the standard substrate. With the optimized the reaction conditions, the desired 
1,2-diol product was prepared in 67% yield without observation of -C−H oxidation.  
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Table 2.1. Selected optimization of reaction conditions. 
 
A series of control reactions was conducted to obtain some detailed insights of 
this aliphatic C−H oxidation reaction (Table 2.1). Without the Pd(OAc)2 or PhI(OAc)2, 
no desired product was detected, while less catalyst loading gave lower yield due to low 
conversion (entry 2 and 4). In the absence of water scavenger, Ac2O, the yield was 
slightly decreased (entry 3). However, the addition of a small amount of water gave 
significant lower yield, implying that water could interfere this reaction (entry 6).
19
 The 
representing solvents gave the product in lower yield as shown from entry 7 to 9. Using 
K2S2O8 as the oxidant led to low yield with a large amount of 2,6-dimethoxybenzonitrile 
which is the side product from elimination (entry 10). Additive, such as LiOAc, did not 
change the yield of the reaction (entry 11). Neither high nor lower concentration from the 
optimal condition gave lower yield (entry 11 and 12). Two other DGs were tested, and 
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with pyridine based DG no product was observed (entry 14), due to the pyridine could 
chelate to Pd too strong to give any catalyst turnover. On the contrary, the chloride in the 
DG B has a much weaker ability to bound the Pd resulted in lower yield (entry 15).
20
  
The substrates were prepared by a two-pot three steps procedure (Scheme 2.4). 
According to the nature of the parent alcohols, the N-alkoxy phthalimides were installed 
by either Mitsunobu reaction for 1
o
 and 2
o
 alcohols, or SN1-type reaction for 3
o
 ones. 
Followed by sequential one-pot deprotection/condensation to give the corresponding 
oxime masked alcohols. This preparation procedure is easy to operate, but the 
corresponding stereocenter of the parent alcohols is inverted. Therefore, a short DG 
installation method with the retention of the stereocenter is still needed. 
Scheme 2.4. Two-pot preparation of oxime substrates. 
 
To our delight, all the oxime masked primary, secondary and tertiary alcohol 
substrates underwent smoothly under the optimized condition, and the 1,2-diols were 
isolated in good yields (entry 1-9). As expected, the aliphatic C−H bonds at the -
position of the parent alcohols were selectively oxidized, and the C−H bond at methyl 
group is found to be more reactive than the one at non-methyl alkyl group (entry 3-7). As 
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shown in entry 5-7, the substrates with different steric hindrance were submitted to the 
optimal reaction condition, and the results suggest the alcohols with more hindered group 
on one side tend to give better yields. Compared to the tertiary substrates, the masked 
secondary alcohol substrates demonstrated to give higher yield attributing to higher 
conversion.  
Other than methyl C−H bonds, the cyclic methylene C−H oxidation also has been 
demonstrated by oxime masked cyclopentanol substrate (entry 10). In that case, both 
mono- and bis-oxidized products were isolated. Notably, the first oxidation occurs at the 
opposite side of the DG to give a trans-diol 2.10b, whereas the second oxidation happens 
on the same side of the DG to generate a cis/trans-triol 2.10c. The observation can be 
explained by the conformational analysis of the preferential transition states of this 
substrate. 
To our surprise, when masked either endo- or exo-norbornyl alcohol substrates 
were used, the selective oxidative C−H functionalization occurred at the methine C−H 
bonds at -position in the presence of the less hindered cyclic -methylene C−H bonds 
(entry 11 and 12). The conformational structure of the products (2.11b and 2.12b) were 
confirmed by removal of both protecting groups and DG to compare with the known 1,2-
diols.
21
 There is only one special example in literature that demonstrates the nonselective 
functionalization tertiary C−H bonds at strained cyclopropane ring.22 As demonstrated by 
our further studies (Scheme 1.3.2 and Scheme 1.3.3), the functional groups, such as ether, 
ester,oxime, and aryl groups should be tolerated in this reaction.  
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Table 2.2. Summary of the substrate scope. 
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Table 2.2. Summary of the substrate scope (continued). 
 
When the oxime masked menthol substrate was used, an interesting ring 
contraction rearrangement to give a five-membered ring product was discovered (Scheme 
2.5).
23
 The starting material and product were confirmed by X-ray crystallography, and 
the product was obtained as a single diastereomer with 1,3-diol moieties in good yield. 
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The detailed mechanism is still unclear, but presumably through palladation to give an 
intermediate similar to 2.16, and the sequential oxidation to offer the palladium III or IV 
species 2.17, which underwent a Pd-triggered oxidative rearrangement to give the final 
product.  
Scheme 2.5. A Pd-triggered oxidative rearrangement. 
 
The reaction scales were also examined by conducting oxidation with substrate 
2.1a in Table 2.3. Interestingly, the reactions on larger scale exhibited a higher catalyst 
turnover to give higher yield. For examples in entry 3, on a 2 mmol scale, the yield was 
increased to 74% from 61% with an even lower catalyst loading of Pd(OAc)2 (2 mol %). 
As shown in entry 4, on a 5 mmol scale, the yield increased to 80%. The results 
demonstrate that the large-scale reaction is less sensitive to the impurities, and the lower 
surface area ratio could prevent the Pd black to aggregate.  
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Table 2.3. The scale of the reaction. 
 
An intermolecular experiment of kinetic isotope effect (KIE) was conducted to 
investigate the reaction mechanism (Figure 2.4). The observed intermolecular KIE result 
(kH/D = 3.35) suggests the C−H cleavage step could be the rate-determining step. 
Figure 2.4.The intermolecular KIE result. 
 
The DG and Ac group were removed in excellent yields using orthogonal 
chemical methods to demonstrate the two hydroxyl groups in the product are chemically 
differentiated (Scheme 2.6). This feature shows a great potential for the application of 
this synthetic method. 
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Scheme 2.6. Orthogonal protecting groups. 
 
2.4 Conclusion 
In summary, a new strategy for the Pd-catalyzed site-selective functionalization of 
unactivated aliphatic C−H bonds to access the chemically differentiated 1,2-diols from 
oxime masked mono alcohols. The oxime group served as both the DG and protection of 
alcohol for this oxidative reaction. The exo-DGs in C−H activation, as demonstrated by 
this work, have opened doors for the discovery of new transformations and new 
removable DGs.  
2.5 Experiment Results 
2.5.1 GENERAL CONSIDERATIONS 
Unless otherwise noted, all experiments were carried out under air atmosphere. 
1,2-Dichloroethane (DCE) was distilled over CaH2. Toluene and tetrahydrofuran (THF) 
were distilled over sodium. The other reagents and solvents were directly used from the 
supplier without further purification unless noted. Analytical thin-layer chromatography 
(TLC) was carried out using 0.2 mm commercial silica gel plates (silica gel 60, F254, 
EMD chemical). The vials (1 dram, 15×45 mm with PTFE-lined cap attached) were 
purchased from Qorpak and dried in an oven overnight and cooled in air. Infrared spectra 
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were recorded on a Nicolet 380 FTIR using neat thin film technique. High-resolution 
mass spectra (HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative 
intensity). Accurate masses are reported for the molecular ion [M+Na]
+
 or [M+H]
+
. 
Nuclear magnetic resonance spectra (
1
H NMR and 
13
C NMR) were recorded with Varian 
Gemini (400 MHz, 
1
H at 400 MHz, 
13
C at 100 MHz) or Varian Unity+ (300 MHz, 
1
H at 
300 MHz, 
13
C at 75 MHz). For CDCl3 solutions, the chemical shifts are reported as parts 
per million (ppm) referenced to residual protium or carbon of the solvents; CHCl3  H 
(7.26 ppm) and CDCl3 C (77.00 ppm). Coupling constants are reported in Hertz (Hz). 
Data for 
1
H NMR spectra are reported as follows: chemical shift (ppm, referenced to 
protium; s = singlet, d = doublet, t = triplet, q = quartet, p = pentet (quintet), dd = doublet 
of doublets, td = triplet of doublets, ddd = doublet of doublet of doublets, m = multiplet, 
coupling constant (Hz), and integration). 
2.5.2 GENERAL PROCEDURE AND CHARACTERIZATION 
General survey of all substrates syntheses 
 
General procedure: Mitsunobu reaction for syntheses of 2.S1a-2.S7a, 2.S10a-2.S12a 
and 2.S13: 
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To a solution of alcohol (5 mmol, 1.0 equiv), N-Hydroxyphthalimide (978 mg, 6 mmol, 
1.2 equiv) and PPh3 (1.572 g, 6 mmol, 1.2 equiv) in 20 mL THF was added diisopropyl 
azodicarboxylate (1.2 mL, 6 mmol, 1.2 equiv) dropwise at 0 
o
C. Then the reaction was 
allowed to room temperature. The reaction was monitored by TLC. Upon done, the 
solvent was removed under reduced pressure. The residue was purified by flash column 
chromatography on silica gel to give the title compounds. All the yields are not 
optimized. 
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2-(sec-Butoxy)isoindoline-1,3-dione (2.S1a) 
White solid. Yield 85%. Rf = 0.3 (Hex/EA=15:1).  
 
1
H NMR (400 MHz, CDCl3) δ 7.83-7.78 (m, 2H), 7.74-7.70 (m, 2H), 4.34-4.26 (m, 1H), 
1.86-1.75 (m, 1H), 1.68-1.57 (m, 1H), 1.31 (d, J = 6.3 Hz, 3H), 1.02 (t, J = 7.5 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.34, 134.35, 128.97, 123.39, 85.61, 27.70, 18.18, 9.53. 
Match cited literature
24
. 
 
  
 40 
 
2-Ethoxyisoindoline-1,3-dione (2.S2a) 
White solid. Yield 90%. Rf = 0.4 (Hex/EA=5:1).  
 
1
H NMR (400 MHz, CDCl3) δ 7.84-7.81 (m, 2H), 7.74-7.73 (m, 2H), 4.27 (q, J = 7.1 Hz, 
2H), 1.40 (t, J = 7.1 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 163.74, 134.45, 128.89, 123.49, 74.10, 13.64. Match cited 
literature
25
. 
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2-Isopropoxyisoindoline-1,3-dione (2.S3a) 
White solid. Yield 97%. Rf = 0.4 (Hex/EA=5:1).  
 
1
H NMR (400 MHz, CDCl3) δ 7.84-7.80 (m, 2H), 7.75-7.71 (m, 2H), 4.53 (hept, J = 6.2 
Hz, 1H), 1.36 (d, J = 6.2 Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.33, 134.40, 128.92, 123.44, 80.65, 20.78. Match cited 
literature
25
. 
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2-(Heptan-2-yloxy)isoindoline-1,3-dione (2.S4a) 
Colorless oil. Yield 61%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2927, 2856, 1790, 1733, 1467, 1377, 1188, 1119, 977 cm
-1
.   
 
1
H NMR (400 MHz, CDCl3) δ 7.82 (td, J = 5.3, 2.1 Hz, 2H), 7.75 (td, J = 5.3, 2.1 Hz, 
2H), 4.37 (dd, J = 12.5, 6.3 Hz, 1H), 1.88-1.72 (m, 1H), 1.68-1.52(m, 2H), 1.52-1.39(m, 
3H), 1.39-1.28 (m, 6H), 0.89 (t, J = 7.1 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.50, 134.50, 129.13, 123.54, 84.64, 34.97, 31.91, 
29.83, 25.08, 22.68, 18.94, 14.16.  
 
HRMS calcd. for C15H19NO3Na
+
 [M+Na]
+
: 284.12571. Found: 284.12612. 
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2-((4-Methylpentan-2-yl)oxy)isoindoline-1,3-dione (2.S5a) 
White solid. Yield 77%. Mp. 60-62 
o
C. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2957, 1790, 1733, 1379, 1188, 976, 878, 713, 519 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.86-7.82 (m, 2H), 7.77-7.73 (m, 2H), 4.51-4.43 (m, 1H), 
1.99-1.88 (m, 1H), 1.77 (ddd, J = 14.1, 7.6, 6.6 Hz, 1H), 1.41 (ddd, J = 14.0, 7.6, 5.7 Hz, 
1H), 1.32 (d, J = 6.2 Hz, 3H), 1.03 (d, J = 6.6 Hz, 3H), 0.93 (d, J = 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.38, 134.35, 128.96, 123.38, 82.79, 44.15, 24.74, 
22.72, 22.57, 19.40.  
 
HRMS: calcd. C14H17NO3Na
+
 [M+Na]
+
: 270.11061. Found: 270.10999. 
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2-((3-Methylbutan-2-yl)oxy)isoindoline-1,3-dione (2.S6a)  
Colorless oil. Yield 51%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2962, 2875, 1733, 1657, 1652, 1448, 1386, 1294, 1129 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.86-7.79 (m, 2H), 7.77-7.71 (m, 2H), 4.24-4.15 (m, 1H), 
2.03 (tt, J = 12.1, 3.4 Hz, 1H), 1.26 (d, J = 6.4 Hz, 3H), 1.05 (t, J = 6.6 Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.50, 134.48, 129.16, 123.51, 88.82, 31.78, 18.79, 
17.22, 14.79.  
 
HRMS calcd. for C13H15NO3Na
+
 [M+Na]
+
: 256.09441. Found: 256.09444. 
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2-(1-Cyclohexylethoxy)isoindoline-1,3-dione (2.S7a) 
Colorless oil. Yield 50%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2926, 2853, 1790, 1733, 1376, 1188, 975, 878, 701 cm
-1
. 
 
1
H NMR (400 MHz, CDCl3) δ 7.83-7.79 (m, 2H), 7.74-7.69 (m, 2H), 4.19-4.13 (m, 1H), 
1.92-1.88 (m, 2H), 1.79-1.73 (m, 2H), 1.71-1.63 (m, 2H), 1.31-1.09 (m, 8H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.37, 134.30, 129.01, 123.34, 88.19, 77.31, 76.99, 
76.67, 41.73, 28.95, 27.64, 26.44, 26.10, 26.04, 15.41.  
 
HRMS: calcd. C16H19NO3Na
+
 [M+Na]
+
: 296.12626. Found: 296.12570. 
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2-(Cyclopentyloxy)isoindoline-1,3-dione (2.S10a) 
White solid. Yield 82%. Mp. 70-73 
o
C. Rf = 0.4 (Hex/EA=15:1).  
 
IR (KBr) 2954, 2872, 1731, 1654, 1649, 1294, 1275, 1129, 1084 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.87-7.80 (m, 2H), 7.78-7.71 (m, 2H), 4.87-4.81 (m, 1H), 
2.09-1.88 (m, 4H), 1.84-1.69 (m, 2H), 1.69-1.56 (m, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.49, 134.52, 129.15, 123.58, 90.51, 31.67, 23.68.  
 
HRMS calcd. for C13H13NO3Na
+
 [M+Na]
+
: 254.07876. Found: 254.07868. 
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Endo-2-((bicyclo[2.2.1]heptan-2-yl)oxy)isoindoline-1,3-dione (2.S11a) 
Starting from exo-norborneol, the reaction was carried out at -78 
o
C, then slowly allowed 
to room temperature. Endo/exo 11:1.   
 
White solid. Yield 23%. Rf = 0.5 (Hex/EA=5:1). Mp. 79-81 
o
C.  
 
IR (KBr) 2956, 2872, 1789, 1730, 1376, 1187, 877, 700 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.83-7.78 (m, 2H), 7.74-7.70 (m, 2H), 4.75-4.70 (m, 1H), 
2.49 (t, J = 4.2 Hz, 1H), 2.40-2.33 (m, 1H), 2.24 (t, J = 4.7 Hz, 1H), 1.98-1.90 (m, 1H), 
1.68-1.57 (m, 1H), 1.52-1.40 (m, 2H), 1.36-1.33 (m, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 163.97, 134.34, 128.95, 123.38, 89.45, 40.37, 37.50, 
36.75, 35.13, 29.58, 20.32.  
 
HRMS: calcd. C15H15NO3Na
+
 [M+Na]
+
: 280.09496. Found: 280.09423. 
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Exo-2-((bicyclo[2.2.1]heptan-2-yl)oxy)isoindoline-1,3-dione (2.S12a) 
Starting from endo-norborneol, the reaction was carried out at room temperature and 
gave single exo isomer.   
 
White solid. Yield 56%. Rf = 0.5 (Hex/EA=5:1). Mp. 105-107 
o
C.  
 
IR (KBr) 2960, 2872, 1789, 1731, 1375, 1186, 978, 878, 701 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.84-7.79 (m, 2H), 7.74-7.71 (m, 2H), 4.37-4.34 (m, 1H), 
2.42 (d, J = 4.8 Hz, 1H), 2.33 (s, 1H), 1.91-1.87 (m, 1H), 1.72-1.63 (m, 2H), 1.55-1.39 
(m, 2H), 1.22-1.18 (m, 1H), 1.08-1.02 (m, 1H), 0.97-0.91 (m, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.22, 134.35, 128.98, 123.41, 90.43, 40.46, 37.36, 
35.18, 34.70, 28.28, 23.67. 
 
HRMS: calcd. C15H15NO3Na
+
 [M+Na]
+
: 280.09496. Found: 280.09427. 
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2-(((1S,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)isoindoline-1,3-dione (2.S13) 
White solid. Yield 20%. Mp. 98-100 
o
C. []D
20
 = +57 º. Rf  = 0.2 (Hex/EA=15:1).  
 
IR (KBr) 2943, 2863, 1729, 1468, 1370, 1131, 882, 698 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.84-7.79 (m, 2H), 7.76-7.71 (m, 2H), 4.66 (d, J = 2.4 Hz, 
1H), 2.40-2.27 (m, 1H), 2.02-1.90 (m, 2H), 1.87-1.81 (m, 1H), 1.76-1.70 (m, 1H), 1.61-
1.50 (m, 1H), 1.19 (d, J = 6.6 Hz, 3H), 1.14-1.07 (m, 1H), 1.01-0.92 (m, 5H), 0.88 (d, J 
= 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 164.45, 134.28, 129.09, 123.25, 83.82, 47.96, 37.92, 
34.94, 28.90, 25.85, 24.27, 22.20, 21.20, 21.07.  
 
HRMS: calcd. C18H23NO3Na
+
 [M+Na]
+
: 324.15756. Found: 324.15707. 
 
  
 50 
SN1 reactions for syntheses of 2.S8a and 2.S9a: 
 
To a slurry of N-hydroxy phthalimide (54 mmol, 2 equiv), tertiary alcohol (27 mmol, 1 
equiv) in 90 mL wet DCM, BF3·OEt2 (8.0 mL, 30 mmol, 1.1 equiv) was added dropwise 
over 10 mins at 0°C. The reaction mixture was stirred for over 1 hour at room 
temperature. When the reaction was finished, 30 mL 5% K2CO3 was added. The aqueous 
layer was extracted with DCM (30 mL × 3), the combined organic layers were combined 
and dried over MgSO4. The residue was purified by flash column chromatography on 
silica gel (Hex/EA=5:1) to give titled compounds. 2.S8a, yield 46%, white solid.  
 
1
H NMR (400 MHz, CDCl3) δ 7.85-7.81 (m, 2H), 7.76-7.74 (m, 2H), 1.42 (s, 9H). 2.S9a, 
yield 44%, white solid.  
 
1
H NMR (400 MHz, CDCl3) δ 7.87-7.81 (m, 2H), 7.78-7.72 (m, 2H), 1.94-1.80 (m, 4H), 
1.72-1.63 (m, 2H), 1.51-1.38 (m, 4H), 1.36 (s, 3H).  
 
Both 2.S8a and 2.S9a match cited literature
26
. 
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The general procedure for preparing compound 2.1a-2.12a, 2.1a DG A, 2.1a DG B 
and 2.13: 
 
To a solution of N-Alkoxyphthalimide (1.0 equiv) in MeOH (5 mL/mmol) was added 
hydrazine monohydrate (1.0 equiv) at room temperature. The reaction was monitored by 
TLC and usually completed in 0.5 h. Then 2,6-dimethoxybenzaldehyde (1.0 equiv) was 
added. The reaction was monitored by TLC. After 0.5 h the mixture was filtered to 
remove precipitate if formed and then the solvent was removed under reduced pressure. 
The residue was purified by flash column chromatography on silica gel to give the title 
compounds. All the yields are not optimized. 
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(E)-2,6-dimethoxybenzaldehyde O-(sec-butyl) oxime (2.1a) 
Colorless oil. Yield 94%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2966, 2935, 2838, 1595, 1470, 1432, 1256, 1207, 1114 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.24 (t, J = 8.4 Hz, 2H), 6.56 (d, J = 8.4 Hz, 
2H), 4.34-4.24 (m, 1H), 3.84 (s, 6H), 1.85-1.70 (m, 1H), 1.63-1.51 (m, 1H), 1.29 (d, J = 
6.3 Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.07, 143.33, 130.58, 110.14, 104.27, 80.26, 56.25, 
28.72, 19.36, 9.89.  
 
HRMS calcd. for C13H20NO3
+
 [M+H]
+
: 238.14377. Found: 238.14356. 
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(E)-Picolinaldehyde O-(sec-butyl) oxime (2.1a DG A) 
2,6-Dimethoxybenzaldehyde was replaced by pyridine-2-carbaldehyde to give a colorless 
oil. Yield 41%. Rf = 0.3 (Hex/EA=5:1).  
 
IR (KBr) 2966, 2925, 2853, 1738, 1585, 1468, 1434, 1375, 1329, 1112 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.61 (ddd, J = 4.9, 1.8, 1.0 Hz, 1H), 8.15 (s, 1H), 7.80 (dt, 
J = 8.0, 1.1 Hz, 1H), 7.68 (tdd, J = 8.0, 1.8, 0.5 Hz, 1H), 7.24 (ddd, J = 7.5, 4.9, 1.2 Hz, 
1H), 4.30 (dd, J = 12.6, 6.3 Hz, 1H), 1.84-1.70 (m, 1H), 1.66-1.53 (m, 1H), 1.30 (d, J = 
6.3 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 152.35, 149.75, 148.60, 136.47, 123.80, 120.97, 81.67, 
28.60, 19.38, 9.86.  
 
HRMS calcd. for C10H15N2O
+
 [M+H]
+
: 179.11789. Found: 179.11779. 
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(E)-2,6-dichlorobenzaldehyde O-(sec-butyl) oxime (2.1a DG B) 
2,6-dimethoxybenzaldehyde was replaced by 2,6-dichlorobenzaldehyde to give a 
colorless oil. Yield 63%. Rf = 0.4 (Hex/EA=15:1).  
 
IR (KBr) 2967, 2924, 2851, 1556, 1441, 1427, 1373, 1188 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H), 7.34 (d, J = 8.0 Hz, 2H), 7.22-7.16 (m, 1H), 
4.29 (h, J = 6.3 Hz, 1H), 1.85-1.73 (m, 1H), 1.67-1.54 (m, 1H), 1.31 (d, J = 6.3 Hz, 3H), 
0.98 (t, J = 7.5 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 143.69, 135.19, 130.04, 129.56, 128.81, 81.43, 28.58, 
19.33, 9.79.  
 
HRMS calcd. for C11H14Cl2NO
+
 [M+H]
+
: 246.04470. Found: 246.04487.  
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(E)-2,6-dimethoxybenzaldehyde O-ethyl oxime (2a) 
Colorless oil. Yield 96%. Rf = 0.5 (Hex/EA=5:1).  
 
IR (KBr) 2973, 2936, 2838, 1595, 1576, 1559, 1472, 1433, 1257, 1208, 1113, 1053 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.43 (s, 1H), 7.25 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.25 (q, J = 7.1 Hz, 2H), 3.83 (s, 6H), 1.33 (t, J = 7.1 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.07, 144.03, 130.82, 109.61, 104.13, 69.46, 56.18, 
14.71.  
 
HRMS calcd. for C11H16NO3
+
 [M+H]
+
: 210.11247. Found: 210.11248. 
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(E)-2,6-dimethoxybenzaldehyde O-isopropyl oxime (2.3a) 
White solid. Yield 99%. Mp. 41-44 
o
C. Rf = 0.6 (Hex/EA=5:1).  
 
IR (KBr) 2972, 2938, 2838, 1595, 1577, 1471, 1433, 1256, 1207, 1149, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.38 (s, 1H), 7.25 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.54-4.46 (m, 1H), 3.84 (s, 6H), 1.31 (d, J = 6.2 Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.91, 143.28, 130.49, 109.88, 104.09, 75.09, 56.05, 
21.76.  
 
HRMS calcd. for C12H18NO3
+
 [M+H]
+
: 224.12812. Found: 224.12814. 
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(E)-2,6-dimethoxybenzaldehyde O-heptan-2-yl oxime (2.4a) 
Colorless oil. Yield 84%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2932, 2857, 1595, 1469, 1431, 1256, 1206, 1114, 1035 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.38 (s, 1H), 7.23 (d, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.34 (dd, J = 12.5, 6.2 Hz, 1H), 3.84 (d, J = 3.7 Hz, 6H), 1.82-1.69 (m, 1H), 1.56-
1.37 (m, 3H), 1.37-1.27 (m, 8H), 0.89 (dd, J = 8.8, 5.1 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.04, 143.24, 130.55, 110.12, 104.23, 79.15, 56.18, 
35.92, 32.14, 25.27, 22.77, 19.96, 14.22.  
 
HRMS calcd. for C16H25NO3Na
+
 [M+Na]
+
: 302.17266. Found: 302.17226. 
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(E)-2,6-dimethoxybenzaldehyde O-(4-methylpentan-2-yl) oxime (2.5a) 
Colorless oil. Yield 91%. Rf = 0.25 (Hex/EA=15:1).  
 
IR (KBr) 2956, 1595, 1470, 1432, 1256, 1114, 947, 777 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.45-4.37 (m, 1H), 3.82 (s, 6H), 1.86-1.76 (m, 1H), 1.65 (ddd, J = 14.1, 7.5, 6.7 Hz, 
1H), 1.31-1.26 (m, 4H), 0.94 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.88, 142.97, 130.37, 109.99, 104.09, 77.38, 56.02, 
45.11, 24.72, 22.97, 22.83, 20.47.  
 
HRMS: calcd. C15H24NO3
+
 [M+H]
+
: 266.17562. Found: 266.17502. 
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(E)-2,6-dimethoxybenzaldehyde O-(3-methylbutan-2-yl) oxime (2.6a) 
Colorless oil. Yield 86%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2961, 2837, 1595, 1470, 1432, 1384, 1256, 1207, 1114, 1055 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.22-4.12 (m, 1H), 3.84 (s, 6H), 2.05-1.94 (m, 1H), 1.23 (d, J = 6.4 Hz, 3H), 0.96 
(dd, J = 13.2, 6.9 Hz, 6H).  
 
13
C NMR (75 MHz, CDCl3) δ 158.98, 143.05, 130.47, 110.10, 104.20, 83.40, 56.12, 
32.21, 18.83, 17.40, 15.83.  
 
HRMS calcd. for C14H22NO3
+
 [M+H]
+
: 252.15942. Found: 252.15921. 
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(E)-2,6-dimethoxybenzaldehyde O-(1-cyclohexylethyl) oxime (2.7a) 
Colorless oil. Yield 83%. Rf = 0.25 (Hex/EA=15:1).  
 
IR (KBr) 2924, 1595, 1470, 1432, 1256, 1114, 948, 777 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.17-4.10 (m, 1H), 3.82 (s, 6H), 1.87-1.84 (m, 1H), 1.76-1.72 (m, 3H), 1.67-1.59 
(m, 2H), 1.29-1.19 (m, 5H), 1.16-0.98 (m, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.89, 142.85, 130.34, 110.08, 104.12, 82.90, 56.06, 
42.39, 29.17, 27.96, 26.71, 26.37, 26.34, 16.55.  
 
HRMS: calcd. C17H26NO3
+
 [M+H]
+
: 292.19127. Found: 292.19058. 
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(E)-2,6-dimethoxybenzaldehyde O-(tert-butyl) oxime (2.8a) 
White Solid. Yield 86%. Mp. 77-81 
o
C. Rf = 0.5 (Hex/EA=5:1).  
 
IR (KBr) 2975, 1593, 1577, 1469, 1359, 1255, 1205, 1192, 1111, 939 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 3.83 (s, 6H), 1.37 (s, 9 H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.06, 142.50, 130.29, 110.75, 104.51, 78.49, 56.21, 
27.79.  
 
HRMS calcd. for C13H20NO3
+
 [M+H]
+
: 238.14377. Found: 238.14370. 
 
  
 62 
 
(E)-2,6-dimethoxybenzaldehyde O-(1-methylcyclohexyl) oxime (2.9a) 
Colorless oil. Yield 99%. E/Z = 6.6:1. Rf = 0.5 (Hex/EA=5:1).  
 
IR (KBr) 2932, 2859, 2838, 1594, 1470, 1432, 1255, 1206, 1166, 1115 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 3.83 (s, 6H), 2.00-1.89 (m, 2H), 1.72-1.59 (m, 2H), 1.59-1.40 (m, 6H), 1.34 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.08, 142.53, 130.21, 110.95, 104.59, 79.23, 56.26, 
36.39, 25.99, 25.90, 22.42.  
 
HRMS  calcd. for C16H24NO3
+
 [M+H]
+
: 278.17507. Found: 278.17483. 
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(E)-2,6-dimethoxybenzaldehyde O-cyclopentyl oxime (2.10a) 
Colorless oil. Yield 96%. Rf = 0.3 (Hex/EA=15:1).  
 
IR (KBr) 2959, 2838, 1595, 1470, 1432, 1340, 1306, 1256, 1207, 1181, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.25 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.88-4.79 (m, 1H), 3.84 (s, 6H), 1.97-1.68 (m, 6H), 1.65-1.51 (m, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.03, 143.73, 130.63, 110.01, 104.20, 84.95, 56.19, 
32.30, 24.02.  
 
HRMS calcd. for C14H20NO3
+
 [M+H]
+
: 250.14377. Found: 250.14374. 
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(E)-2,6-dimethoxybenzaldehyde O-((endo)-bicyclo[2.2.1]heptan-2-yl) oxime (2.11a) 
White solid. Yield 99%. Mp. 50-51 
o
C.  Rf = 0.3 (Hex/EA=10:1).  
 
IR (KBr) 2952, 2869, 1595, 1470, 1257, 1114, 1031, 947 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.73 (dtd, J = 10.4, 4.0, 1.4 Hz, 1H), 3.82 (s, 6H), 2.57 (t, J = 3.3 Hz, 1H), 2.19 (t, J 
= 4.3 Hz, 1H), 1.95 (dddd, J = 13.4, 10.5, 4.7, 3.1 Hz, 1H), 1.90-1.83 (m, 1H), 1.66-1.49 
(m, 1H), 1.42-1.27 (m, 4H), 1.10 (dt, J = 13.1, 3.6 Hz, 1H). 
 
13
C NMR (100 MHz, CDCl3) δ 158.95, 143.91, 130.54, 109.81, 104.13, 83.38, 56.08, 
40.81, 37.31, 36.71, 35.98, 29.74, 20.61.  
 
HRMS: calcd. C16H22NO3
+
 [M+H]
+
: 276.15997. Found: 276.15936. 
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(E)-2,6-dimethoxybenzaldehyde O-((exo)-bicyclo[2.2.1]heptan-2-yl) oxime (2.12a) 
2.12a:  
Colorless oil. Yield 99%. Rf = 0.3 (Hex/EA=10:1).  
 
IR (KBr) 2956, 1595, 1470, 1432, 1257, 1113, 1001, 944 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.33 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.31-4.28 (m, 1H), 3.82 (s, 6H), 2.52 (d, J = 4.2 Hz, 1H), 2.25 (t, J = 3.4 Hz, 1H), 
1.68-1.61 (m, 2H), 1.58-1.38 (m, 4H), 1.14-1.04 (m, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.87, 143.67, 130.50, 109.78, 104.01, 85.40, 56.03, 
41.02, 38.17, 35.39, 34.65, 28.63, 24.24.  
 
HRMS: calcd. C16H22NO3
+
 [M+H]
+
: 276.15997. Found: 276.15955. 
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(E)-2,6-dimethoxybenzaldehyde O-((1S,2S,5R)-2-isopropyl-5-methylcyclohexyl) 
oxime (2.13) 
White solid. Yield 93%. Mp. 72-74 
o
C. []D
20
 = -56 º.  Rf = 0.25 (Hex/EA=15:1).  
 
IR (KBr) 3018, 2952, 2840, 1602, 1471, 1258, 1115, 967, 777, 636 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.21 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.60 (d, J = 2.5 Hz, 1H), 3.82 (s, 6H), 2.24 (ddd, J = 13.7, 6.0, 3.5 Hz, 1H), 1.75-
1.66 (m, 4H), 1.44-1.33 (m, 1H), 1.02-0.95 (m, 5H), 0.94-0.88 (m, 4H), 0.85 (d, J = 6.4 
Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.86, 142.50, 130.20, 110.23, 104.13, 78.58, 56.01, 
47.48, 39.60, 35.19, 29.07, 26.05, 25.21, 22.54, 21.26, 21.01.  
 
HRMS: calcd. C19H30NO3
+
 [M+H]
+
: 320.22257. Found: 320.22204. 
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General procedure for Pd-catalyzed -oxidation of oximes: 
 
Pd(OAc)2 (2.2 mg, 0.01 mmol, 10 mol %), iodosobenzene diacetate (42 mg, 0.13 mmol, 
1.3 equiv) and oxime (0.1 mmol, 1 equiv) were charged in a scintillation vial, followed 
by 0.5 mL AcOH, 10 L Ac2O. The vial was tightly capped and stirred at 100 
o
C. The 
reaction was monitored by TLC and observation of Pd black. Upon done, the mixture was 
directly purified by flash column chromatography on silica gel (Hex/EA= about 15:1 in 
most cases) to give the title compounds. 
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Procedure for large scale reaction for preparation of compound 2.1b:  
Pd(OAc)2 (10 mol %), iodosobenzene diacetate (1.3 equiv) and 2.1a (1 equiv) were 
charged in a scintillation vial, followed by AcOH and Ac2O to make a 0.2 M solution. 
The vial was tightly capped and stirred at 100 
o
C. The reaction was monitored by both 
TLC and observation of Pd black. Upon done, the mixture was diluted with Ethyl 
Acetate. The solvent was removed under reduced pressure. The residue was purified by 
flash column chromatography on silica gel (Hex/EA=15:1) to give 2.1b. 
 
On 0.3 mmol scale: Obtained 2.1b as yellow oil 53 mg, yield 68%, E/Z = 3.6:1. 
 
On 5 mmol scale: Obtained 2.1b as yellow oil 1.18 g, yield 80%, E/Z = 3.0:1. 
 
On 2 mmol scale with 2 mol % Pd(OAc)2 (9 mg):  Obtained 2.1b as yellow oil 0.436 g, 
yield 74%, E/Z = 4.6:1. 
Note: NMR assignments of the minor Z-isomer are provided for all the compounds 
when E/Z ratio is less than 5:1. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)butyl acetate (2.1b) 
Yellow oil. Yield 61%. E/Z = 10.7:1. Rf = 0.4 (Hex/EA=15:1).  
 
IR (KBr) 2966, 2940, 2839, 1739, 1595, 1471, 1433, 1368, 1305, 1256, 1208, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.24 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.36-4.30 (m, 1H), 4.30-4.27 (m, 2H), 3.82 (s, 6H), 2.09-2.02 (s, 3H), 1.83-1.58 (m, 
2H), 1.00 (t, J = 7.5 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.31, 159.14, 144.42, 130.91, 109.65, 104.23, 81.67, 
65.14, 56.19, 23.89, 21.13, 9.92.  
 
HRMS calcd. for C15H21NO5Na
+
 [M+Na]
+
: 318.13119. Found: 318.13114. 
 
  
 70 
 
(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl acetate (2.2b) 
Used 1.0 equiv oxidant. Colorless oil. Yield 65%. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr) 2941, 2840, 1738, 1595, 1472, 1433, 1372, 1305, 1257, 1209, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.28 (t, J = 8.4 Hz, 1H), 6.57 (d, J = 8.4 Hz, 
2H), 4.39 (s, 4H), 3.85 (s, 6H), 2.10 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.26, 159.15, 145.24, 131.18, 109.17, 104.14, 71.69, 
63.24, 56.19, 21.13.  
 
HRMS calcd. for C13H17NNaO5
+
 [M+Na]
+
: 290.09989. Found: 290.09973. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)propyl acetate (2.3b) 
Used 1.0 equiv oxidant. Colorless oil. Yield 57%. E/Z = 6.3:1. Rf = 0.4 (Hex/EA=15:1).  
 
IR (KBr) 2919, 2848, 1737, 1595, 1481, 1472, 1433, 1371, 1304, 1257, 1208, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.44 (t, J = 8.5 Hz, 1H), 6.59-6.55 (m, 2H), 
4.62-4.52 (m, 1H), 4.26 (dd, J = 4.8, 2.0 Hz, 2H), 3.84 (s, 6H), 2.09 (s, 3H), 1.34 (d, J = 
6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.09, 158.98, 144.41, 130.80, 109.42, 104.05, 76.36, 
66.41, 56.03, 20.94, 16.47.  
 
HRMS: calcd. for C14H19NO5Na
+
 [M+Na]
+
: 304.11554. Found: 304.11552. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)propane-1,3-diyl diacetate (2.3c) 
Used 1.0 equiv oxidant. Colorless oil. Yield 22%. E/Z = 7.7:1. Rf = 0.2 (Hex/EA=5:1). 
 
IR (KBr) 2940, 2840, 1740, 1595, 1472, 1433, 1368, 1306, 1257, 1229, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.27 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.65 (p, J = 5.2 Hz, 1H), 4.36 (d, J = 5.2 Hz, 4H), 3.84 (s, 6H), 2.09 (s, 6H).  
 
13
C NMR (75 MHz, CDCl3) δ 170.97, 159.23, 145.65, 131.31, 109.12, 104.18, 78.06, 
62.87, 56.18, 21.02.  
 
HRMS: calcd. for C16H21NO7Na
+
 [M+Na]
+
: 362.12102. Found: 362.12119. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)heptyl acetate (2.4b) 
Colorless oil. Yield 86%. E/Z = 5.6:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr) 2933, 2858, 1740, 1595, 1471, 1433, 1367, 1256, 1208, 1114, 1036 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.25 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 
2H), 4.43-4.36 (m, 1H), 4.29 (dd, J = 4.7, 1.5 Hz, 2H), 3.83 (s, 6H), 2.08 (s, 3H), 1.81-
1.69 (m, 1H), 1.67-1.56 (m, 2H), 1.56-1.36 (m, 1H), 1.35-1.24 (m, 4H), 0.89 (t, J = 7.1 
Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.31, 159.13, 144.34, 130.89, 109.67, 104.21, 80.50, 
65.52, 56.17, 32.00, 30.81, 25.16, 22.68, 21.13, 14.19.  
 
HRMS: calcd. for C18H27NO5Na
+
 [M+Na]
+
: 361.18144. Found: 361.18022. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)-4-methylpentyl acetate (2.5b) 
Colorless oil. Yield 72%. E/Z = 5:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr) 2962, 1740, 1595, 1471, 1306, 1256, 1114, 1065, 939, 778 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.47 (td, J = 9.0, 4.9 Hz, 1H), 4.27-4.26 (m, 2H), 3.81 (s, 6H), 2.06 (s, 3H), 1.90-
1.79 (m, 1H), 1.72-1.65 (m, 1H), 1.39-1.32 (m, 1H), 0.95 (d, J = 1.9 Hz, 3H), 0.94 (d, J 
= 2.0 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.15, 158.96, 144.05, 130.72, 109.50, 104.05, 78.67, 
65.76, 55.99, 39.69, 24.47, 23.24, 22.35, 20.96.  
 
HRMS: calcd. C17H26NO5
+
 [M+H]
+
: 324.18110. Found: 324.18039. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)-3-methylbutyl acetate (2.6b) 
Colorless oil. Yield 74%. E/Z = 4.3:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr, mixed isomer) 2962, 1740, 1595, 1471, 1306, 1256, 1114, 1065, 939, 778 cm
-1
.  
Major isomer: 
 
1
H NMR (400 MHz, CDCl3) δ 8.43 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.36-4.32 (m, 1H), 4.29-4.25 (m, 1H), 4.19-4.09 (m, 2H), 3.81 (s, 6H), 2.05 (s, 3H), 
1.03 (d, J = 6.8 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.18, 158.95, 143.96, 130.68, 109.54, 104.06, 85.03, 
63.78, 56.00, 29.15, 20.98, 18.44.  
 
Minor isomer (distinct resonances):   
1
H NMR (400 MHz, CDCl3) δ 7.37 (s, 1H), 3.77 (s, 6H), 2.01 (s, 3H), 0.90 (d, J = 6.9 
Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.02, 157.71, 141.31, 130.33, 103.42, 85.30, 63.99, 
55.60, 29.28, 20.91, 17.80.  
 
HRMS (mixed isomers): calcd. C16H24NO5
+
 [M+H]
+
: 310.16545. Found: 310.16485. 
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(E)-2-cyclohexyl-2-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl acetate (2.7b) 
Colorless oil. Yield 68%. E/Z = 3.7:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr, mixed isomers) 2926, 2851, 1738, 1595, 1471, 1256, 1114, 1046, 939, 778 cm
-
1
.  
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.38-4.34 (m, 1H), 4.29-4.25 (m, 1H), 4.20-4.11 (m, 2H), 3.81 (s, 6H), 2.05 (s, 3H), 
1.80-1.69 (m, 5H), 1.19-1.05 (m, 5H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.20, 158.94, 143.84, 130.66, 109.59, 104.07, 84.44, 
63.76, 56.00, 38.84, 28.81, 28.74, 26.45, 26.22, 26.10, 21.01.  
 
Minor isomer (distinct resonances):  
1
H NMR (400 MHz, CDCl3) δ 7.36 (s, 1H), 3.77 (s, 6H), 2.01 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.04, 157.71, 141.20, 130.33, 109.62, 103.45, 84.91, 
63.96, 55.61, 39.04, 28.72, 28.22, 26.17, 26.07, 20.93.  
 
HRMS (mixed isomers): calcd. C19H28NO5
+
 [M+H]
+
: 350.19675. Found: 350.19603. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)-2-methylpropyl acetate (2.8b) 
Used 1.0 equiv oxidant. Colorless oil. Yield 29%. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr) 2933, 2839, 1740, 1595, 1472, 1433, 1387, 1374, 1256, 1239, 1206, 1177, 1114 
cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.24 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 4.23 (s, 2H), 3.83 (s, 6H), 2.09 (s, 3H), 1.37 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 171.30, 159.17, 143.60, 130.65, 110.25, 104.38, 78.78, 
69.12, 56.19, 23.29, 21.16.  
 
HRMS calcd. for C15H21NO5Na
+
 [M+Na]
+
: 318.13119. Found: 318.13138. 
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(E)-2-(((2,6-dimethoxybenzylidene)amino)oxy)-2-methylpropane-1,3-diyl diacetate 
(2.8c) 
Used 1.0 equiv oxidant. Colorless oil. Yield 21%. E/Z = 5.6:1. Rf = 0.2 (Hex/EA=5:1).  
 
IR (KBr) 2924, 2853, 1740, 1595, 1471, 1433, 1377, 1256, 1113, 1045 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.25 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 
2H), 4.31 (q, J = 11.4 Hz, 4H), 3.83 (s, 6H), 2.09 (s, 6H), 1.40 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.99, 159.23, 144.59, 130.98, 109.73, 104.25, 79.45, 
66.06, 56.16, 21.09, 18.93. 
 
HRMS: calcd. for C17H23NO7Na
+
 [M+Na]
+
: 376.13667. Found: 376.13656. 
 
  
 79 
 
(E)-(1-(((2,6-dimethoxybenzylidene)amino)oxy)cyclohexyl)methyl acetate (2.9b) 
White solid. Yield 44%. E/Z = 3.9:1. Rf = 0.4 (Hex/EA=5:1). Mp. 82-85 
o
C.  
 
IR (KBr, mixed isomers) 2935, 2860, 1740, 1594, 1472, 1432, 1380, 1304, 1255, 1207, 
1114, 1043 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.25 (s, 2H), 3.81 (s, 6H), 2.06 (s, 3H), 2.00-1.82 (m, 2H), 1.70-1.55 (m, 2H), 1.53-
1.22 (m, 6H).  
13
C NMR (100 MHz, CDCl3) δ 171.27, 159.01, 143.43, 130.40, 110.23, 104.26, 79.08, 
68.08, 56.03, 31.24, 25.64, 21.25, 21.02. 
 
Minor isomer (distinct resonances):  
1
H NMR (400 MHz, CDCl3) δ 7.40 (s, 1H), 4.16 (s, 2H), 3.79 (s, 6H), 2.01 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 171.15, 158.02, 140.96, 130.27, 110.29, 103.68, 79.09, 
68.53, 55.74, 31.27, 21.14, 21.06. 
 
HRMS (mixed isomers): calcd. for C18H25NO5Na
+
 [M+Na]
+
: 358.16249. Found: 
358.16282. 
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Trans-2-((((E)-2,6-dimethoxybenzylidene)amino)oxy)cyclopentyl acetate (2.10b) 
Used 3.0 equiv oxidant. Colorless oil. Yield 42%. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr) 2924, 2851, 1735, 1595, 1470, 1433, 1374, 1256, 1208, 1113, 1036 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.27 (t, J =8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 
2H), 5.44-4.96 (m, 1H), 4.92-4.55 (m, 1H), 3.84 (s, 6H), 2.21-2.05 (m, 2H), 2.04 (s, 3H), 
1.93-1.58 (m, 4H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.52, 159.14, 144.77, 130.97, 109.57, 104.17, 87.33, 
79.32, 56.18, 30.86, 29.93, 22.08, 21.47.  
 
HRMS calcd. for C16H21NO5Na
+
 [M+Na]
+
: 330.13119. Found: 330.13092. 
 
This trans stereochemistry is assigned based on 1D nOe and a fact that cleavage of the 
DG to give a known mono-protected-diol
27
.  
Possible transition state of the first trans-activation: 
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Cis/trans-2-((((E)-2,6-dimethoxybenzylidene)amino)oxy)cyclopentane-1,3-diyl 
diacetate (2.10c) 
Used 3.0 equiv oxidant. Colorless oil. Yield 20%. Rf = 0.3 (Hex/EA=5:1).   
 
IR (KBr) 2938, 2848, 1742, 1689, 1595, 1475, 1435, 1373, 1305, 1257, 1114 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 7.26 (t, J = 8.4 Hz, 1H), 6.56 (d, J = 8.4 Hz, 
2H), 5.44-5.34 (m, 2H), 4.85-4.78 (m, 1H), 3.84 (s, 6H), 2.37-2.14 (m, 2H), 2.07 (s, 3H), 
2.04 (s, 3H), 1.92-1.75 (m, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.23, 169.95, 159.01, 145.05, 130.92, 109.23, 103.98, 
84.40, 76.74, 73.11, 55.99, 27.18, 26.43, 20.94, 20.84.  
 
HRMS calcd. for C18H23NO7Na
+
 [M+Na]
+
: 388.13667. Found: 388.13638. 
 
Possible transition state of the second cis-activation: 
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Endo-2-((((E)-2,6-dimethoxybenzylidene)amino)oxy)bicyclo[2.2.1]heptan-1-yl 
acetate (2.11b) 
Colorless oil. Yield 78%. E/Z = 4.2:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr, mixed isomers) 2961, 2838, 1738, 1595, 1471, 1257, 1114, 937, 779 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 7.23 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 5.19-5.16 (m, 1H), 3.82 (s, 6H), 2.28-2.10 (m, 4H), 2.00 (s, 3H), 1.89-1.66 (m, 4H), 
1.38 (dt, J = 13.3, 3.6 Hz, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.56, 159.03, 144.53, 130.51, 109.52, 104.20, 90.07, 
80.88, 56.09, 39.43, 36.29, 33.27, 28.63, 24.39, 22.12.  
 
Minor isomer (distinct resonances):  
1
H NMR (400 MHz, CDCl3) δ 7.41 (s, 1H), 5.08-5.04 (m, 1H), 3.79 (s, 6H), 2.01 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 157.77, 141.70, 103.49, 90.07, 80.88, 55.74.  
 
HRMS (mixed isomers): calcd. C18H24NO5
+
 [M+H]
+
: 334.16545. Found: 334.16481. 
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Exo-2-((((E)-2,6-dimethoxybenzylidene)amino)oxy)bicyclo[2.2.1]heptan-1-yl acetate 
(2.12b) 
Colorless oil. Yield 75%. E/Z = 4.3:1. Rf = 0.4 (Hex/EA=5:1).  
 
IR (KBr, mixed isomers) 2965, 1742, 1594, 1471, 1257, 1114, 943, 778 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.47 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.53 (d, J = 8.4 Hz, 
2H), 4.87-4.85 (m, 1H), 3.83 (s, 6H), 2.16-2.06 (m, 2H), 2.03-1.93 (m, 2H), 1.90 (s, 3H), 
1.81-1.64 (m, 3H), 1.59-1.55 (m, 1H), 1.38-1.29 (m, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.41, 159.00, 143.92, 130.57, 109.40, 103.85, 88.65, 
80.30, 55.83, 38.60, 38.39, 30.39, 29.97, 28.28, 21.41. 
 
Minor isomer (distinct resonances):  
1
H NMR (400 MHz, CDCl3) δ 7.34 (s, 1H), 6.51 (d, J = 8.4 Hz, 2H), 4.77-4.74 (m, 1H). 
3.77 (s, 6H), 1.92 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 170.41, 157.78, 140.99, 130.21, 103.37, 88.51, 80.92, 
55.60, 38.26, 38.13, 30.41, 29.93, 28.12, 21.36.  
 
HRMS (mixed isomers): calcd. C18H24NO5
+
 [M+H]
+
: 334.16545. Found: 334.16435.  
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(R)-1-((1R,2R,3S)-2-((((E)-2,6-dimethoxybenzylidene)amino)oxy)-3-isopropyl 
cyclopentyl)ethyl acetate (2.14) 
White solid. Yield 69%. E/Z = 4.3:1.  Mp. 73-75 
o
C. []D
20
 = +7 º. Rf = 0.4 
(Hex/EA=5:1).  
IR (KBr, mixed isomers) 2956, 1734,1595, 1472, 1256, 1115, 951, 778 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H), 7.19 (t, J = 8.4 Hz, 1H), 6.51 (d, J = 8.4 Hz, 
2H), 4.93 (dq, J = 10.1, 6.2 Hz, 1H), 4.78-4.76 (m, 1H), 3.79 (s, 6H), 1.90 (s, 3H), 1.78-
1.69 (m, 3H), 1.59-1.44 (m, 4H), 1.19 (d, J = 6.2 Hz, 3H), 1.04 (d, J = 6.4 Hz, 3H), 0.86 
(d, J = 6.7 Hz, 3H).  
13
C NMR (100 MHz, CDCl3) δ 170.43, 158.93, 142.22, 130.09, 110.07, 104.06, 84.75, 
71.14, 55.84, 53.70, 50.03, 28.27, 27.58, 25.39, 22.14, 21.92, 21.26, 19.08.  
 
Minor isomer (distinct resonances):  
1
H NMR (400 MHz, CDCl3) δ 7.24 (s, 1H), 6.48 (d, J = 8.4 Hz, 1H), 3.76 (s, 6H), 2.02 
(s, 3H), 1.12 (d, J = 6.2 Hz, 3H), 0.95 (d, J = 6.4 Hz, 3H), 0.78 (d, J = 6.6 Hz, 3H).  
13
C NMR (100 MHz, CDCl3) δ
 
170.24, 157.61, 140.25, 129.89, 109.89, 103.06, 85.02, 
55.47, 52.95, 50.41, 28.01, 27.40, 25.03, 21.99, 21.78, 21.42, 19.02.  
 
HRMS (mixed isomers): calcd. C21H32NO5
+
 [M+H]
+
: 378.22805. Found: 378.22734.  
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Isotope materials syntheses and kinetic isotope effect experiment 
The procedure for preparing compound 2.4a-d: 
 
Magnesium (1.200 g, 50 mmol) was charged in a 2-necked round bottom flask equipped 
with a condenser and a septum, followed by 20 mL dry THF. To this mixture was added 
1,2-dibromoethane (564 mg, 3 mmol) at 60 
o
C. The reaction started to bubble and ceased 
in about 15 min. Then a solution of deuterated methyl iodide (725 mg, 5 mmol) in 10 mL 
THF was added dropwise over 10 min. The reaction was allowed at this temperature for 
additional 0.5 h and cooled down to 0 
o
C. The above Grignard solution was injected into 
a solution of hexanal (500 mg, 5 mmol) in 10 mL dry THF via syringe at 0 
o
C. After 
additional 1 h at this temperature, the reaction was quenched by 20 mL NH4Cl saturated 
aqueous solution, extracted with EA (10 mL × 3), combined organic layers were dried 
over Na2SO4. The solvent was removed under reduced pressure, and the residue was 
purified by flash column chromatography on silica gel (Hex/EA= 10:1) to give 246 mg 
2.S4-d as a colorless oil, 41% yield.  Rf = 0.2 (Hex/EA = 10:1).  
 
IR (KBr) 3440, 2956, 2931, 2860, 1732, 1467, 1177 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 3.77 (s, 1H), 1.61-1.27 (m, 9H), 0.87 (t, J = 6.8 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 68.03, 39.24, 31.82, 25.41, 22.61, 14.01. 
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Followed the general procedure to prepare compound 2.4a-d: 
 
 
 
2.S4a-d: Colorless oil. Yield 65%. Rf = 0.3 (Hex/EA=10:1).  
IR (KBr) 2930, 2860, 1789, 1734, 1467, 1376, 1188, 1122, 1082, 977, 878, 700, 519 cm
-
1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.86-7.82 (m, 2H), 7.77-7.72 (m, 2H), 4.37 (t, J = 6.3 Hz, 
1H), 1.85-1.76 (m, 1H), 1.64-1.55 (m, 1H), 1.52-1.44 (m, 2H), 1.38-1.25 (m, 4H), 0.92-
0.88 (m, 3H).  
 
13
C NMR (100 MHz, CDCl3) 164.35, 134.46, 128.97, 123.50, 84.33, 34.74, 31.76, 24.91, 
22.52, 14.07.  
 
HRMS: calcd. C15H16D3NO3Na
+
 [M+Na]
+
: 287.14509. Found: 287.14421. 
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2.4a-d: Colorless oil. Yield 84%. Rf = 0.5 (Hex/EA=5:1).  
 
IR (KBr) 2931, 2858, 1595, 1470, 1432, 1256, 1114, 941 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.22 (t, J = 8.4 Hz, 1H), 6.54 (d, J = 8.4 Hz, 
2H), 4.31 (t, J = 6.1 Hz, 1H), 3.82 (s, 6H), 1.77-1.69 (m, 1H), 1.54-1.27 (m, 7H), 0.88 (t, 
J = 7.0 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.89, 143.08, 130.41, 109.98, 104.03, 78.87, 56.10, 
35.70, 31.99, 25.10, 22.61, 14.09. 
 
HRMS: calcd. C16H23D3NO3
+
 [M+H]
+
: 283.21010. Found: 283.20950. 
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Kinetic isotope effect experiment: 
 
Pd(OAc)2 (4.4 mg, 0.02 mmol, 10 mol %), iodosobenzene diacetate (32 mg, 0.1 mmol, 
0.5 equiv) were charged in a 2 mL scintillation vial, followed by 2.4a (28 mg, 0.1 mmol, 
0.5 equiv), 2.4a-d (28 mg, 0.1 mmol, 0.5 equiv), 1 mL AcOH and 20 L Ac2O. The vial 
was tightly capped and stirred at 100 
o
C for 1 h. The mixture was directly purified by 
flash column chromatography on silica gel (Hex/EA= 15:1). A broad range around the 
product was collected to give 25 mg product as yellow oil. 
1
H NMR analysis of this crude 
showed that when the integral of OAc group (2.06 ppm) was set to 3, the adjacent CH2 
(4.32-4.22 ppm) integral was 1.54. Thus, the KIE number is determined as 3.35. 
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Removal of directing groups and hydrolysis of acetic esters. 
 
To a solution of 2.4b (220 mg, 0.65 mmol, 1 equiv) in 7.5 mL AcOH-THF-Water (3:1:1), 
Zinc powder (390 mg, 6 mmol, 9.2 equiv) was added in portion at room temperature. 
Then the mixture was stirred at 60 
o
C. The reaction was monitored by TLC. After 2 h, the 
mixture was quenched with 20 mL water and extracted with EA (20 mL×3), dried over 
Na2SO4, the solvent was removed under reduced pressure. The residue was purified by 
flash column chromatography on silica gel (Hex/EA 5:1 to 4:1) to give 110 mg 
compound 2.18 as a yellow oil, yield 97%.  
 
IR (KBr) 3435, 2956, 2932, 2860, 1741, 1371, 1240, 1040 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 4.12 (dd, J = 11.4, 3.0 Hz, 1H), 3.94 (dd, J = 11.4, 7.4 Hz, 
1H), 3.86-3.80 (m, 1H), 2.08 (s, 3H), 2.07 (s, 1H), 1.49-1.40 (m, 3H), 1.34-1.23 (m, 5H), 
0.87 (t, J = 6.8 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) 171.38, 69.93, 68.68, 33.19, 31.69, 24.99, 22.50, 20.87, 
13.97.  
 
HRMS: calcd. C9H18O3Na
+
 [M+H]
+
: 197.11536. Found: 197.11474. Match cited 
literature
28
. 
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To a solution of 2.4b (100 mg, 0.29 mmol, 1 equiv) in 2 mL MeOH, K2CO3 (138 mg, 1 
mmol, 3.4 equiv) was added. The reaction was stirred at room temperature, monitored by 
TLC. After 1 h, the solvent was removed under reduced pressure, and the residue was 
purified by flash column chromatography on silica gel (Hex/EA= 5:1) to give 80 mg 
compound 2.17 as white solid, yield 92%. E/Z = 2.7:1.  
 
IR (KBr, mixed isomers) 3430, 2936, 2858, 1596, 1481, 1434, 1259, 1114, 778 cm
-1
.  
 
Major Isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.24 (t, J = 8.4 Hz, 1H), 6.53 (d, J = 8.4 Hz, 
2H), 4.72 (s, 1H), 4.30-4.24 (m, 1H), 3.81 (s, 8H), 1.66-1.56 (s, 1H), 1.52-1.22 (m, 7H), 
0.86 (t, J = 7.0 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.95, 143.57, 131.07, 108.73, 103.85, 83.19, 68.23, 
55.77, 31.80, 30.13, 25.36, 22.52, 14.02.  
 
Minor isomer (distinct resonances): 
1
H NMR (400 MHz, CDCl3) δ 7.40 (t, J = 8.5 Hz, 1H), 3.87 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 162.63, 134.64, 103.37, 56.15.  
 
HRMS (mixed isomers): calcd. C16H26NO4
+
 [M+H]
+
: 296.18618. Found: 296.18582. 
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To a solution of 2.11b (198 mg, 0.59 mmol) in 10 mL AcOH-THF-Water (3:1:1), Zinc 
powder (390 mg, 6 mmol) was added in a portion at room temperature. Then the mixture 
was stirred at 60 
o
C. The reaction was monitored by TLC. After 4 h, the mixture was 
quenched with 20 mL water and extracted with EA (20 mL×3), dried over Na2SO4. The 
solvent was removed under reduced pressure, and the residue was directly used in the 
next step without further purification. To above residue in 1 mL MeOH was added 
K2CO3 (83 mg, 0.6 mmol). The reaction was stirred at room temperature, monitored by 
TLC. After 2 h, the solvent was removed under reduced pressure, and the residue was 
purified by flash column chromatography on silica gel (Hex/EA 2:1 to 1:1) to give 30 mg 
compound 2.19 as white solid, yield 80%. Mp. 213-215 
o
C. Rf = 0.1 (Hex/EA=1:1). 
 
IR (KBr) 3325, 2951, 2870, 1451, 1235, 1137, 1076, 1047, 970, 732, 606 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 4.06 (ddd, J = 10.7, 3.3, 2.4 Hz, 1H), 3.20 (d, J = 22.9 Hz, 
2H), 2.21-2.10 (m, 2H), 2.00 (t, J = 4.6 Hz, 1H), 1.85-1.76 (m, 1H), 1.55-1.46 (m, 3H), 
1.37 (tdd, J = 12.5, 4.3, 2.2 Hz, 1H), 1.13 (dt, J = 13.2, 3.2 Hz, 1H).  
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13
C NMR (100 MHz, CDCl3) δ 84.97, 75.09, 42.37, 38.70, 33.68, 30.32, 25.94.  
 
HRMS: calcd. C7H12O2Na
+
 [M+Na]
+
: 151.07350. Found: 151.07277. 
2.12b was obtained by following the two-step procedure to give compound 2.20 as white 
solid in 82% yield. Mp. 164-166 
o
C.   
 
IR (KBr) 3370, 2957, 2872, 1307, 1224, 1170, 11121, 1079, 1045 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 3.57 (d, J = 6.8 Hz, 1H), 2.54 (b, 2H), 2.04-2.02 (m, 1H), 
1.87 (ddd, J = 13.4, 6.9, 2.3 Hz, 1H), 1.81-1.59 (m, 3H), 1.54-1.49 (m, 1H), 1.31-1.22 
(m, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 83.30, 73.96, 41.51, 38.79, 32.16, 30.41, 29.72.  
 
HRMS: calcd. C7H12O2Na
+
 [M+Na]
+
: 151.07350. Found: 151.07288. 
 
Both 2.12a and 2.12b match cited literature
21
. 
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X-Ray data for compound 2.9b, 2.13 and 2.14. 
X-ray structure of compound 2.9b: 
 
 
 
Table 2.4.  Crystal data and structure refinement for 2.9b. 
Empirical formula     C18 H25 N O5 
Formula weight     335.39 
Temperature      100(2) K 
Wavelength      0.71075 Å 
Crystal system     Orthorhombic 
Space group      Pca21 
Unit cell dimensions    a = 29.976(4) Å  
      b = 7.7137(11) Å  
      c = 7.5088(10) Å  
Volume     1736.2(4) Å3 
Z      4 
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Density (calculated)    1.283 Mg/m3 
Absorption coefficient   0.093 mm-1 
F(000)      720 
Crystal size     0.21 x 0.19 x 0.01 mm3 
Theta range for data collection  3.03 to 25.00°. 
Index ranges     -35<=h<=35, -9<=k<=8, -7<=l<=8 
Reflections collected    10288 
Independent reflections   1620 [R(int) = 0.1600] 
Completeness to theta = 25.00°  98.0 %  
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission   1.00 and 0.310 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   1620 / 1 / 220 
Goodness-of-fit on F2    1.190 
Final R indices [I>2sigma(I)]   R1 = 0.0970, wR2 = 0.2167 
R indices (all data)    R1 = 0.1412, wR2 = 0.2449 
Largest diff. peak and hole   0.375 and -0.349 e.Å-3 
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X-ray structure of compound 2.13: 
 
 
Table 2.5.  Crystal data and structure refinement for 2.13. 
Empirical formula     C19 H29 N O3 
Formula weight     319.43 
Temperature      100(2) K 
Wavelength      0.71075 Å 
Crystal system     Monoclinic 
Space group      P21 
Unit cell dimensions    a = 6.8937(12) Å  
      b = 15.987(3) Å  
      c = 16.978(3) Å  
Volume     1830.8(6) Å3 
Z      4 
Density (calculated)    1.159 Mg/m3 
Absorption coefficient   0.077 mm-1 
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F(000)      696 
Crystal size     0.30 x 0.10 x 0.02 mm 
Theta range for data collection  3.02 to 27.50°. 
Index ranges     -8<=h<=8, -20<=k<=20, -21<=l<=22 
Reflections collected    33914 
Independent reflections   4324 [R(int) = 0.1207] 
Completeness to theta = 27.50°  99.6 %  
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission   1.00 and 0.390 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   4324 / 1 / 425 
Goodness-of-fit on F2    1.107 
Final R indices [I>2sigma(I)]   R1 = 0.0669, wR2 = 0.1347 
R indices (all data)    R1 = 0.0940, wR2 = 0.1472 
Largest diff. peak and hole   0.247 and -0.247 e.Å-3 
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X-ray structure of compound 2.14: 
 
Table 2.6.  Crystal data and structure refinement for 2.14. 
Empirical formula     C21 H31 N O5 
Formula weight     377.47 
Temperature      100(2) K 
Wavelength      0.71075 Å 
Crystal system     Monoclinic 
Space group      P21 
Unit cell dimensions    a = 13.5787(15) Å  
      b = 5.2656(8) Å  
      c = 14.435(2) Å  
Volume     1031.7(2) Å3 
Z      2 
Density (calculated)    1.215 Mg/m3 
Absorption coefficient   0.086 mm-1 
F(000)      408 
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Crystal size     0.26 x 0.07 x 0.04 mm 
Theta range for data collection  3.00 to 27.48°. 
Index ranges     -17<=h<=17, -6<=k<=6, -18<=l<=18 
Reflections collected    19263 
Independent reflections   2610 [R(int) = 0.0644] 
Completeness to theta = 27.48°  99.8 %  
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission   1.00 and 0.729 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   2610 / 1 / 250 
Goodness-of-fit on F2    1.107 
Final R indices [I>2sigma(I)]   R1 = 0.0484, wR2 = 0.1113 
R indices (all data)    R1 = 0.0568, wR2 = 0.1151 
Largest diff. peak and hole   0.214 and -0.272 e.Å-3 
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CHAPTER 3:  PALLADIUM-CATALYZED ORTHO-
ACETOXYLATION OF MASKED BENZYL ALCOHOLS VIA AN 
EXO-DIRECTING MODE 
3.1 Introduction 
Directing strategy has been widely applied to control the site-selectivity in 
transition metal (TM)-catalyzed aromatic C−H bond activation for various carbon-
heteroatom bond formation reactions.
1
 For nitrogen based directing groups (DGs), the 
endo-directing strategy has been studied and utilized by many other groups.
2
 Our group 
has come up with a novel exo-directing strategy for C−H bonds activation for carbon-
oxygen bonds formation.
3
 The ring size for the exo-directing strategy is a six-membered 
metallocycle instead of five-memebered metallocycle (Scheme 3.1). 
Scheme 3.1. Different directing modes in aromatic palladation.   
 
The pioneer DGs, such as pyridine, generally requires harsh conditions to remove, 
while that would limit the application of those methods.
4
 Therefore, many efforts were 
attempted to utilize advanced DG, which should be easy to remove or even through 
temporary functional groups.
5
 Considered the prevalence of hydroxyl groups in bioactive 
compounds, e.g. Salbutamol (anti-asthma) and Simocyclinone D8 (antibiotic),
6
 the 
alcohols or masked alcohols based directing strategies would provide rapid access to 
functionalize the C−H bonds in late stage. As demonstrated by few established examples 
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in this area, the elimination of hydroxyl group is one of the obstacles in the development 
of alcohol-based DGs for oxidation of C−H bonds.7 
3.2 Background 
Among various oxidation methods of aromatic C−H bonds at ortho position have 
been achieved, only two methods were developed using free or masked alcohols as DGs. 
In 2008, Yu developed a synthesis of dihydrobenzofurans via free alcohol-directed 
intramolecular C−H cyclization (Scheme 3.2.A).7 This method works well on tertiary 
alcohol substrates, but the secondary alcohol suffers from lower yield and side reaction. 
Later, Hartwig and coworkers reported an Ir-catalyzed ortho-silylation of aromatic C−H 
bond, and after the Tamao-Fleming oxidation step, the C−Si bond was transferred into a 
C−O bond. (Scheme 3.2.B).8  
Scheme 3.2. Alcohol or masked alcohol-directed arene C−H oxidation. 
 
Oxime has been documented as a ligand for Pd and Pt since 1970,
9
 while the 
catalytic aliphatic and aromatic C−H oxidation reactions were developed by Sanford and 
coworkers in 2006 and 2008 respectively.
2, 4a
 Especially, from a mechanistic point of 
view, there was one example of using 2-heptanone oxime as DG for directed ortho-arene 
oxidation.
10
 In 2012, the catalytic activation of an aliphatic C−H bond to form the C-O 
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bonds at β-position of the masked alcohol was developed by our group, in which the use 
of a 2,6-dimethoxylbenzaldoxime as the DG was found efficient.
3
 We hypothesized that 
this special aldoxime DG has an advantageous for aromatic C−H oxidation, because 1) 
the potential oxidation of DG would be avoided, as the ketoximes would have acidic -
hydrogens that are known to be oxidized under strong oxidative conditions;
11
 2) the weak 
chelation from the methoxy groups on the DG could enhance the catalyst stability during 
the catalytic cycle to give a higher catalyst turnover.  
 
3.3 Reaction development and scope 
The substrate 3.1a was used as the standard substrate to test our hypothesis. After 
a series of optimizations, when using 1 mol % Pd(OAc)2 as the catalyst and 1.3 equiv of 
PhI(OAc)2 as the oxidant in AcOH/Ac2O (5:1) at 100 
o
C, the desired ortho-acetoxylated 
product (3.1b) was isolated in 87 % yield (Table 3.1). A series of control experiments 
were conducted to gain further insights into this reaction. No desired product was 
observed without the Pd catalyst or the oxidant (entry 2 and 3). A 10 mol % catalyst 
loading gave a faster reaction but a lower yield (entry 4), which is due to the elimination 
of aldoxime in the presence of Pd catalyst. In the absence of Ac2O, the yield was 
decreased dramatically, suggesting that water might hamper the reaction (entry 5).
12
 
Other metal salts, such as Co(II) or Ag(I) acetate, did not give any desirable products 
under these conditions (entry 6 and 7). When K2S2O8 was used as the oxidant, the yield 
was decreased to only 30 % (entry 8). However, the addition of a catalytic amount of 
PhI(OAc)2 or PhI (10 mol %) along with K2S2O8 increased the yield to 79 % and 72 % 
respectively (entries 9 and 10). Presumably, under these conditions, the more effective 
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oxidant, PhI(OAc)2, was generated in situ from a more practical oxidant.
13
 Moreover, by 
using 2.5 equiv of K2S2O8, the isolated yield can reach 85 % (entry 11).  
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Table 3.1. Selected Optimization of Reaction Conditions.  
 
Three general ways are developed to prepare the benzyl alcohol-derived oxime 
substrates to test the substrate scope. The first protocol is the previously demonstrated 
procedure, through a Mitsunobu reaction between the corresponding alcohol and hydroxy 
phthalimide followed by a one-pot deprotection/condensation.
3a
 The second is via an SN2 
reaction between the corresponding benzyl halides and 2,6-dimethoxybenzaldoxime. 
Alternatively, by adopting Ellman’s oxaziridine,14 the oxime substrates can be prepared 
in one-pot from the corresponding benzyl alcohols via electrophilic amination followed 
by condensation.  
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Scheme 3.3. The scope with primary alcohol-derived substrates. 
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Scheme 3.4. The scope with secondary alcohol-derived substrates.  
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The results with masked primary benzyl alcohol substrates were shown in Table 
3.2. Benzylic alcohols with various electronic and steric properties all reacted to give the 
ortho-acetoxylation, in the present of just 1 mol % catalyst loading, the corresponding 2-
hydroxymethylphenol derivatives can be isolated in good to excellent yields. A number 
of FGs can be tolerated, including aryl bromides and chlorides, trifluoromethyl, anisole, 
naphthalene, and esters. Mono-oxidation can be achieved when there is an ortho- or 
meta-substituent. While bis-oxidation was observed when possible, the isolation of 
products is easy, due to their significant difference of polarity introduced by acetate 
groups. Moreover, by controlling the loading of the catalyst and oxidant, the mono-
oxidation product can also be obtained with a good selectivity (Scheme 3.5). In addition, 
a lower reaction temperature (e.g. 80 °C) can be used to enhance the regioselectivity. 
Notably, with the sterically hindered substrates, such as 3.10a, the oxidation occurs 
selectively at ortho position.  
The masked secondary alcohol-derived substrates were subsequently examined 
(Scheme 3.4). Either acyclic or cyclic benzyl alcohols gave the desired ortho-oxidation 
products in good to excellent yields. While the substrates contain β-aliphatic C−H bonds 
that are available for the Pd-catalyzed vicinal oxidation,
3, 15 
only a small amount of the 
sp
3
 C−H activation product (7.5 % yield) was observed in substrate 3.12a along with an 
87 % yield on the aromatic oxidation. Obviously, the aromatic C−H functionalization is 
much more favorable. Both the -tetralol (3.17b) and 1-indanol (3.18b) derived oximes 
proved to be excellent substrates. It is exciting to find that the 9-fluorenol-derived 
substrate gave the desired 1,8-di-O-substituted product 3.19b in almost a quantitative 
yield, which is difficult to prepare by other means.
16
 In the case of the diphenylmethanol 
substrate, by choosing different amounts of oxidants, mono- to tetra-acetoxylated 
products 20b-e can be formed with different selectivity. It is noteworthy that the second 
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oxidation took place on the other phenyl group. The fourth oxidation was much slower 
which could be the result of a higher rotation barrier, and all these products can be easily 
separated.  
Scheme 3.5. Reaction TON test and mono-oxidation.  
 
Figure 3.1. Isolation of Palladacycle 3.19c. 
 
As shown in scheme 3.5, the turnover number (TON) of the catalyst was 
examined with substrate 3.19a. Indeed, using our 2,6-dimethoxyl benzaldoxime DG, the 
TON can reach 1700 for each acetoxylation with 0.1 mol % of the catalyst. By using a 
lower catalyst loading (0.06 mol %) and less oxidant, the mono-oxidation product 3.8b 
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can be selectively obtained with 600 TON with Pd(OAc)2 catalyst (Scheme 3.5). The 
coordination mode of the DG during the C−H activation step was investigated by 
obtaining a palladacycle intermediate for substrate 3.19a (Figure 3.1). After HCl workup, 
the palladium chloride species as a mononuclear pseudo-square planar exo-palladacycle 
3.19c was obtained and confirmed by X-ray crystallography. The high catalyst turnover 
of this reaction is presumably due to the chelation of the methoxy group as a weak ligand 
to further stabilize the palladacycle. 
Scheme 3.6. Cleavage of the Directing Group 
 
There are two strategies that have been demonstrated to remove the DG through 
either N−O bond or C−O bond cleavage (Scheme 3.6). As our established method, the 
N−O bond of the oximes was selectively cleaved using inexpensive zinc metal.17 It is 
interesting to know that, after the N-O bond cleavage, a free phenol was obtained through 
transesterification of the resulting benzyl alcohol from 3.1b, while an orthoacetate 3.23 
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was obtained for substrate 3.16b. On the other hand, a Pd-catalyzed hydrogenolysis can 
be applied to the benzyl C−O bond cleavage.18 As the oxime substrates can be ultimately 
synthesized from the corresponding benzylic halides followed by an SN2 reaction, this 
approach can provide the highly substituted phenols in a traceless fashion. 
3.4. Conclusion 
In conclusion, a Pd-catalyzed ortho-acetoxylation of masked benzyl alcohols has 
been developed, and the exo-directing strategy can be extended to aromatic C−H 
functionalization. A variety of 2-hydroxyalkyl phenol derivatives can be synthesized in 
good to excellent yields under optimized condition. The methoxy group on the 2,6-
dimethoxybenzaldoxime has been proved to be important during the C−H activation step. 
The DG can be removed either by N-O bond to provide the benzyl alcohols, or in a 
traceless fashion to give highly substituted phenols. 
3.5. Experiment Results 
3.5.1 GENERAL CONSIDERATION 
Unless otherwise noted, all experiments were carried out under air atmosphere. 
Tetrahydrofuran (THF) were distilled over sodium. The other reagents and solvents were 
directly used from the supplier without further purification unless noted. Analytical thin-
layer chromatography (TLC) was carried out using 0.2 mm commercial silica gel plates 
(silica gel 60, F254, EMD chemical). The vials (1 dram, 15×45 mm with PTFE-lined cap 
attached) were purchased from Qorpak and dried in an oven overnight and cooled in air. 
Infrared spectra were recorded on a Nicolet iS5 FT-IR Spectrometer using neat thin film 
technique. High-resolution mass spectra (HRMS) were obtained on a Karatos MS9 and 
are reported as m/z (relative intensity). Accurate masses are reported for the molecular 
ion [M+Na]
+
 or [M+H]
+
. Nuclear magnetic resonance spectra (
1
H NMR and 
13
C NMR) 
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were recorded with Varian Gemini (400 MHz, 
1
H at 400 MHz, 
13
C at 100 MHz). For 
CDCl3 solutions, the chemical shifts are reported as parts per million (ppm) referenced to 
residual protium or carbon of the solvents; CHCl3  H (7.26 ppm) and CDCl3  C (77.16 
ppm). Coupling constants are reported in Hertz (Hz). Data for 
1
H NMR spectra are 
reported as follows: chemical shift (ppm, referenced to protium; s = singlet, d = doublet, t 
= triplet, q = quartet, p = pentet (quintet), dd = doublet of doublets, td = triplet of 
doublets, ddd = doublet of doublet of doublets, m = multiplet, coupling constant (Hz), 
and integration). 
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3.5.2 GENERAL PROCEDURE AND CHARACTERIZATION 
General procedure for oxime substrates with three approaches 
 
General procedure for method A: 
 
3,3’-Di-tert-butyl oxziridine was prepared according to the modified Ellman’s procedure, 
and the amination procedure was adopted from the Ellman’s publication.14 
To a suspension of KH (1.5 equiv) and 18-crown-6 (0.1 equiv) in DMPU (3ml/1mmol 
alcohol) was added the alcohol (1.0 equiv) under a nitrogen atmosphere at room 
temperature. After stirring at room temperature for 1h and no gas evolution was 
observed, the resulting solution was slowly added into a DMPU solution (1.5ml/1mmol 
alcohol) of 3,3’-di-tert-butyl oxziridine (2.5 equiv) at -40 °C. The reaction was then 
warmed to room temperature and stirred for another 1.5 h. Several drops of HOAc were 
added in, followed by the addition of 2,6-dimethoxy benzaldehyde (1.3 equiv). The 
mixture was stirred for 0.5 h and then diluted with 1M NaOH, extracted with EtOAc and 
washed with water and brine. The combined organic extracts were dried over Na2SO4 and 
concentrated under reduced pressure. The desired compound was purified by flash 
column chromatography on silica gel. All the yields are not optimized. 
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General procedure for method B: 
 
Step 1: To a solution of the alcohol (10 mmol, 1.0 equiv), N-hydroxy phthalimide 
(1.956g, 12 mmol, 1.2 equiv) and PPh3 (3.144 g, 12 mmol, 1.2 equiv) in 20 mL THF was 
added diisopropyl azodicarboxylate (2.4 mL, 12 mmol, 1.2 equiv) dropwise at 0 °C. The 
reaction was then allowed to warm to room temperature and stirred overnight. After the 
reaction is finished, hexanes were added, and the precipitation was collected and directly 
used in the next step without further purification. 
Step 2: To a solution of N-alkoxy phthalimide (1.1 equiv) in DCM/MeOH=1:1 (10 
mL/mmol) was added hydrazine monohydrate (1.15 equiv) at room temperature. The 
reaction was monitored by TLC and usually completed in 20 min. The 2,6-
demethoxybenzaldehyde (1.0 equiv) was then added. The reaction was monitored by 
TLC. After 0.5 h the solvent was removed under reduced pressure. The desired oxime 
product was purified by flash column chromatography on silica gel. All the yields are 
not optimized. 
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General procedure for method C: 
2,6-dimethoxy benzaldehyde oxime was prepared according to the literature procedure.
19
 
 
In a pre-dried flask, 2,6-dimethoxy benzaldehyde oxime (1.25 equiv) and sodium hydride 
(1 equiv) was added, followed by addition of DMF (2mL/1mmol). After 0.5 h, the 
corresponding benzyl bromide was added and heated to 80
o
C overnight. After the 
reaction was complete, the reaction mixture was diluted by EA and washed with excess 
water and brine. The desired compound was purified by flash column chromatography 
(15:1 to 5:1 Hexanes: EA) on silica gel. All the yields are not optimized. 
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(E)-2,6-dimethoxybenzaldehyde O-(2-methylbenzyl) oxime (3.1a) 
White solid. General Method B: yield 80%. General Method C: yield 74%. E/Z > 19:1. 
Mp. 71-72 
o
C. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 3005, 2937, 2838, 1595, 1578, 1469, 1432, 1255 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.43 (d, J = 7.3 Hz, 1H), 7.27 (t, J = 8.4 Hz, 
1H), 7.21 (dd, J = 4.0, 3.1 Hz, 2H), 6.57 (d, J = 8.4 Hz, 2H), 5.27 (s, 2H), 3.84 (s, 6H), 
2.43 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.17, 144.71, 137.24, 135.72, 130.99, 130.27, 129.59, 
128.14, 125.91, 109.45, 104.18, 74.37, 56.19, 19.23.  
 
HRMS calcd. for C17H19NO3
+
 [M+H]
+
: 286.1438. Found: 286.1440. 
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(E)-2,6-dimethoxybenzaldehyde O-(2-bromobenzyl) oxime (3.2a) 
White solid. General Method B: yield 84%. E/Z > 19:1. Mp. 91-92 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 2937, 2837, 1595, 1470, 1432, 1360, 1256, 1208 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.58 (s, 1H), 7.62 – 7.52 (m, 2H), 7.32 (td, J = 7.5, 1.2 Hz, 
1H), 7.27 (t, J = 8.4 Hz, 1H), 7.15 (ddd, J = 8.0, 7.4, 1.7 Hz, 1H), 6.57 (d, J = 8.4 Hz, 
2H), 5.34 (s, 2H), 3.84 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.16, 145.20, 137.66, 132.57, 131.13, 129.92, 129.02, 
127.31, 122.95, 109.28, 104.15, 75.19, 56.19.  
 
HRMS calcd. for C16H17BrNO3
+
 [M+H]
+
: 350.0386. Found: 350.0387. 
 
  
 165 
 
(E)-2,6-dimethoxybenzaldehyde O-(3-methoxybenzyl) oxime (3.3a) 
Colorless oil. General Method C: yield 82%. E/Z > 19:1. Rf = 0.45 (Hex/EA=3:1).  
 
IR 3002, 2938, 2837, 1595, 1470, 1432, 1360, 1340, 1307, 1286, 1186 (KBr) cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.54 (s, 1H), 7.31 – 7.24 (m, 2H), 7.07 – 7.03 (m, 2H), 
6.86 (ddd, J = 8.3, 2.5, 1.1 Hz, 1H), 6.57 (d, J = 8.4 Hz, 2H), 5.24 (s, 2H), 3.84 (s, 6H), 
3.82 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.68, 159.09, 144.86, 139.40, 131.00, 129.40, 120.78, 
113.84, 113.55, 109.32, 104.11, 75.95, 56.11, 55.28.  
 
HRMS calcd. for C17H20NO4
+
 [M+H]
+
: 302.1387. Found: 302.1391. 
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(E)-2,6-dimethoxybenzaldehyde O-(3-bromobenzyl) oxime (3.4a) 
Colorless oil. General Method C: yield 73%. E/Z > 19:1. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 3003, 2936, 2837, 1595, 1571, 1470, 1431, 1257, 1270, 1114 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.66 (t, J = 1.7 Hz, 1H), 7.46 – 7.40 (m, 1H), 
7.37 (d, J = 7.7 Hz, 1H), 7.30 – 7.19 (m, 2H), 6.56 (dd, J = 8.4, 3.3 Hz, 2H), 5.21 (s, 2H), 
3.83 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.04, 145.06, 140.41, 131.41, 131.09, 130.75, 129.90, 
126.89, 122.40, 109.08, 104.04, 74.97, 56.09.  
 
HRMS calcd. for C16H16BrNO3Na
+
 [M+Na]
+
: 372.0206. Found: 372.0203. 
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(E)-2,6-dimethoxybenzaldehyde O-(3-(trifluoromethyl)benzyl) oxime (3.5a) 
White solid. General Method C: yield 77%. E/Z > 19:1. Mp. 74-77 
o
C. Rf = 0.65 
(Hex/EA=3:1).  
 
IR (KBr) 3006, 2962, 2939, 2840, 1596, 1471, 1433, 1363, 1329, 1285, 1258 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.75 (s, 1H), 7.65 – 7.61 (m, 1H), 7.56 (d, J = 
7.8 Hz, 1H), 7.48 (t, J = 7.7 Hz, 1H), 7.27 (t, J = 8.4 Hz, 1H), 6.57 (d, J = 8.4 Hz, 2H), 
5.28 (s, 2H), 3.83 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.23, 145.36, 139.27, 131.71 (d, J = 1.2 Hz), 131.21, 
130.76 (q, J = 32.2 Hz), 128.83, 125.24 (q, J = 3.8 Hz), 124.59 (q, J = 3.8 Hz), 124.36 (q, 
J = 272.2 Hz), 109.27, 104.22, 75.13, 56.17.  
 
HRMS calcd. for C17H17F3NO3
+
 [M+H]
+
: 340.1155. Found: 340.1158. 
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(E)-2,6-dimethoxybenzaldehyde O-(3,4-dichlorobenzyl) oxime (3.6a) 
White solid. General Method B: yield 81%. E/Z > 19:1. Mp. 61-63 
o
C. Rf = 0.45 
(Hex/EA=3:1).  
 
IR (KBr) 3004, 2937, 2838, 1595, 1470, 1432, 1398, 1257, 1114 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.50 (s, 1H), 7.59 (d, J=2.0, 1H), 7.42 (d, J=8.2, 1H), 7.30 
– 7.25 (m, 2H), 6.56 (d, J=8.4, 2H), 5.16 (d, J=0.6, 2H), 3.84 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.15, 145.37, 138.58, 132.39, 131.69, 131.26, 130.45, 
130.33, 127.70, 109.08, 104.13, 74.41, 56.18.  
 
HRMS calcd. for C16H16Cl2NO3
+
 [M+H]
+
: 340.0502. Found: 340.0502. 
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(E)-2,6-dimethoxybenzaldehyde O-naphthalen-1-ylmethyl oxime (3.7a) 
White solid. General Method B: yield 90%. E/Z > 19:1. Mp. 129-131 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 3005, 2937, 2837, 1595, 1470, 1257, 1113, 1028 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.56 (s, 1H), 8.23 (dd, J = 8.5, 0.9 Hz, 1H), 7.91 – 7.81 
(m, 2H), 7.65 – 7.61 (m, 1H), 7.58 – 7.44 (m, 3H), 7.25 (dd, J = 11.0, 5.8 Hz, 1H), 6.55 
(d, J = 8.4 Hz, 2H), 5.72 (s, 2H), 3.83 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.15, 144.91, 133.83, 133.32, 132.06, 131.03, 128.88, 
128.57, 127.44, 126.31, 125.80, 125.40, 124.45, 109.34, 104.14, 74.46, 56.15.  
 
HRMS calcd. for C20H19NO3Na
+
 [M+Na]
+
: 344.1257. Found: 344.1258. 
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(E)-2,6-dimethoxybenzaldehyde O-benzyl oxime (3.8a) 
Colorless oil. General Method B: yield 93%. E/Z > 19:1. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 3062, 3004, 2937, 2838, 1595, 1496, 1470, 1432, 1366, 1342 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.50 – 7.45 (m, 2H), 7.41 – 7.35 (m, 2H), 
7.35 – 7.29 (m, 1H), 7.27 (t, J=8.4, 1H), 6.57 (d, J=8.4, 2H), 5.26 (s, 2H), 3.84 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.03, 144.71, 137.78, 130.94, 128.55, 128.33, 127.81, 
109.28, 104.06, 76.04, 56.06.  
 
HRMS calcd. for C16H17NO3Na
+
 [M+Na]
+
: 294.1101. Found: 294.1114. 
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(E)-2,6-dimethoxybenzaldehyde O-(4-isopropylbenzyl) oxime (3.9a) 
Colorless oil. General Method B: yield 92%. E/Z > 19:1. Mp. 41-44 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 3006, 2959, 2869, 2838, 1595, 1578, 1469, 1432, 1255, 1208 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.41 (d, J = 8.1 Hz, 2H), 7.30 – 7.22 (m, 3H), 
6.57 (d, J = 8.4 Hz, 2H), 5.22 (s, 2H), 3.85 (s, 6H), 2.99 – 2.86 (m, 1H), 1.32 – 1.19 (m, 
6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.14, 148.67, 144.71, 135.08, 130.95, 128.89, 126.53, 
109.49, 104.16, 76.10, 56.17, 34.05, 24.15.  
 
HRMS calcd. for C19H24NO3
+
 [M+H]
+
: 314.1751. Found: 314.1752. 
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(E)-2,6-dimethoxybenzaldehyde O-(3,5-dimethylbenzyl) oxime (3.10a) 
White solid. General Method C: yield 75%. E/Z > 19:1. Mp. 58-60 
o
C. Rf = 0.5 
(Hex/EA=3:1). 
 
IR (KBr) 3004, 2937, 2838, 1595, 1470, 1432, 1356, 1257, 1207, 1113, 1034 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H), 7.27 (t, J = 8.4 Hz, 1H), 7.10 (dd, J = 1.0, 0.5 
Hz, 2H), 6.96 (s, 1H), 6.57 (d, J = 8.4 Hz, 2H), 5.18 (s, 2H), 3.85 (s, 6H), 2.34 (d, J = 0.6 
Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.15, 144.76, 137.97, 137.46, 130.96, 129.61, 126.59, 
109.49, 104.16, 76.33, 56.18, 21.42.  
 
HRMS calcd. for C18H22NO3
+
 [M+H]
+
: 300.1594. Found: 300.1598. 
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Methyl (E)-4-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)benzoate (3.11a) 
White solid. General Method C: yield 82%. E/Z > 12:1. Mp. 71-73 
o
C. Rf = 0.3 
(Hex/EA=3:1).  
 
IR (KBr) 2949, 2839, 1720, 1595, 1471, 1433, 1279, 1257, 1209, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 8.01 (dq, J=8.2, 1.8, 2H), 7.54 – 7.46 (m, 
2H), 7.28 – 7.20 (m, 1H), 6.53 (d, J=8.4, 2H), 5.27 (s, 2H), 3.88 (s, 3H), 3.80 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 167.06, 159.08, 145.13, 143.41, 131.14, 129.64, 129.38, 
127.99, 109.12, 104.09, 75.20, 56.11, 52.14.  
 
HRMS calcd. for C18H20NO5
+
 [M+H]
+
: 330.1336. Found: 330.1339. 
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(E)-2,6-dimethoxybenzaldehyde O-(1-(o-tolyl)ethyl) oxime (3.12a) 
Colorless oil. General Method B: yield 78%. E/Z > 19:1. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 2973, 2935, 2837, 1595, 1470, 1432, 1306, 1285, 1257, 1207 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.51 – 7.46 (m, 1H), 7.26 – 7.13 (m, 4H), 
6.55 (d, J=8.4, 2H), 5.64 (q, J=6.5, 1H), 3.80 (s, 6H), 2.43 (s, 3H), 1.63 (d, J=6.6, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.08, 144.14, 141.38, 135.33, 130.73, 130.33, 127.17, 
126.06, 109.89, 104.27, 77.63, 56.14, 21.02, 19.40.  
 
HRMS calcd. for C18H21NO3Na
+
 [M+Na]
+
: 322.1414. Found: 322.1414. 
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(E)-2,6-dimethoxybenzaldehyde O-(1-(m-tolyl)ethyl) oxime (3.13a) 
Colorless oil. General Method B: yield 67%. E/Z > 19:1. Mp. 41-44 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 2973, 2934, 2837, 1595, 1432, 1368, 1341, 1306, 1257, 1207 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.47 (s, 1H), 7.28 – 7.21 (m, 4H), 7.12 – 7.07 (m, 1H), 
6.55 (t, J = 5.7 Hz, 2H), 5.38 (q, J = 6.6 Hz, 1H), 3.79 (s, 6H), 2.37 (s, 3H), 1.63 (d, J = 
6.6 Hz, 3H). 
 
13
C NMR (100 MHz, CDCl3) δ 159.10, 144.18, 143.28, 137.82, 130.73, 128.22, 128.17, 
127.46, 123.80, 109.93, 104.28, 80.86, 56.16, 22.04, 21.64.  
 
HRMS calcd. for C18H21NO3Na
+
 [M+Na]
+
: 322.1414. Found: 322.1414. 
 
  
 176 
 
(E)-2,6-dimethoxybenzaldehyde O-(1-(3-bromophenyl)ethyl) oxime (3.14a) 
Colorless oil. General Method B: yield 96%. E/Z > 19:1. Rf = 0.45 (Hex/EA=3:1).  
 
IR (KBr) 2974, 2934, 2837, 1595, 1470, 1431, 1338, 1306, 1256, 1207, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.46 (s, 1H), 7.58 (q, J = 1.7 Hz, 1H), 7.39 (ddd, J = 7.9, 
2.0, 1.1 Hz, 1H), 7.35 – 7.31 (m, 1H), 7.25 – 7.17 (m, 2H), 6.54 (d, J = 8.4 Hz, 2H), 5.35 
(q, J = 6.6 Hz, 1H), 3.79 (s, 6H), 1.60 (d, J = 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.12, 146.11, 144.65, 130.94, 130.37, 129.92, 129.89, 
125.32, 122.43, 109.65, 104.25, 80.03, 56.18, 22.04.  
 
HRMS calcd. for C17H18BrNO3Na
+
 [M+Na]
+
: 386.0362. Found: 386.0362. 
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(E)-2,6-dimethoxybenzaldehyde O-(cyclohexyl(phenyl)methyl) oxime (3.15a) 
White solid. General Method B: yield 67%. E/Z > 19:1. Mp. 109-110 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 2926, 2851, 1595, 1470, 1451, 1431, 1256, 1207, 1114 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.33 (d, J=0.5, 2H), 7.32 – 7.30 (m, 2H), 7.24 
(ddd, J=4.9, 3.6, 2.6, 1H), 7.20 (t, J=8.3, 1H), 6.50 (d, J=8.4, 2H), 4.99 (d, J=7.3, 1H), 
3.73 (s, 6H), 2.12 – 2.02 (m, 1H), 1.88 (dtd, J=11.4, 7.7, 3.4, 1H), 1.81 – 1.73 (m, 1H), 
1.66 (dddd, J=15.4, 11.1, 5.5, 2.9, 3H), 1.51 (ddt, J=12.8, 3.5, 1.9, 1H), 1.30 – 1.14 (m, 
4H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.07, 143.72, 141.82, 130.58, 128.32, 127.81, 127.54, 
126.96, 126.76, 110.18, 104.42, 89.62, 79.53, 77.48, 77.36, 77.16, 76.84, 56.14, 45.11, 
43.20, 29.50, 29.46, 29.24, 28.97, 26.68, 26.56, 26.35, 26.32, 26.24, 26.15.  
 
HRMS calcd. for C22H27NO3Na
+
 [M+Na]
+
: 376.1883. Found: 376.1884. 
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(E)-2,6-dimethoxybenzaldehyde O-(1-phenylethyl) oxime (3.16a) 
Colorless oil. General Method B: yield 74%. E/Z= 14:1. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 2973, 2935, 2837, 1595, 1470, 1432, 1306, 1257, 1209, 1113 cm
-1
. 
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.45 (ddd, J = 6.1, 1.3, 0.6 Hz, 2H), 7.41 – 
7.33 (m, 2H), 7.29 (dt, J = 4.4, 1.8 Hz, 1H), 7.24 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 
2H), 5.43 (q, J = 6.6 Hz, 1H), 3.79 (s, 6H), 1.66 (d, J = 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.07, 144.19, 143.46, 130.75, 128.28, 127.36, 126.70, 
109.86, 104.27, 80.78, 56.13, 22.06.  
 
HRMS calcd. for C17H20NO3
+
 [M+H]
+
: 308.1257. Found: 308.1258. 
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(E)-2,6-dimethoxybenzaldehyde O-(1,2,3,4-tetrahydronaphthalen-1-yl) oxime 
(3.17a) 
White solid. General Method A: 38%. General Method B: yield 80%. E/Z > 19:1. Mp. 
104-105 
o
C. Rf = 0.45 (Hex/EA=3:1).  
 
IR (KBr) 3003, 2936, 2836, 1595, 1470, 1432, 1306, 1256 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 7.59 – 7.53 (m, 1H), 7.25 (t, J=8.4, 1H), 7.22 
– 7.16 (m, 2H), 7.12 (dd, J=6.6, 2.3, 1H), 6.56 (d, J=8.4, 2H), 5.37 (t, J=4.0, 1H), 3.85 (s, 
6H), 2.86 (dt, J=17.0, 4.5, 1H), 2.81 – 2.69 (m, 1H), 2.42 – 2.28 (m, 1H), 2.08 – 1.93 (m, 
2H), 1.79 (tdd, J=10.4, 6.7, 4.0, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.11, 144.11, 138.24, 135.39, 130.75, 130.60, 129.02, 
127.90, 125.86, 109.88, 104.22, 78.38, 56.20, 29.53, 28.83, 18.53.  
 
HRMS calcd. for C19H21NO3Na
+
 [M+Na]
+
: 334.1414. Found: 334.1418. 
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(E)-2,6-dimethoxybenzaldehyde O-(2,3-dihydro-1H-inden-1-yl) oxime (3.18a) 
White solid. General Method B: yield 78%. E/Z > 19:1. Mp. 154-156 
o
C. Rf = 0.45 
(Hex/EA=3:1).  
 
IR (KBr) 2994, 2946, 2905, 2838, 1608, 1595, 1584, 1260 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.30 – 7.24 (m, 3H), 7.21 – 7.17 (m, 2H), 
6.57 (d, J=8.4, 2H), 5.27 – 5.21 (m, 1H), 3.85 (s, 6H), 3.35 – 3.21 (m, 4H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.06, 144.62, 141.45, 130.84, 126.55, 124.90, 109.74, 
104.19, 83.20, 56.19, 39.33.  
 
HRMS calcd. for C18H19NO3Na
+
 [M+Na]
+
: 320.1257. Found: 320.1262. 
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(E)-2,6-dimethoxybenzaldehyde O-(9H-fluoren-9-yl) oxime (3.19a) 
White solid. General Method B: yield 94%. E/Z > 19:1. Mp. 151-153 
o
C. Rf = 0.45 
(Hex/EA=3:1).  
 
IR (KBr) 3003, 2938, 2837, 1595, 1470, 1452, 1431, 1303, 1256, 1207, 1186 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.56 (s, 1H), 7.87 (ddt, J = 7.4, 1.3, 0.7 Hz, 2H), 7.68 (dd, 
J = 6.7, 0.8 Hz, 2H), 7.41 (tdd, J = 7.5, 1.2, 0.5 Hz, 2H), 7.34 – 7.28 (m, 3H), 6.61 (d, J = 
8.4 Hz, 2H), 6.33 (s, 1H), 3.91 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.25, 145.52, 143.26, 141.05, 131.12, 129.22, 127.61, 
126.51, 119.94, 109.52, 104.21, 83.97, 56.21.  
 
HRMS calcd. for C22H19NO3Na
+
 [M+Na]
+
: 368.1257. Found: 368.1261. 
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(E)-2,6-dimethoxybenzaldehyde O-benzhydryl oxime (3.20a) 
White solid. General Method B: yield 94%. E/Z > 19:1. Mp. 104-106 
o
C. Rf = 0.5 
(Hex/EA=3:1).  
 
IR (KBr) 3027, 2937, 2837, 1595, 1470, 1431, 1346, 1256, 1113 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.59 (s, 1H), 7.48 – 7.40 (m, 4H), 7.38 – 7.32 (m, 4H), 
7.30 – 7.26 (m, 2H), 7.24 (dd, J = 11.7, 5.0 Hz, 1H), 6.53 (d, J = 8.4 Hz, 2H), 6.41 (s, 
1H), 3.75 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 159.15, 144.93, 141.77, 130.91, 128.30, 127.82, 127.48, 
109.78, 104.34, 86.44, 56.15.  
 
HRMS calcd. for C22H22NO3
+
 [M+H]
+
: 348.1594. Found: 348.1596. 
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Pd-catalyzed oxidation of ortho C−H bonds in benzyl oximes: 
 
General Procedure: 
Iodosobenzene diacetate (1.5 equiv) and oxime (0.1 mmol, 1 equiv) were charged in a 
scintillation vial, followed by 0.5 mL 2mM Pd(OAc)2 in AcOH solution (0.22 mg, 0.001 
mmol, 1 mol%) and 100L Ac2O. The vial was tightly capped and stirred at 100 
o
C. The 
reaction was monitored by TLC. Upon done, the mixture was directly purified by flash 
column chromatography on silica gel. The E/Z ratio was determined by 
1
H NMR 
spectrum. 
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Primary Alcohol-Derived Substrates: 
 
1b: Yellow solid. Yield 85%. E/Z = 6.1:1. Mp. 106-108 
o
C. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 2934, 2840, 1763, 1595, 1581, 1468, 1433, 1367, 1256, 1205, 1186 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.25 (td, J = 8.1, 2.4 Hz, 2H), 7.10 (d, J = 7.3 
Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H), 5.23 (s, 2H), 3.83 (s, 6H), 
2.52 (s, 3H), 2.33 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.89, 159.12, 150.32, 144.72, 140.42, 130.97, 129.08, 
128.15, 127.59, 120.23, 109.30, 104.11, 67.77, 56.08, 21.10, 19.71.  
 
HRMS calcd. for C19H21NO5Na
+
 [M+Na]
+
: 366.1312. Found: 366.1253. 
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(E)-3-bromo-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)phenyl acetate 
(3.2b) 
White solid. Yield 97%. E/Z = 8.2:1. Mp. 83-85 
o
C. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 3004, 2941, 2894, 2838, 1769, 1595, 1572, 1471, 1447, 1432, 1368, 1257 cm
-1
.  
 
Major isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 7.50 (dd, J = 8.0, 1.1 Hz, 1H), 7.24 (dt, J = 
12.9, 8.2 Hz, 2H), 7.08 (dd, J = 8.1, 1.1 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H), 5.37 (s, 2H), 
3.83 (s, 6H), 2.33 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.39, 159.19, 151.08, 145.10, 131.07, 130.68, 130.22, 
129.58, 126.35, 122.39, 109.24, 104.13, 70.57, 56.11, 21.03.  
 
HRMS calcd. for C18H18BrNO5Na
+
 [M+Na]
+
: 430.0261. Found: 430.0262. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-4-methoxyphenyl acetate 
(3.3b) 
Colorless oil. Yield 58%. E/Z = 10:1. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 2924, 2839, 1759, 1595, 1496, 1469, 1432, 1368, 1257 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 7.28 (d, J=8.4, 1H), 7.10 (d, J=3.1, 1H), 7.00 
(d, J=8.8, 1H), 6.84 (dd, J=8.8, 3.0, 1H), 6.56 (d, J=8.4, 2H), 5.17 (s, 2H), 3.84 (s, 6H), 
3.81 (s, 3H), 2.30 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.77, 159.01, 157.25, 144.98, 142.16, 130.96, 130.81, 
122.94, 114.90, 113.96, 109.11, 104.00, 70.88, 56.01, 55.57, 20.82.  
 
HRMS calcd. for C19H21NO6Na
+
 [M+Na]
+
: 382.1261. Found: 382.1261. 
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(E)-4-bromo-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)phenyl acetate 
(3.4b) 
Colorless oil. Yield 74%. E/Z = 14:1.Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 3004, 2934, 2839, 1763, 1595, 1472, 1432, 1368, 1257, 1204, 1171 cm
-1
.  
 
Major isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.73 (d, J = 2.4 Hz, 1H), 7.44 
(dd, J = 8.6, 2.5 Hz, 1H), 7.27 (t, J = 8.4 Hz, 1H), 6.98 (d, J = 8.6 Hz, 1H), 6.56 (d, J = 
8.4 Hz, 2H), 5.15 (s, 2H), 3.85 (s, 6H), 2.31 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.95, 159.01, 147.58, 145.28, 132.76, 132.37, 131.56, 
131.10, 123.93, 119.04, 108.92, 103.97, 70.06, 56.05, 20.82.  
 
HRMS calcd. for C18H18BrNO5Na
+
 [M+Na]
+
: 430.0261. Found: 430.0260. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-4-(trifluoromethyl)phenyl 
acetate (3.5b) 
Colorless oil. Yield 77%. E/Z = 13:1. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 2940, 2841, 1770, 1596, 1500, 1472, 1433, 1330 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.85 (dd, J=1.8, 1.0, 1H), 7.61 – 7.55 (m, 
1H), 7.27 (d, J=8.4, 1H), 7.21 (dd, J=8.5, 0.9, 1H), 6.54 (d, J=8.5, 2H), 5.21 (s, 2H), 3.81 
(s, 6H), 2.33 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.81, 159.23, 151.23 (d, J=1.7), 145.63, 131.48, 
131.31, 128.31 (q, J=32.7), 127.35 (q, J=3.7), 125.93 (q, J=3.8), 122.98, 123.88 (q, 
J=225.4), 109.10, 104.19, 70.32, 56.15, 20.99. 
19
F NMR (375 MHz, CDCl3) δ -62.20 (s).  
 
HRMS calcd. for C19H19F3NO5
+
 [M+H]
+
: 398.1210. Found: 398.1211. 
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(E)-4,5-dichloro-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)phenyl acetate 
(3.6b) 
White solid. Yield 69%. E/Z = 8.2:1. Mp. 108-109 
o
C. Rf = 0.25 (Hex/EA=3:1).  
 
IR (KBr) 2926, 2840, 1768, 1596, 1472, 1432, 1286, 1197, 1114 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 7.69 (s, 1H), 7.28 (t, J = 8.4 Hz, 1H), 7.24 (s, 
1H), 6.57 (d, J = 8.4 Hz, 2H), 5.12 (s, 2H), 3.85 (s, 6H), 2.32 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.63, 159.00, 147.05, 145.47, 131.83, 131.19, 131.12, 
130.68, 129.72, 124.34, 108.78, 103.95, 69.62, 56.02, 20.74.  
 
HRMS calcd. for C18H17Cl2NO5Na
+
 [M+Na]
+
: 420.0376. Found: 420.0379. 
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(E)-1-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)naphthalen-2-yl acetate 
(3.7b) 
Colorless oil. Yield 84%. E/Z = 6.1:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 3057, 3004, 2940, 2898, 2838, 1762, 1624, 1595, 1471, 1432, 1367, 1257 cm
-1
.  
 
Major isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 8.35 – 8.30 (m, 1H), 7.89 – 
7.84 (m, 2H), 7.58 (ddd, J=8.4, 6.9, 1.4, 1H), 7.49 (ddd, J=8.0, 6.8, 1.2, 1H), 7.29 – 7.24 
(m, 2H), 6.56 (d, J=8.4, 2H), 5.66 (s, 2H), 3.83 (s, 6H), 2.41 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.79, 159.05, 147.62, 144.94, 133.26, 131.92, 130.94, 
130.19, 128.31, 126.85, 125.52, 125.03, 123.20, 121.48, 109.12, 103.99, 66.77, 55.99, 
21.05.  
 
HRMS calcd. for C22H22NO5
+
 [M+H]
+
: 380.1492. Found: 380.1493. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)phenyl acetate (3.8b) 
Colorless oil. Yield 47%. E/Z = 12:1. Rf = 0.3 (Hex/EA=3:1). 
 
IR (KBr) 3005, 2924, 2852, 1763, 1591, 1472, 1433, 1368, 1254, 1205, 1175, 1113, 
1061, 1034 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.50 (s, 1H), 7.59 – 7.54 (m, 1H), 7.34 (ddd, J=8.1, 7.5, 
1.8, 1H), 7.28 (d, J=8.3, 1H), 7.24 (dd, J=7.5, 1.3, 1H), 7.10 (dd, J=8.0, 1.3, 1H), 6.56 (d, 
J=8.4, 2H), 5.21 (s, 2H), 3.84 (s, 6H), 2.32 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.36, 159.00, 148.88, 144.85, 130.93, 130.19, 129.81, 
128.86, 125.93, 122.31, 109.16, 104.02, 70.99, 56.01, 20.89.  
 
HRMS calcd. for C18H19NO5Na
+
 [M+Na]
+
: 352.1155. Found: 352.1155. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-1,3-phenylene diacetate 
(3.8c) 
Colorless oil. Yield 51%. E/Z = 7.7:1.Rf = 0.1 (Hex/EA=3:1).  
 
IR (KBr) 3004, 2924, 2851, 1764, 1595, 1470, 1432, 1257, 1206, 1176, 1112 cm
-1
.  
 
Major isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.37 (dd, J=8.4, 8.0, 1H), 7.26 (t, J=8.4, 1H), 
7.04 (d, J=8.2, 2H), 6.56 (d, J=8.4, 2H), 5.17 (s, 2H), 3.83 (s, 6H), 2.32 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.20, 159.02, 150.54, 144.79, 130.95, 129.21, 122.35, 
120.37, 109.12, 104.02, 65.73, 55.98, 20.92.  
 
HRMS calcd. for C20H21NO7Na
+
 [M+Na]
+
: 410.1210. Found: 410.1210. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-5-isopropylphenyl acetate 
(3.9b) 
Colorless oil. Yield 11%. E/Z >19:1. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 3003, 2961, 2934, 2872, 2839, 1767, 1620, 1595, 1577, 1506, 1471, 1432, 
1368, 1257 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.47 (d, J=7.9, 1H), 7.29 – 7.23 (m, 1H), 7.12 
(dd, J=7.9, 1.7, 1H), 6.95 (d, J=1.7, 1H), 6.56 (d, J=8.4, 2H), 5.17 (s, 2H), 3.84 (s, 6H), 
2.91 (hept, J=6.9, 1H), 2.31 (s, 3H), 1.25 (d, J=6.9, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.30, 158.99, 150.84, 150.35, 144.61, 130.86, 119.44, 
118.49, 109.17, 103.99, 65.80, 55.97, 33.81, 23.54, 20.92.  
 
HRMS calcd. for C21H26NO5
+
 [M+H]
+
: 372.1805. Found: 372.1806. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-5-isopropyl-1,3-phenylene 
diacetate (3.9c) 
Colorless oil. Yield 63%. E/Z > 19:1. Rf = 0.1 (Hex/EA=3:1).  
 
IR (KBr) 3003, 2962, 2935, 2872, 2840, 1769, 1626, 1596, 1577, 1471, 1432, 1368 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.29 – 7.24 (m, 1H), 6.89 (s, 2H), 6.56 (d, J = 
8.4 Hz, 2H), 5.12 (s, 2H), 3.83 (s, 6H), 2.96 – 2.85 (m, 1H), 2.31 (s, 6H), 1.24 (d, J = 6.9 
Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.30, 158.99, 150.84, 150.35, 144.61, 130.86, 119.44, 
118.49, 109.17, 103.99, 65.80, 55.97, 33.81, 23.54, 20.92.  
 
HRMS calcd. for C23H28NO7
+
 [M+H]
+
: 430.1860. Found: 430.1862. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-4,6-dimethylphenyl acetate 
(3.10b) 
Colorless oil. Yield 55%. E/Z = 14:1.Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2936, 2839, 1758, 1595, 1472, 1432, 1368, 1257, 1213, 1188 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.27 (t, J = 8.4 Hz, 1H), 7.18 (d, J = 1.5 Hz, 
1H), 7.01 (s, 1H), 6.56 (d, J = 8.4 Hz, 2H), 5.14 (s, 2H), 3.84 (s, 6H), 2.32 (s, 3H), 2.32 
(s, 3H), 2.14 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.13, 159.00, 145.63, 144.74, 135.42, 131.39, 130.86, 
130.17, 129.22, 128.46, 109.25, 104.02, 71.48, 56.01, 20.86, 20.53, 16.13.  
 
HRMS calcd. for C20H23NO5Na
+
 [M+Na]
+
: 380.1468. Found: 380.1470. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-4,6-dimethyl-1,3-phenylene 
diacetate (3.10c) 
Colorless oil. Yield 30%. E/Z > 19:1. Rf = 0.6 (Hex/EA=3:1). 
 
 IR (KBr) 3005, 2989, 1762, 1595, 1472, 1433, 1275, 1259, 1193, 1113 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.24 (t, J = 8.4 Hz, 2H), 7.09 (s, 1H), 6.54 (d, 
J = 8.4 Hz, 2H), 5.07 (s, 2H), 3.81 (s, 6H), 2.31 (s, 6H), 2.12 (d, J = 0.7 Hz, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.17, 159.30, 147.30, 144.97, 132.91, 131.11, 128.66, 
122.26, 109.57, 104.33, 66.75, 56.24, 20.79, 16.33.  
 
HRMS calcd. for C22H25NO7Na
+
 [M+Na]
+
: 438.1523. Found: 438.1524. 
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Methyl (E)-3-acetoxy-4-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)benzoate 
(3.11b) 
Colorless oil. Yield 44%. E/Z = 7.9:1. Rf = 0.2 (Hex/EA=3:1).  
 
IR (KBr) 3004, 2951, 2840, 1769, 1723, 1596, 1501, 1472, 1434, 1415, 1369, 1289, 1258 
cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.52 (s, 1H), 7.93 (dd, J=8.0, 1.7, 1H), 7.76 (d, J=1.6, 1H), 
7.67 – 7.64 (m, 1H), 7.27 (t, J=8.4, 1H), 6.56 (d, J=8.4, 2H), 5.24 (s, 2H), 3.91 (s, 3H), 
3.83 (s, 6H), 2.34 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.98, 166.11, 159.00, 148.33, 145.26, 135.45, 131.12, 
130.61, 129.57, 127.04, 123.49, 108.90, 103.99, 70.44, 56.02, 52.24, 20.80.  
 
HRMS calcd. for C20H22NO7
+
 [M+H]
+
: 388.1391. Found: 388.1390. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)methyl)-5-(methoxycarbonyl)-1,3-
phenylene diacetate (3.11c) 
Colorless oil. Yield 53%. E/Z > 19:1. Rf = 0.35 (Hex/EA=1:1).  
 
IR (KBr) 2952, 2841, 1771, 1725, 1596, 1434, 1421, 1368, 1308 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.70 (s, 2H), 7.29 – 7.23 (m, 1H), 6.55 (d, J = 
8.4 Hz, 2H), 5.18 (s, 2H), 3.90 (s, 3H), 3.82 (s, 6H), 2.34 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.89, 165.25, 159.03, 150.37, 145.12, 131.28, 131.07, 
127.50, 121.57, 108.91, 104.01, 65.60, 55.97, 52.47, 20.84.  
 
HRMS calcd. for C22H23NO9Na
+
 [M+Na]
+
: 468.1265. Found: 468.1263. 
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Secondary Alcohol-Derived Substrates: 
 
(E)-2-(1-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl)-3-methylphenyl acetate 
(3.12b) 
Colorless oil. Yield 87%. E/Z = 14:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2972, 2937, 2838, 1766, 1595, 1471, 1432, 1367, 1306, 1284, 1256, 1206 cm
-1
. 
Major isomer:  
 
1
H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.22 (t, J=8.4, 1H), 7.17 (t, J=7.8, 1H), 7.04 
(ddd, J=7.6, 1.4, 0.7, 1H), 6.90 – 6.85 (m, 1H), 6.52 (d, J=8.4, 2H), 5.74 (q, J=6.9, 1H), 
3.77 (s, 6H), 2.49 (s, 3H), 2.34 (s, 3H), 1.65 (d, J=6.9, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.95, 159.13, 149.13, 143.90, 137.93, 133.02, 130.76, 
128.78, 127.87, 121.18, 109.89, 104.40, 76.36, 56.18, 21.47, 20.43, 19.31.  
 
HRMS calcd. for C20H24NO5
+
 [M+H]
+
: 358.1649. Found: 358.1651. 
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(E)-2-(1-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl)-4-methylphenyl acetate 
(3.13b) 
Colorless oil. Yield 52%. E/Z= 16:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2975, 2934, 2839, 1762, 1595, 1496, 1471, 1433, 1369, 1306, 1285, 1257, 
1190, 1158, 1113 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.34 (d, J=1.9, 1H), 7.23 (d, J=8.4, 1H), 7.09 
(ddd, J=8.2, 2.2, 0.6, 1H), 6.94 (d, J=8.2, 1H), 6.54 (d, J=8.4, 2H), 5.51 (q, J=6.6, 1H), 
3.80 (s, 6H), 2.36 (s, 3H), 2.31 (s, 3H), 1.58 (d, J=6.6, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.84, 159.11, 145.74, 144.43, 135.77, 134.63, 130.84, 
128.87, 128.11, 122.20, 109.79, 104.30, 75.57, 56.17, 21.24, 21.19, 21.17.  
 
HRMS calcd. for C20H24NO5
+
 [M+H]
+
: 358.1649. Found: 358.1650. 
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(E)-4-bromo-2-(1-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl)phenyl acetate 
(3.14b) 
Colorless oil. Yield 57%. E/Z > 19:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2932, 2838, 1764, 1595, 1472, 1432, 1257, 1203, 1172, 1113, 1088 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.46 (s, 1H), 7.67 (d, J = 2.4 Hz, 1H), 7.38 (s, 1H), 7.25 (t, 
J = 8.4 Hz, 1H), 6.96 (d, J = 8.6 Hz, 1H), 6.54 (d, J = 8.4 Hz, 2H), 5.49 (q, J = 6.6 Hz, 
1H), 3.80 (s, 6H), 2.32 (s, 3H), 1.55 (d, J = 6.6 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.01, 158.98, 146.72, 144.82, 137.56, 130.88, 130.87, 
130.62, 124.09, 119.21, 109.36, 104.10, 74.95, 56.02, 20.96.  
 
HRMS calcd. for C19H20BrNO5Na
+
 [M+Na]
+
: 444.0417. Found: 444.0411. 
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(E)-2-(1-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl)phenyl acetate (3.15b) 
Colorless oil. Yield 50%. E/Z= 9.6:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2959, 2931, 1764, 1595, 1472, 1257, 1205, 1113, 1075 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.56 – 7.52 (m, 1H), 7.31 – 7.27 (m, 1H), 
7.26 – 7.24 (m, 1H), 7.22 (d, J=8.3, 1H), 7.08 – 7.04 (m, 1H), 6.54 (d, J=8.4, 2H), 5.55 
(q, J=6.6, 1H), 3.79 (s, 6H), 2.32 (s, 3H), 1.59 (d, J=6.6, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.43, 158.98, 147.87, 144.32, 135.09, 130.71, 128.05, 
127.54, 126.03, 122.35, 109.66, 104.20, 75.41, 56.04, 21.04, 20.98.  
 
HRMS calcd. for C19H22NO5
+
 [M+H]
+
: 344.1492. Found: 344.1497. 
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(E)-2-(1-(((2,6-dimethoxybenzylidene)amino)oxy)ethyl)-1,3-phenylene diacetate 
(3.15c) 
Colorless oil. Yield 42%. E/Z > 19:1. Rf = 0.6 (Hex/EA=3:1).  
 
IR (KBr) 2938, 2840, 1767, 1595, 1470, 1433, 1368, 1258, 1188, 1112, 1033 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 7.33 – 7.28 (m, 1H), 7.22 (t, J = 8.4 Hz, 1H), 
6.97 (d, J = 8.2 Hz, 2H), 6.52 (d, J = 8.4 Hz, 2H), 5.61 (q, J = 6.8 Hz, 1H), 3.78 (s, 6H), 
2.35 (s, 6H), 1.66 (d, J = 6.8 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.25, 158.99, 149.30, 144.02, 130.69, 128.15, 127.61, 
120.93, 109.58, 104.27, 74.25, 56.05, 21.15, 19.16.  
 
HRMS calcd. for C21H23NO7Na
+
 [M+Na]
+
: 424.1367. Found: 424.1370. 
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(E)-2-(cyclohexyl(((2,6-dimethoxybenzylidene)amino)oxy)methyl)phenyl acetate 
(3.16b) 
With 3 equiv PhI(OAc)2. Yellow wax. Yield 76%. E/Z > 19:1. Rf = 0.1 (Hex/EA=3:1).  
 
IR (KBr) 2929, 2851, 1771, 1595, 1469, 1432, 1367, 1257, 1185 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.30 – 7.27 (m, 1H), 7.17 (t, J=8.4, 1H), 6.97 
(d, J=8.1, 2H), 6.48 (d, J=8.4, 2H), 5.30 (d, J=9.7, 1H), 3.73 (s, 6H), 2.34 (s, 6H), 2.32 – 
2.22 (m, 1H), 1.85 – 1.74 (m, 1H), 1.71 – 1.56 (m, 3H), 1.38 – 1.13 (m, 5H), 0.86 (qd, 
J=12.8, 12.3, 3.2, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.88, 159.00, 149.71, 143.54, 130.46, 127.66, 126.32, 
120.63, 109.81, 104.39, 82.96, 56.00, 41.11, 30.73, 29.44, 26.42, 26.14, 26.03, 21.32.  
 
HRMS calcd. for C21H23NO5Na
+
 [M+Na]
+
: 392.1468. Found: 392.1470. 
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(E)-8-(((2,6-dimethoxybenzylidene)amino)oxy)-5,6,7,8-tetrahydronaphthalen-1-yl 
acetate (3.17b) 
White solid. Yield 83%. E/Z > 19:1. Mp. 161-163 
o
C. Rf = 0.35 (Hex/EA=3:1).  
 
IR (KBr) 2937, 2838, 1763, 1654, 1594, 1472, 1432, 1369, 1256, 1202, 1112 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 7.30 – 7.26 (m, 1H), 7.05 (d, J = 7.7 Hz, 1H), 
6.95 (d, J = 7.9 Hz, 1H), 6.57 (d, J = 8.4 Hz, 2H), 5.46 (t, J = 2.9 Hz, 1H), 3.91 (s, 1H), 
3.84 (s, 6H), 3.73 (s, 1H), 2.88 (d, J = 16.7 Hz, 1H), 2.56 – 2.47 (m, 1H), 2.27 (s, 3H), 
2.13 – 1.91 (m, 2H), 1.82 – 1.72 (m, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.87, 158.91, 150.55, 143.93, 140.56, 130.62, 128.52, 
126.75, 126.72, 120.34, 109.77, 104.10, 73.02, 56.01, 29.41, 28.19, 20.86, 17.26.  
 
HRMS calcd. for C21H23NO5Na
+
 [M+Na]
+
: 392.1468. Found: 392.1470. 
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(E)-3-(((2,6-dimethoxybenzylidene)amino)oxy)-2,3-dihydro-1H-inden-4-yl acetate 
(3.18b) 
Colorless oil. Yield 75%. E/Z = 11:1. Rf = 0.35 (Hex/EA=3:1).  
 
IR (KBr) 2940, 2839, 1762, 1595, 1470, 1432, 1256, 1207 cm
-
1.  
 
1
H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.30 (ddd, J=8.0, 7.5, 0.5, 1H), 7.25 (t, J=8.4, 
1H), 7.15 (ddd, J=7.5, 1.0, 0.5, 1H), 6.93 (dq, J=8.0, 0.8, 1H), 6.56 (d, J=8.4, 2H), 5.90 – 
5.83 (m, 1H), 3.83 (s, 6H), 3.18 (dddt, J=14.3, 8.5, 6.7, 0.9, 1H), 2.88 (dddt, J=16.2, 8.6, 
4.6, 0.8, 1H), 2.55 – 2.34 (m, 2H), 2.26 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.54, 159.10, 148.32, 147.75, 144.19, 133.73, 130.83, 
130.21, 122.66, 120.08, 109.78, 104.25, 85.16, 56.14, 32.20, 30.71, 21.01.  
 
HRMS calcd. for C20H21NO5Na
+
 [M+Na]
+
: 378.1312. Found: 378.1311. 
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(E)-9-(((2,6-dimethoxybenzylidene)amino)oxy)-9H-fluorene-1,8-diyl diacetate 
(3.19b) 
With 3 equiv PhI(OAc)2. Yellow wax. Yield 99%. E/Z=6.0:1. Rf = 0.1 (Hex/EA=3:1).  
 
IR (KBr) 3009, 2937, 2840, 1759, 1591, 1480, 1470, 1433, 1368, 1256, 1194 cm
-1
. Major 
isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.53 (dd, J = 7.5, 0.8 Hz, 2H), 7.41 
(dd, J = 11.8, 4.1 Hz, 2H), 7.27 (t, J = 8.4 Hz, 1H), 7.01 (dd, J = 8.0, 0.8 Hz, 2H), 6.56 (d, 
J = 8.4 Hz, 2H), 6.48 (s, 1H), 3.80 (s, 6H), 2.20 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.24, 159.15, 148.67, 144.25, 142.45, 134.60, 131.00, 
130.81, 122.00, 118.00, 109.46, 104.23, 83.64, 56.01, 20.94.  
 
HRMS calcd. for C26H24NO7
+
 [M+H]
+
: 462.1547. Found: 462.1546. 
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(E)-2-((((2,6-dimethoxybenzylidene)amino)oxy)(phenyl)methyl)phenyl acetate 
(3.20b) 
With 1 equiv PhI(OAc)2. Colorless oil. Yield 45%. E/Z > 19:1. Rf = 0.3 (Hex/EA=3:1).  
 
IR (KBr) 2934, 2839, 1766, 1595, 1471, 1453, 1432, 1257, 1202, 1171, 1113 cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.55 (s, 1H), 7.49 (dd, J = 7.7, 1.8 Hz, 1H), 7.38 (dt, J = 
2.9, 1.9 Hz, 2H), 7.36 – 7.27 (m, 4H), 7.26 – 7.21 (m, 2H), 7.10 (dd, J = 8.0, 1.3 Hz, 1H), 
6.56 (s, 1H), 6.53 (t, J = 5.6 Hz, 2H), 3.76 (s, 6H), 2.16 (d, J = 1.3 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.95, 159.00, 148.33, 144.95, 140.25, 133.29, 130.83, 
128.87, 128.34, 128.15, 127.82, 127.59, 125.72, 122.66, 109.47, 104.14, 81.47, 55.98, 
20.87.  
 
HRMS calcd. for C24H24NO5
+
 [M+H]
+
: 406.1649. Found: 406.1648. 
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(E)-((((2,6-dimethoxybenzylidene)amino)oxy)methylene)bis(2,1-phenylene) diacetate 
(3.20c) 
With 1 equiv PhI(OAc)2. Colorless oil. Yield 49%. E/Z > 19:1. Rf = 0.1 (Hex/EA=3:1).  
 
IR (KBr) 2936, 2840, 1766, 1595, 1471, 1432, 1369, 1257 cm
-1
.  
 
Major isomer: 
1
H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 7.37 – 7.31 (m, 4H), 7.25 – 
7.19 (m, 3H), 7.14 – 7.10 (m, 2H), 6.73 (s, 1H), 6.53 (d, J = 8.4 Hz, 2H), 3.76 (s, 6H), 
2.15 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.20, 159.15, 148.81, 145.21, 131.87, 131.06, 129.38, 
128.87, 125.86, 122.84, 109.52, 104.26, 77.18, 56.10, 20.90.  
 
HRMS calcd. for C26H26NO7
+
 [M+H]
+
: 464.1704. Found: 464.1702. 
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(E)-2-((2-acetoxyphenyl)(((2,6-dimethoxybenzylidene)amino)oxy)methyl)-1,3-
phenylene diacetate (3.20d) 
With 5 equiv PhI(OAc)2. Colorless oil. Yield 47%. E/Z = 7.0:1. Rf = 0.45 (Hex/EA=1:1).  
 
IR (KBr) 3062, 3007, 2939, 2840, 1768, 1595, 1471, 1433, 1369, 1257, 1179, 1113, 1025 
cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H), 7.58 – 7.52 (m, 1H), 7.38 – 7.33 (m, 1H), 
7.33 – 7.28 (m, 1H), 7.26 – 7.20 (m, 2H), 7.07 (dd, J=8.0, 1.3, 1H), 7.03 (d, J=8.2, 2H), 
6.79 (s, 1H), 6.52 (d, J=8.4, 2H), 3.77 (s, 6H), 2.13 (s, 3H), 2.12 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.05, 168.64, 159.05, 149.82, 148.16, 144.89, 131.77, 
130.87, 128.71, 128.61, 128.36, 125.37, 124.56, 122.53, 120.81, 109.28, 104.13, 75.28, 
55.92, 20.84, 20.76.  
 
HRMS calcd. for C28H28NO9
+
 [M+H]
+
: 522.1759. Found: 522.1755. 
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(E)-((((2,6-dimethoxybenzylidene)amino)oxy)methylene)bis(benzene-2,1,3-triyl) 
tetraacetate (3.20e) 
With 5 equiv PhI(OAc)2. White solid. Yield 37%. E/Z > 19:1. Mp. > 200 
o
C. Rf = 0.35 
(Hex/EA=1:1).  
 
IR (KBr) 2924, 2849, 1762, 1607, 1593, 1577, 1470, 1435, 1256, 1182, 1110, 1044, 1022 
cm
-1
.  
 
Major isomer:  
1
H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H), 7.33 (t, J = 8.2 Hz, 2H), 7.21 (t, J = 8.4 Hz, 
1H), 7.01 (d, J = 8.2 Hz, 4H), 6.90 (s, 1H), 6.50 (d, J = 8.4 Hz, 2H), 3.74 (s, 6H), 2.12 (s, 
12H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.99, 159.20, 149.76, 144.92, 131.02, 128.46, 124.61, 
120.94, 109.33, 104.29, 74.46, 56.03, 21.03.  
 
HRMS calcd. for C28H27NO9Na
+
 [M+Na]
+
: 602.1633. Found: 602.1631. 
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Removal of the directing group: N−O bond cleavage and C−O bond cleavage: 
General procedure for N−O cleavage: 
 
To a solution of oxime (0.1 mmol, 1 equiv) in 1.2 mL AcOH-THF-water (3:1:1), zinc 
powder (65 mg, 1 mmol, 10 equiv) was added in one portion at room temperature. Then 
the mixture was stirred at 60 
o
C. The reaction was monitored by TLC. After 2.5 h, the 
mixture was quenched with 5 mL water and extracted with EA (10 mL×3), the combined 
organic layer was dried over Na2SO4, the solvent was removed under reduced pressure. 
The desired compound was purified by flash column chromatography on silica gel 
(Hex/EA 10:1 to 5:1). 
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2-hydroxy-6-methylbenzyl acetate (3.21) 
Colorless oil. Yield 92%. Rf = 0.45 (Hex/EA=1:1). 
 
IR (KBr) 3354, 2923, 2853, 1710, 1611, 1591, 1468, 1384, 1362 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.98 (s, broad, 1H), 7.17 (dd, J=8.4, 7.4, 1H), 6.80 (dddd, 
J=14.8, 7.5, 1.2, 0.6, 2H), 5.19 (s, 2H), 2.41 (t, J=0.7, 3H), 2.10 (s, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 173.97, 156.01, 139.83, 130.57, 122.47, 120.83, 115.88, 
59.87, 20.87, 19.27.  
 
HRMS: calcd. C10H12O3
+
 [M]
+
: 180.0786. Found: 180.0785. 
 
  
 214 
 
4-cyclohexyl-2-hydroxy-2-methyl-4H-benzo[d][1,3]dioxin-5-yl acetate (3.23) 
Colorless oil. Yield 95%. Rf = 0.45 (Hex/EA=1:1).  
 
IR (KBr) 3426, 2930, 2852, 1765, 1740, 1612, 1594, 1466, 1370 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.17 (t, J=8.2, 1H), 6.76 (dd, J=8.3, 1.1, 1H), 6.63 (dd, 
J=8.1, 1.1, 1H), 6.61 (s, 1H), 5.80 (d, J=9.8, 1H), 2.33 (s, 3H), 2.06 (s, 3H), 1.81 – 1.73 
(m, 1H), 1.72 – 1.58 (m, 3H), 1.36 – 1.28 (m, 1H), 1.24 – 1.11 (m, 3H), 1.08 – 0.83 (m, 
2H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.22, 155.93, 149.29, 129.37, 115.38, 115.35, 115.32, 
115.18, 74.25, 40.21, 29.97, 28.82, 26.10, 25.69, 25.54, 21.09, 20.77.  
 
HRMS: calcd. C17H22O5Na
+
 [M+Na]
+
: 329.1359. Found: 329.1347. The compound is 
unstable. 
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9-hydroxy-9H-fluorene-1,8-diyl diacetate (3.25) 
White solid. Yield 84%. Rf = 0.45 (Hex/EA=1:1). Mp. 165-167
o
C.  
 
IR (KBr) 3452, 2924, 2360, 1759, 1619, 1586, 1481, 1207 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.56 – 7.51 (m, 2H), 7.45 – 7.38 (m, 2H), 7.02 – 6.98 (m, 
2H), 5.73 (s, 1H), 2.38 (s, 6H), 1.97 (s, 1H). 
 
13
C NMR (100 MHz, CDCl3) δ 169.85, 148.49, 141.84, 135.99, 130.92, 122.13, 118.29, 
73.23, 21.15.  
 
HRMS: calcd. C17H14O5Na
+
 [M+Na]
+
: 321.0733. Found: 321.0735. 
 
  
 216 
General procedure for C−O bond cleavage: 
To a 2 mL solution (solvent varies) of the oxime (0.1 mmol, 1 equiv) was added to a tube 
charged with corresponding Pd catalyst (1:1 to oxime by weight). The reaction was run 
under a hydrogen atmosphere. After the reaction was completed, the mixture was filtrated 
through a short pipette of Celite, and then the solvent was removed under reduced 
pressure. The desired compound was purified by flash column chromatography on silica 
gel (Hex/EA 10:1 to 5:1). 
 
 
2,3-dimethylphenol (3.22) 
THF/AcOH=1:1 as a solvent, 1 atm hydrogen gas with Pd/C (10% w/w) was used.  
 
White solid. Yield 97%. Rf = 0.45 (Hex/EA=3:1).  
1
H NMR (400 MHz, CDCl3) δ 6.96 (d, J=7.8, 1H), 6.79 – 6.74 (m, 1H), 6.66 – 6.62 (m, 
1H), 4.61 (s, 1H), 2.28 (s, 3H), 2.17 (s, 3H). Match the literature.
20
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2-(cyclohexylmethyl)-1,3-phenylene diacetate (3.24) 
Ac2O/AcOH=1:1 as solvent, 100 psi hydrogen gas with Pd/C (10% w/w) was used, 
reaction conducted at 100
o
C in Q-tube with freeze-pump-thaw three times.  
 
Colorless oil. Yield 33%. Rf = 0.5 (Hex/EA=3:1).  
IR (KBr) 2925, 2850, 1769, 1463, 1449, 1369, 1204, 1190 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.20 (dd, J=8.5, 7.8, 1H), 6.97 – 6.93 (m, 2H), 2.35 – 2.32 
(m, 2H), 2.29 (s, 6H), 1.73 – 1.57 (m, 5H), 1.48 – 1.35 (m, 1H), 1.20 – 1.07 (m, 3H), 0.91 
(td, J=13.3, 12.8, 6.5, 2H).  
 
13
C NMR (100 MHz, CDCl3) δ 169.20, 150.11, 126.61, 126.38, 120.10, 38.59, 33.64, 
32.63, 26.50, 26.41, 21.16. 
 
HRMS: calcd. C17H22O4Na
+
 [M+Na]
+
: 313.1410. Found: 313.1398. 
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9H-fluorene-1,8-diyl diacetate (3.26) 
THF/AcOH=1:1 as solvent, 1 atm hydrogen gas with Pd(OH)2/C (20% w/w) was used 
and reaction conducted at 100
o
C.  
 
Colorless oil. Yield 67%. Rf = 0.5 (Hex/EA=3:1).  
 
IR (KBr) 2937, 1758, 1581, 1480, 1436, 1369, 1214, 1187 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.67 (dd, J=7.6, 0.9, 2H), 7.46 – 7.36 (m, 2H), 7.06 (dd, 
J=8.0, 0.9, 2H), 3.71 (s, 2H), 2.39 (s, 6H).  
 
13
C NMR (100 MHz, CDCl3) δ 168.88, 147.65, 143.71, 134.36, 128.66, 120.51, 118.21, 
32.23, 21.18.  
 
HRMS: calcd. C17H14O4Na
+
 [M+Na]
+
: 305.0784. Found: 305.0789. 
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Reaction TON test: 
 
Iodosobenzene diacetate (48.3 mg, 1.5 equiv in most cases) and oxime 3.19a (34.5mg, 
0.1 mmol, 1 equiv) were charged in a scintillation vial, followed by 50 2mM 
Pd(OAc)2 solution in AcOH (0.0001 mmol, 0.1 mol%) and followed by 450 L AcOH 
and 0.1 mL Ac2O. The vial was tightly capped and stirred at 100 
o
C for 24h. Upon done, 
the mixture was directly purified by flash column chromatography on silica gel 
(Hex/EA= about 10:1 to 3:1) to give the compounds 3.19b in 85% yield with E/Z = 
4.2:1.The TON for each oxidation catalytic cycle is 1700. Note this reaction was not 
monitored by TLC due to the very low catalyst loading. 
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Mono-Oxidation Procedure: 
 
Iodosobenzene diacetate (48.3 mg, 1.5 equiv in most cases) and the oxime 3.8a (34.5mg, 
0.1 mmol, 1 equiv) were charged in a scintillation vial, followed by 15 L 2mM 
Pd(OAc)2 solution in AcOH (0.0001 mmol, 0.1 mol%) and followed by 485 L AcOH 
and 0.1 mL Ac2O. The vial was tightly capped and stirred at 100 
o
C for 4h. The vial was 
then opened and added another 15 L 2mM Pd(OAc)2 solution. The vial was resealed 
and stirred at 100
o
C for 4h. Upon done, the mixture was directly purified by flash column 
chromatography on silica gel (Hex/EA= about 10:1 to 3:1) to give the compounds 3.8b in 
36% yield with E/Z = 5.6:1. The TON for each oxidation catalytic cycle is 600. The 
bisoxidized product was generated in a trace amount and observable on LC-MS but not 
isolatable. Note this reaction was not monitored by TLC due to the very low catalyst 
loading. 
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Preparation and X-ray structure data of 3.19c: 
 
The oxime 3.19a (345mg, 1 mmol, 1 equiv), PdCl2 (212mg, 1.2 mmol, 1.2 equiv) and 
NaOAc (246 mg, 3 mmol, 3 equiv) was added into a 20 mL vial, followed by 5 mL acetic 
acid. The vial was added stir-bar and then sealed. The reaction was conducted at 100
o
C, 
and monitored by TLC. After 1h, the reaction was complete and the solvent was removed 
under reduced pressure. The residue was dissolved in chloroform and washed with 1N 
HCl. The organic layer was dried over MgSO4, and the solvent was removed under 
reduced pressure. The desired compound was purified by flash column chromatography 
on silica gel (Hex/EA 10:1 to 3:1) to give the yellow solid. The crystal was obtained by 
slow evaporation DCM solvent.  
 
HRMS: calcd. C22H18NO3Pd
+
 [M-Cl]
+
: 450.0325. Found: 450.0319. 
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X-ray structure of Compound 3.19c: 
 
 Table 1. Crystal data and structure refinement for 3.19c. 
Empirical formula  C22 H18 Cl N O3 Pd 
Formula weight  486.22 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/c 
 Unit cell dimensions a = 19.306(8) Å  
 b = 4.5687(19) Å  
 c = 22.128(9) Å  
Volume 1896.5(14) Å3 
Z 4 
Density (calculated) 1.703 Mg/m3 
Absorption coefficient 1.143 mm-1 
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F(000) 976 
Crystal size 0.300 x 0.020 x 0.020 mm 
Theta range for data collection 3.202 to 25.349°. 
Index ranges -22<=h<=23, -5<=k<=5, -26<=l<=25 
Reflections collected 10572 
Independent reflections 3475 [R(int) = 0.1525] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.513 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3475 / 0 / 255 
Goodness-of-fit on F2 1.017 
Final R indices [I>2sigma(I)] R1 = 0.0771, wR2 = 0.1476 
R indices (all data) R1 = 0.1351, wR2 = 0.1706 
Extinction coefficient n/a 
Largest diff. peak and hole 0.930 and -1.213 e.Å-3 
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CHAPTER 4:  PRELIMINARY MECHANISTIC STUDIES ON 
PALLADIUM CATALYZED C−H BOND ACTIVATION WITH EXO-
DIRECTING GROUPS 
4.1 Introduction 
Pd-catalyzed C−H bond activation and carbon-heteroatom bond formation 
reactions are demonstrated as efficient transformations.
1
 Site selectivity is one of the 
grand challenges for developing synthetic methods because the wide existence of C−H 
bonds in molecules and their subtle differences.
2
 To achieve such selectivity, directing 
groups (DGs) are introduced, and among those, the endo-DGs are well established and 
studied by many other groups.
3
 The emergence of exo-directing strategy, as demonstrated 
for both aliphatic and aromatic C−H functionalization, has a significant impact on the 
late-stage C−H activation.4 
As demonstrated in previous chapters, by using oximes as DGs, there are three 
types of C−H bonds at -position of masked alcohols can be activated, and they are 
methyl, cyclic methylene, and bridgehead methine C−H bonds (Scheme 4.1).4f  
Scheme 4.1. Pd-Catalyzed C−H oxidation with exo-directing strategy. 
 
As the tertiary carbon radicals are stabilized by hyperconjugation, the methine 
C−H bonds are the weakest among all unactivated aliphatic C−H bonds (93 kcal/mol). 
Thus, the main obstacle to preparing the methine complex should not be thermodynamic 
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but due to the steric hindrance of the regular tertiary C−H bond. Since there is no 
precedent evidence that direct C−H activation could occur at methine C−H bonds with Pd 
precursor, the mechanistic pathway for this reaction is in doubt (Figure 4.1). Therefore, 
stoichiometric studies of the preparation of tertiary alkyl palladacycles through activation 
of a bridgehead C–H bond would provide important mechanistic information for 
palladium-catalyzed methine C–H activation. 
Figure 4.1. The mechanism for C−H activation at tertiary carbon center. 
 
4.2 Background 
With the efforts of many research groups, Pd-catalyzed functionalization of 
primary methyl C–H bonds has been extensively studied and several seminar works have 
also been realized for secondary methylene C–H bonds.2,5 Nevertheless, few examples 
have been developed for activating an unactivated tertiary C–H bond with Pd catalysis 
(Scheme 4.2).
4b, 6
  
In particularly, Babu and co-worker also demonstrated that using bidentate DG 
for the functionalization of the methine C–H bonds at bridgehead in norbornyl substrate 
in 2014. In this case, the methylene C−H bonds are more reactive than the methine ones 
(Figure 4.2). Interestingly, this result is a controversy to our observation using exo-DG 
that oxidation exclusively occurs at bridgehead C−H bonds. Therefore, to demonstrate 
the unique feature of our exo-directing strategy, it is important to obtain the Pd 
intermediate before the oxidation, to avoid the interference of any potential oxidative 
rearrangement.   
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Scheme 4.2. Representative Pd-catalyzed methine C−H functionalization. 
 
Figure 4.2. Pd-catalyzed C−H functionalization of norbornyl substrate. 
 
According to the literature, there are only a few reports on tertiary alkyl palladium 
complexes that have been obtained via three approaches: 1) transmetalation with an 
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acidic carbon nucleophile;
7
 2) cyclometalation with alkylidene cyclopropanes;
8
 and 3) 
alkyl group migration.
9
 These methods all requires special electronic or steric properties 
of the methine C−H bonds, and direct C−H activation at tertiary positions has not been 
reported previously. Thus, the success in obtaining a tertiary alkyl Pd complex would not 
only help to explain the mechanism of our reaction but answer a long existing 
organometallic question. 
Scheme 4.3. Representative tertiary alkyl Pd complexes. 
 
4.3 Reaction Design and Discussion 
As the mechanism of the reaction is not clear, the reaction could undergo radical 
pathway, which would make the attempts to isolate Pd complex pointless. Therefore, 
some preliminary studies were required to exclude the typical radical pathway through a 
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series of control experiments with substrates 4.1a and 4.1b. As shown in scheme 4.2, 
under the metal-free condition, or with other metal salts that typically promote radical 
formation, such as Cu(II), Fe(II) and Co(II), there was no desired product was observed. 
These results suggest a radical approach for C−H abstraction is disfavored. Thus, a 
cyclopalladation pathway is worth to explore. 
Scheme 4.4. Pd-catalyzed oxidation of bridgehead C−H bonds via an exo-DG. 
  
However, using oxime 4.1a substrate under various conditions to form a 
cyclopalladation complex remained unfruitful. In the absence of strong oxidants, e.g. 
PhI(OAc)2, the major reaction was found to be the Pd-mediated elimination of aldoxime 
to give 2,6-dimethoxynitrile (Figure 4.3). These unsuccessful results suggest that the 
active Pd complex with the 2,6-dimethoxylaldoxime DG was too reactive to isolate, and a 
more stable DG was required.  
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Figure 4.3. Pd-mediated elimination of aldoxime to give 2,6-dimethoxynitrile. 
 
When the more stable ketoxime 4.4 was used to avoid the potential elimination, 
the C–H activation Pd complex was expected to be formed. However, the complex 
obtained in 68% yield was a chloride-bridged palladium dimer, Pd complex 4.5, which 
precipitated during the reaction (Scheme 4.3). The absence of OAc group in complex 4.5 
was unexpected as the reaction was carried out with 3 equiv of NaOAc and the solvent 
amount of HOAc and without HCl workup. We hypothesized the further reaction did not 
occur as its solubility is too low in organic solvents. 
Scheme 4.5. Preparation of Pd complex 4.5. 
 
The low solubility of Pd complex 4.5 is presumably due to the inorganic nature of 
the chloride as X ligand, which leads us to consider the role of X ligands on Pd metal. 
Therefore, it is critical to apply an X ligand that could enable the concerted metalation-
deprotonation (CMD) pathway and stabilize the pallacycle intermediate. According to 
this analysis, we replaced an L ligand, the methoxy group on the 2,6-dimethoxyaloxime 
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DG, with an X ligand would provide a more suitable DG. To test this hypothesis, the 
salicylaldehyde aldoxime 4.6 was introduced as the substrate for cyclopalladation 
(Scheme 4.4), which contains one L ligand, the sp
2
 nitrogen of oxime, and one X ligand, 
the hydroxyl group. Although the salicylaldehyde-based DG has an available ortho-aryl 
C–H bond at the endo position, it is expected that the chelation between the phenoxide 
and imine nitrogen would overcome the endo effect to inhibit the potential ortho-
metalation. Upon treating the aldoxime 4.6 with PdCl2 and NaOAc in HOAc, there is no 
ortho C–H activation which is consistent with our speculation. However, the Pd species 
obtained are square planar complexes coordinated with two oxime substrates as 
inseparable diastereomers, in which the C−H bond remained intact.  
Scheme 4.6. Preparation of Pd complex 4.7. 
 
With this discouraging while inspiring result, we hypothesized that the formation 
of complex 4.7 was likely due to the lack of OAc group for the CMD process. Therefore, 
it is critical to remove one strong bidentate salicylaldoxime substrate from the Pd center 
for C–H cyclometalation to occur. Therefore, one equivalent of triphenylphosphine as an 
incoming strong L ligand was subsequently added at room temperature to compete with 
one oxime ligand in the presence of HOAc. To our delight, the desired tertiary alkyl 
palladacycle, Pd complex 4.8, was formed in high yield via an intramolecular C–H 
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abstraction, which was confirmed and characterized via crystallography (Scheme 4.5). 
Unfortunately, complex 4.8 exhibits low solubility in most organic solvents that become 
an obstacle for NMR characterization and further experiments with this complex. 
Scheme 4.7. C−H cyclopalladation at tertiary sp3 positions with substrate 4.6 
 
To overcome the solubility problem, the 5-tert-butylsalicylaldoxime was 
employed as DG in substrate 4.9, after many failed attempts. Following the similar two-
step procedure for preparation of complex 4.8, the desired palladacycle 4.10 was isolated 
in high yield (Scheme 4.6). With this new DG, the Pd complex 4.10 exhibits good 
solubility in most solvents, which allows full NMR characterization in addition to X-ray 
crystallography. According to the data obtained from the X-ray structure, there is no 
torsion for the spare planar Pd(II) complex, which could be a possible explanation of the 
unique site selectivity. 
It is worth to note that mix the triphenylphosphine at the beginning of the reaction 
with PdCl2 did not provide any cyclometalation complex, because of the reduction of 
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Pd(II) to Pd(0) by phosphine ligand. The reactivity of the Pd complex 4.10 was also 
tested by treating the complex with I2 at room temperature. The iodination smoothly 
furnished the tertiary C−H functionalization product, giving the C1-iodinated norbornene 
product 4.11, which is tedious to prepare through the carbon skeleton rearrangement 
through a carbocation.
10
   
Scheme 4.8. C−H cyclopalladation at tertiary sp3 positions with substrate 4.9 
 
 
4.4 Conclusion 
In summary, it is the first report of prepared and characterization of tertiary alkyl-
Pd(II) complexes via C–H activation, which is enabled by exo-DGs. This study indicates 
that C−H cyclopalladation can occur at tertiary sp3 positions in the present of cyclic 
methylene C−H bonds. The catalytic Pd functionalization of tertiary sp3 C–H bonds with 
different reactivity is under developing. This study would provide a solid basis for the 
further studies toward the mechanistic understanding of exo-directing strategy. 
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4.5 Experiment results 
4.5.1 GENERAL CONSIDERATIONS 
Unless otherwise noted, all experiments were carried out under air atmosphere. 
The other reagents and solvents were directly used from the supplier without further 
purification unless noted. Analytical thin-layer chromatography (TLC) was carried out 
using 0.2 mm commercial silica gel plates (silica gel 60, F254, EMD chemical). The vials 
(1 dram, 15×45 mm with PTFE-lined cap attached) were purchased from Qorpak and 
dried in an oven overnight and cooled in air. Infrared spectra were recorded on a Nicolet 
iS5 FT-IR Spectrometer using neat thin film technique. High-resolution mass spectra 
(HRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). 
Accurate masses are reported for the molecular ion [M+Na]
+
, [M+H]
+ 
or [2M-Cl]
+
. 
Nuclear magnetic resonance spectra (
1
H NMR and 
13
C NMR) were recorded with Varian 
Gemini (400 MHz, 
1
H at 400 MHz, 
13
C at 100 MHz) or Varian Gemini (500 MHz, 
1
H at 
500 MHz, 
13
C at 125 MHz). For CDCl3 solutions, the chemical shifts are reported as parts 
per million (ppm) referenced to residual protium or carbon of the solvents; CHCl3 
(7.26 ppm) and CDCl3 
Data for 
1
H NMR spectra are reported as follows: chemical shift (ppm, referenced to 
protium; s = singlet, d = doublet, t = triplet, q = quartet, p = pentet (quintet), dd = doublet 
of doublets, td = triplet of doublets, ddd = doublet of doublet of doublets, m = multiplet, 
coupling constant (Hz), and integration). 
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4.5.2 GENERAL PROCEDURE AND CHARACTERIZATION 
General Procedure Preparation and Characterization of Oxime Starting Materials 
 
To a solution of compound S1 (1 equiv) in MeOH (1.5 mL/mmol) was added hydrazine 
hydrate (1 equiv) at room temperature. After 1.5 h, the corresponding aldehyde or ketone 
was added (when ketone was used, 2 drops of AcOH were added). After the reaction was 
complete (30 mins for aldehyde and overnight for ketone), the solvent was removed 
under vacuo. The desired oxime product was further purified by flash column 
chromatography on silica gel. Compounds S1 and 1a were prepared according to our 
previous reported procedure.
4b
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(E)-1-(2,6-dimethoxyphenyl)ethan-1-one O-(endo-bicyclo[2.2.1]heptan-2-yl) oxime 
(4.4) 
The reaction was conducted on a 1.5 mmol scale with 2,6-dimethoxyacetophenone. The 
title compound was isolated as a white solid (0.4023 g, 93%). Rf value= 0.1 in 
Hexanes/EA= 10:1. Melting Point (air): 87-89 
o
C.
  
 
IR (neat): 2955, 2870, 2836, 1709, 1595, 1471, 1432, 1351, 1304, 1250 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 7.22 (t, J = 8.4 Hz, 1H), 6.55 (d, J = 8.4 Hz, 2H), 4.29 
(ddt, J = 7.2, 2.3, 1.0 Hz, 1H), 3.79 (s, 6H), 2.50 – 2.44 (m, 1H), 2.27 (td, J = 4.1, 1.7 Hz, 
1H), 2.07 (s, 3H), 1.67 – 1.41 (m, 5H), 1.15 – 1.03 (m, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 158.33, 152.37, 129.72, 116.36, 104.27, 85.31, 56.11, 
41.21, 38.30, 35.53, 34.89, 28.80, 24.29, 16.64.  
 
HRMS (ESI) Calcd. For C17H23NO3Na
+
 [M+Na]
+
: 312.1570, Found: 312.1579.  
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(E)-2-hydroxybenzaldehyde O-(exo-bicyclo[2.2.1]heptan-2-yl) oxime (4.6) 
The reaction was conducted on a 1.0 mmol scale with salicylaldehyde. The title 
compound was isolated as a colorless oil (0.2119 g, 92%). Rf value= 0.6 in Hexanes/EA= 
10:1.  
 
IR (neat): 3188, 2960, 2872, 1622, 1609, 1494, 1394, 1354, 1264 cm
-1
. 
 
1
H NMR (400 MHz, CDCl3) δ 10.08 (d, J = 0.4 Hz, 1H), 8.14 (s, 1H), 7.29 – 7.24 (m, 
1H), 7.14 (ddt, J = 7.7, 1.7, 0.5 Hz, 1H), 6.98 (ddt, J = 8.3, 1.1, 0.5 Hz, 1H), 6.93 – 6.87 
(m, 1H), 4.25 (ddt, J = 7.1, 2.3, 1.0 Hz, 1H), 2.53 – 2.47 (m, 1H), 2.34 – 2.28 (m, 1H), 
1.72 – 1.65 (m, 1H), 1.60 – 1.45 (m, 4H), 1.18 – 1.06 (m, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 157.56, 151.29, 131.05, 130.67, 119.63, 116.78, 116.77, 
86.81, 40.87, 37.96, 35.45, 34.71, 28.60, 24.23.  
 
HRMS (ESI) Calcd. For C14H17NO2
+
 [M+H]
+
: 232.1332, Found: 232.1331.  
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 (E)-5-(tert-butyl)-2-hydroxybenzaldehyde O-(exo-bicyclo[2.2.1]heptan-2-yl) oxime 
(4.9) 
The reaction was conducted on a 10.0 mmol scale with 5-(tert-butyl)-2-
hydroxybenzaldehyde. The title compound was isolated as a yellow oil (2.4041 g, 84%). 
Rf value= 0.5 in Hexanes/EA= 10:1.  
 
1
H NMR (400 MHz, CDCl3) δ 9.90 (s, 1H), 8.14 (s, 1H), 7.30 (dd, J = 8.6, 2.5 Hz, 1H), 
7.11 (d, J = 2.5 Hz, 1H), 6.94 – 6.89 (m, 1H), 4.24 (ddt, J = 7.1, 2.2, 1.0 Hz, 1H), 2.49 (d, 
J = 4.9 Hz, 1H), 2.34 – 2.26 (m, 1H), 1.67 (ddd, J = 13.4, 7.1, 2.5 Hz, 1H), 1.56 – 1.41 
(m, 4H), 1.29 (s, 9H), 1.12 (dddd, J = 11.5, 6.8, 3.8, 2.1 Hz, 3H).  
 
13
C NMR (100 MHz, CDCl3) δ 155.29, 151.75, 142.32, 128.32, 127.23, 116.31, 116.04, 
86.69, 40.86, 37.97, 35.46, 34.69, 34.09, 31.55, 28.63, 24.24.  
 
IR (neat): 3188, 2960, 2872, 1622, 1609, 1494, 1394, 1354, 1264 cm
-1
.  
 
HRMS (ESI) Calcd. For C18H25NO2Na
+
 [M+Na]
+
: 310.1778, Found: 310.1785. 
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General Procedure Preparation Procedure for the Palladium Complexes 
 
PdCl2 (17.7 mg, 0.1 mmol, 1 equiv), NaOAc (24.6mg, 0.3 mmol, 3 equiv) and the oxime 
substrate (0.1 mmol, 1 equiv) were added in a Schlenk flask, followed by 0.5 mL AcOH. 
The flask was freeze-pump-thawed for three times and charged with Ar, and then the 
reaction was stirred at 100 
o
C. The reaction was monitored by TLC and generally 
finished within 2. The mixture was purified according to the specific procedure in each 
case. In general, the crystal structures are obtained by slow evaporation of DCM and 
hexanes unless otherwise mentioned. 
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Pd complex 4.5 
The reaction was conducted on a 0.1 mmol scale. After the reaction was complete in 2h, 
the reaction was diluted with DCM and sequentially washed with water, and brine. The 
crude mixture was purified by column chromatography to give the title complex as a 
yellow solid (0.0319 g, 68%). However, the complex could form a number of isomers in 
solution, and the NMR spectra (-50 
o
C) are difficult to understand. Rf value= 0.27 in 
Hexanes/EA= 3:1. Melting Point (air): decompose at 120 
o
C.  
 
IR (neat): 2959, 2872, 2837, 1623, 1596, 1474, 1431, 1356, 1306, 1291, 1257 cm
-1
.  
 
HRMS (ESI) Calcd. For C34H36Cl3N4O2Pd2
+
 [2M-Cl]
+
: 850.9970, Found: 850.9978. 
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Pd complex 4.7 
The reaction was conducted on a 0.1 mmol scale. After the reaction was finished in 1h, 
the reaction was diluted with DCM and sequentially washed with water, and brine. The 
crude mixture was purified by column chromatography to give the title compound as a 
yellow-orange solid (0.0137 g, 97%). The mixture contains inseparable diastereomers in 
3:1 ratio, which is determined by NMR. Both of the diastereomers are not C2-
symmetrical according to the X-ray structure presumably due to the steric hindrance of 
the norbornyl skeleton. Rf value= 0.4 in Hexanes/EA= 5:1. Melting Point (air): 
decompose at 205 
o
C.  
 
IR (neat): 2958, 2870, 1602, 1533, 1465, 1440, 1350, 1307, 1194, 1149, 1128, 1070, 
1031 cm
-1
.  
 
1
H NMR for the distinctive peaks of major isomer (400 MHz, CDCl3) δ 7.97 (s, 1H), 7.29 
(ddd, J = 8.7, 4.5, 2.6 Hz, 1H), 7.14 (ddd, J = 7.9, 3.1, 1.8 Hz, 1H), 6.91 (d, J = 8.5 Hz, 
1H), 6.61 (dddd, J = 7.9, 6.8, 2.0, 1.1 Hz, 1H), 4.58 (ddt, J = 15.0, 7.4, 2.1 Hz, 1H), 2.40 
(dd, J = 23.7, 4.9 Hz, 1H), 2.34 (s, 1H), 1.76 (ddt, J = 13.7, 7.3, 2.3 Hz, 1H), 1.64 (dd, J 
= 5.4, 2.7 Hz, 2H), 1.56 – 1.41 (m, 3H), 1.13 – 1.03 (m, 2H).  
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13
C NMR for the distinctive peaks of major isomer (125 MHz, CDCl3) δ 164.56, 164.54, 
157.52, 135.10, 133.41, 120.41, 120.37, 115.49, 115.46, 114.63, 114.55, 88.25, 88.19, 
39.05, 38.79, 37.63, 37.55, 35.52, 35.50, 35.00, 34.83, 28.43, 28.42, 24.09, 23.95.  
 
HRMS (ESI) Calcd. For C26H36ClN2O6Pd2
+
 [M]
+
: 721.0337, Found: 721.0331. 
 
 
Pd complex 4.8 
The reaction was conducted on a 0.5 mmol scale. After the reaction was finished in 1h, 1 
equiv of PPh3 was added, and the reaction was stirred for another 30 mins. The solid was 
suspended in the large excess amount of DCM and washed with hexanes and water three 
times. After addition of hexanes to the solution, a yellow solid was precipitated and 
collected to give Pd complex 4.8 as a yellow solid (0.1435 g, 96%). The crystal was 
obtained by dissolving the complex in a large amount of DCM, and then slowly diffusion 
with hexanes. The complex 4.8 has low solubility in most organic solvents for NMR 
characterization. Melting Point (air): decompose at 200 
o
C.  
 
FT-IR (neat): 2955, 2870, 2836, 1709, 1595, 1471, 1432, 1351, 1304, 1250 cm
-1
.  
 
HRMS (ESI) Calcd. For C32H30NO2PPd
+
 [M+H]
+
: 598.1134, Found: 598.1128. 
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Pd complex 4.10 
The reaction was conducted on a 0.1 mmol scale. After the reaction was finished in 2h, 1 
equiv of PPh3 was added, and the reaction was purified by column chromatography to 
give the title complex as a yellow solid (0.0269 g, 82%). Rf value= 0.4 in Hexanes/EA= 
3:1. Melting Point (air): decompose at 215 
o
C.  
 
IR (neat): 3054, 2952, 2860, 1612, 1518, 1469, 1435 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 8.3 Hz, 1H), 7.77 (ddd, J = 11.1, 8.0, 1.6 Hz, 
6H), 7.55 – 7.32 (m, 9H), 7.21 (dd, J = 8.9, 2.7 Hz, 1H), 6.99 (d, J = 2.7 Hz, 1H), 6.49 (d, 
J = 8.9 Hz, 1H), 4.05 (dt, J = 6.3, 1.6 Hz, 1H), 1.90 (t, J = 4.3 Hz, 1H), 1.56 (ddt, J = 
13.0, 4.3, 2.5 Hz, 1H), 1.44 – 1.39 (m, 1H), 1.37 – 1.32 (m, 1H), 1.25 (s, 9H), 1.03 – 0.91 
(m, 2H), 0.81 (ddd, J = 11.2, 6.8, 4.1 Hz, 1H), 0.67 – 0.56 (m, 1H), 0.21 (dq, J = 9.7, 1.3 
Hz, 1H).  
 
13
C NMR (100 MHz, CDCl3) δ 165.31, 148.62 (d, J = 2.8 Hz), 135.43, 135.22 (d, J = 
12.3 Hz), 131.21, 130.48 (d, J = 46.1 Hz), 130.44 (d, J = 2.4 Hz), 128.80, 128.06 (d, J = 
10.5 Hz), 122.30, 115.24, 92.43, 60.93 (d, J = 5.0 Hz), 39.03, 35.11, 34.21, 33.62, 32.46 
(d, J = 6.1 Hz), 31.56, 29.64 (d, J = 3.5 Hz).  
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31
P NMR (160 MHz, CDCl3) δ 34.93. 
 
HRMS (ESI) Calcd. For C36H38NO2PPd
+
 [M+H]
+
: 654.1761, Found: 654.1776. 
Reaction of Pd complex 10 with Iodine 
 
In a vial charged with Pd complex 10 (0.0654 g, 0.1 mmol, 1 equiv) and I2 (0.0284g, 0.1 
mmol, 1 equiv), 1 mL of DCM was added as solvent. The reaction was stirred at room 
temperature for 30 min. After the reaction had been finished, the reaction was purified by 
column chromatography to give the title compound as a dark oil light sensitive (0.0222 g, 
54%). Rf value= 0.3 in Hexanes/EA= 10:1.  
IR (neat): 3217, 2961, 2871, 1621, 1608, 1580, 1494, 1462, 1439, 1384, 1364, 1262 cm
-1
.  
 
1
H NMR (400 MHz, CDCl3) δ 9.65 (s, 1H), 8.25 (s, 1H), 7.31 (dd, J = 8.7, 2.5 Hz, 1H), 
7.13 (d, J = 2.4 Hz, 1H), 6.92 (dd, J = 8.6, 0.5 Hz, 1H), 4.21 (td, J = 4.9, 1.4 Hz, 1H), 
2.24 – 2.17 (m, 1H), 2.14 – 2.04 (m, 2H), 1.87 – 1.78 (m, 3H), 1.74 – 1.53 (m, 3H), 1.29 
(s, 9H).  
 
13
C NMR (100 MHz, CDCl3) δ 155.22, 152.38, 142.42, 128.61, 127.49, 116.38, 115.89, 
87.91, 47.05, 40.39, 39.45, 39.22, 34.81, 34.11, 31.55, 31.43.  
 
HRMS (ESI) Calcd. For C18H24INO2
+
 [M+H]
+
: 414.0924, Found: 414.0924. 
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X-ray Structures Data: 
X-ray structure data of Pd complex 4.5: 
 
 
Table 4.1.1. Crystal data and structure refinement for Pd complex 4.5. 
Empirical formula     C34 H46 Cl4 N2 O6 Pd2 
Formula weight     933.33 
Temperature      100(2) K 
Wavelength      1.54184 Å 
Crystal system     monoclinic 
Space group      P 21/n 
  Unit cell dimensions   a = 14.9412(8) Å  
      b = 8.7902(6) Å  
 301 
      c = 15.9120(9) Å  
Volume     1863.8(2) Å3 
Z      2 
Density (calculated)    1.663 Mg/m3 
Absorption coefficient   10.797 mm-1 
F(000)      944 
Crystal size     0.076 x 0.051 x 0.025 mm3 
Theta range for data collection  3.370 to 74.553°. 
Index ranges     -18<=h<=18, -10<=k<=7, -19<=l<=19 
Reflections collected    8709 
Independent reflections   3662 [R(int) = 0.0431] 
Completeness to theta = 67.684°  99.5 %  
Absorption correction Gaussian 
Max. and min. transmission   0.940 and 0.872 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   3662 / 0 / 220 
Goodness-of-fit on F2    1.051 
Final R indices [I>2sigma(I)]   R1 = 0.0498, wR2 = 0.1102 
R indices (all data)    R1 = 0.0687, wR2 = 0.1201 
Extinction coefficient    n/a 
Largest diff. peak and hole   0.727 and -0.782 e.Å-3 
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Table 4.1.2. Atomic coordinates and equivalent isotropic displacement parameters for Pd 
complex 4.5. 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. Atomic 
coordinates  ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
________________________________________________________________________ 
Atom     x     y     z   U(eq) 
________________________________________________________________________ 
C1  8725(5)  2004(9)  6363(4)  63(2) 
C2  7684(4)  2404(8)  5623(4)  45(1) 
C3  7040(4)  1147(7)  5010(4)  41(1) 
C4  6529(4)  164(7)   5331(4)  42(1) 
C5  5971(5)  -1035(7)  4770(4)  46(1) 
C6  5958(4)  -1264(8)  3904(4)  47(2) 
C7  6485(4)  -349(7)  3596(4)  46(2) 
C8  7050(4)  858(7)   4156(4)  42(1) 
C9  6380(6)  -736(9)  6671(5)  61(2) 
C10  7600(6)  1654(11)  3034(4)  74(2) 
C11  8073(4)  6142(7)  5569(4)  45(2) 
C12  8657(6)  7410(10)  6288(5)  71(2) 
C13  9589(6)  7589(11)  6243(5)  74(2) 
C14  9377(5)  8344(9)  5305(5)  67(2) 
C15  8826(7)  7080(11)  4587(6)  82(3) 
C16  8781(6)  5746(10)  5152(5)  67(2) 
C17  9833(5)  5988(8)  6083(5)  59(2) 
N1  7324(3)  3740(6)  5467(3)  38(1) 
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O1  6642(3)  458(5)   6213(3)  51(1) 
O2  7671(3)  1763(6)  3964(3)  50(1) 
O3  7960(3)  4859(5)  6079(3)  50(1) 
Cl1  4270(1)  5363(2)  3918(1)  45(1) 
Cl2  6011(1)  4434(2)  3318(1)  50(1) 
Pd1  5903(1)  4450(1)  4695(1)  38(1) 
_____________________________________________________________ 
Table 4.1.3. Bond lengths [Å] and angles [°] for Pd complex 4.5. 
________________________________________________________________________ 
 
C1-C2  1.507(8) 
C1-H1A   0.98 
C1-H1B   0.98 
C1-H1C   0.98 
C2-N1  1.268(8) 
C2-C3  1.500(8) 
C3-C8  1.390(8) 
C3-C4  1.394(9) 
C4-O1  1.361(7) 
C4-C5  1.389(9) 
C5-C6  1.383(8) 
C5-H5  0.9500 
C6-C7  1.362(9) 
C6-H6  0.9500 
C7-C8  1.397(8) 
C7-H7  0.9500 
C8-O2  1.357(7) 
C9-O1  1.430(8) 
C9-H9A   0.98 
C9-H9B   0.98 
C9-H9C   0.98 
C10-O2   1.439(7) 
C10-H10A   0.98 
C10-H10B   0.98 
C10-H10C   0.98 
C11-O3   1.443(7) 
C11-C16   1.522(10) 
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C11-C12   1.552(9) 
C11-H11   1.00 
C12-C13   1.434(11) 
C12-H12A   0.99 
C12-H12B   0.99 
C13-C17   1.505(11) 
C13-C14   1.530(10) 
C13-H13   1.00 
C14-C15   1.539(11) 
C14-H14A   0.99 
C14-H14B   0.99 
C15-C16   1.497(11) 
C15-H15A   0.99 
C15-H15B   0.99 
C16-C17   1.614(9) 
C16-H16   1.00 
C17-H17A   0.99 
C17-H17B   0.99 
N1-O3   1.408(6) 
N1-Pd1   2.012(5) 
Cl1-Pd1   2.3223(14) 
Cl1-Pd1#1   2.3408(15) 
Cl2-Pd1   2.2698(15) 
Pd1-Cl1#1   2.3408(15) 
C2-C1-H1A  109.5 
C2-C1-H1B  109.5 
H1A-C1-H1B  109.5 
C2-C1-H1C  109.5 
H1A-C1-H1C  109.5 
H1B-C1-H1C  109.5 
N1-C2-C3  117.6(5) 
N1-C2-C1  124.5(6) 
C3-C2-C1  117.9(6) 
C8-C3-C4  119.7(6) 
C8-C3-C2  118.9(6) 
C4-C3-C2  121.0(5) 
O1-C4-C5  124.5(6) 
O1-C4-C3  115.3(5) 
C5-C4-C3  120.2(5) 
C6-C5-C4  119.0(6) 
C6-C5-H5  120.5 
C4-C5-H5  120.5 
C7-C6-C5  121.5(6) 
C7-C6-H6  119.3 
C5-C6-H6  119.3 
C6-C7-C8  120.0(6) 
C6-C7-H7  120.0 
C8-C7-H7  120.0 
O2-C8-C3  115.1(5) 
O2-C8-C7  125.4(5) 
 305 
C3-C8-C7  119.4(6) 
O1-C9-H9A  109.5 
O1-C9-H9B  109.5 
H9A-C9-H9B  109.5 
O1-C9-H9C  109.5 
H9A-C9-H9C  109.5 
H9B-C9-H9C  109.5 
O2-C10-H10A 109.5 
O2-C10-H10B 109.5 
H10A-C10-H10B 109.5 
O2-C10-H10C 109.5 
H10A-C10-H10C 109.5 
H10B-C10-H10C 109.5 
O3-C11-C16  110.3(6) 
O3-C11-C12  108.5(5) 
C16-C11-C12  102.5(6) 
O3-C11-H11  111.7 
C16-C11-H11  111.7 
C12-C11-H11  111.7 
C13-C12-C11  106.1(7) 
C13-C12-H12A 110.5 
C11-C12-H12A 110.5 
C13-C12-H12B 110.5 
C11-C12-H12B 110.5 
H12A-C12-H12B 108.7 
C12-C13-C17  102.8(7) 
C12-C13-C14  108.6(7) 
C17-C13-C14  101.5(7) 
C12-C13-H13  114.2 
C17-C13-H13  114.2 
C14-C13-H13  114.2 
C13-C14-C15  102.5(7) 
C13-C14-H14A 111.3 
C15-C14-H14A 111.3 
C13-C14-H14B 111.3 
C15-C14-H14B 111.3 
H14A-C14-H14B 109.2 
C16-C15-C14  105.9(6) 
C16-C15-H15A 110.6 
C14-C15-H15A 110.6 
C16-C15-H15B 110.6 
C14-C15-H15B 110.6 
H15A-C15-H15B 108.7 
C15-C16-C11  108.2(7) 
C15-C16-C17  99.1(6) 
C11-C16-C17  98.6(6) 
C15-C16-H16  116.1 
C11-C16-H16  116.1 
C17-C16-H16  116.1 
C13-C17-C16  93.9(6) 
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C13-C17-H17A 112.9 
C16-C17-H17A 112.9 
C13-C17-H17B 112.9 
C16-C17-H17B 112.9 
H17A-C17-H17B 110.4 
C2-N1-O3  114.7(4) 
C2-N1-Pd1  130.1(4) 
O3-N1-Pd1  113.7(4) 
C4-O1-C9  116.9(5) 
C8-O2-C10  116.9(5) 
N1-O3-C11  111.8(4) 
Pd1-Cl1-Pd1#1 93.42(4) 
N1-Pd1-Cl2  94.06(14) 
N1-Pd1-Cl1  175.22(14) 
Cl2-Pd1-Cl1  90.27(5) 
N1-Pd1-Cl1#1  89.00(14) 
Cl2-Pd1-Cl1#1 175.82(6) 
Cl1-Pd1-Cl1#1 86.58(4) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       
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Table 4.1.4. Anisotropic displacement parameters for Pd complex 4.5. 
The anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ... + 2 h k 
a* b* U12 ]. Anisotropic displacement parameters (Å2x 103). 
________________________________________________________________________  
Atom U11  U22   U33  U23  U13  U12 
________________________________________________________________________  
C1 46(4)   74(5)  44(3)   -8(3)  0(3)   11(3) 
C2 39(3)   58(4)  33(3)   2(3)  11(2)   3(3) 
C3 34(3)   49(3)  32(3)   0(2)  8(2)   0(3) 
C4 38(3)   54(4)  31(2)   5(3)  15(2)   10(3) 
C5 42(3)   45(3)  46(3)   4(3)  15(3)   5(3) 
C6 44(3)   50(4)  40(3)   -1(3)  14(3)   3(3) 
C7 42(3)   61(4)  32(3)   -4(3)  13(2)   5(3) 
C8 35(3)   54(4)  30(2)   4(3)  8(2)   6(3) 
C9 72(5)   68(5)  45(3)   16(3)  29(3)   15(4) 
C10 61(4)   120(7)  43(3)   6(4)  27(3)   -16(5) 
C11 33(3)   44(3)  48(3)   -4(3)  7(2)   -5(3) 
C12 67(5)   84(6)  56(4)   -12(4)  22(4)   -17(4) 
C13 60(5)   97(7)  60(4)   -8(4)  23(4)   -8(5) 
C14 56(4)   63(5)  66(4)   9(4)  14(3)   -10(4) 
C15 87(6)   95(7)  63(5)   -1(5)  34(4)   -1(5) 
C16 74(5)   70(5)  58(4)   0(4)  31(4)   -8(4) 
C17 39(3)   58(4)  65(4)   0(3)  11(3)   -2(3) 
N1 36(2)   42(3)  28(2)   -3(2)  7(2)   -10(2) 
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O1 59(3)   59(3)  35(2)   2(2)  22(2)   7(2) 
O2 42(2)   71(3)  37(2)   2(2)  17(2)   -5(2) 
O3 46(2)   57(3)  33(2)   -3(2)  6(2)   -12(2) 
Cl1 40(1)   57(1)  29(1)   7(1)  9(1)   8(1) 
Cl2 46(1)   67(1)  30(1)   5(1)  11(1)   4(1) 
Pd1 36(1)   40(1)  27(1)   2(1)  6(1)   -2(1) 
________________________________________________________________________  
 
Table 4.1.5. H coordinates and isotropic displacement parameters for Pd complex 4.5. 
Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
________________________________________________________________________ 
Hydrogen x    y    z    U(eq) 
________________________________________________________________________  
H1A  9093   1501   6064   94 
H1B  8678   1316   6827   94 
H1C  9079   2933   6679   94 
H5  5605   -1688   4977   56 
H6  5573   -2077   3516   56 
H7  6468   -533   3001   55 
H9A  5649   -859   6370   91 
H9B  6618   -479   7338   91 
H9C  6693   -1688   6621   91 
H10A  7859   666   2960   110 
H10B  7995   2469   2943   110 
H10C  6896   1753   2564   110 
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H11  7410   6514   5076   55 
H12A  8272   8373   6119   85 
H12B  8779   7111   6931   85 
H13  10128   8096   6808   89 
H14A  10007   8638   5287   80 
H14B  8947   9255   5190   80 
H15A  8142   7413   4140   98 
H15B  9197   6812   4226   98 
H16  8679   4729   4840   80 
H17A  9920   5288   6602   71 
H17B  10421   5929   5954   71 
________________________________________________________________________  
 
Table 4.1.6. Torsion angles [°] for Pd complex 4.5. 
_____________________________________________________________________ 
N1-C2-C3-C8   85.9(8) 
C1-C2-C3-C8   -92.3(7) 
N1-C2-C3-C4   -101.6(7) 
C1-C2-C3-C4   80.1(8) 
C8-C3-C4-O1   173.9(5) 
C2-C3-C4-O1   1.5(8) 
C8-C3-C4-C5   -4.7(9) 
C2-C3-C4-C5   -177.1(5) 
O1-C4-C5-C6   -176.5(5) 
C3-C4-C5-C6   2.0(9) 
C4-C5-C6-C7   0.5(9) 
C5-C6-C7-C8   -0.4(9) 
C4-C3-C8-O2   -171.9(5) 
C2-C3-C8-O2   0.6(8) 
C4-C3-C8-C7   4.8(8) 
C2-C3-C8-C7   177.4(5) 
C6-C7-C8-O2   174.1(6) 
C6-C7-C8-C3   -2.3(9) 
O3-C11-C12-C13  115.2(7) 
C16-C11-C12-C13  -1.4(8) 
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C11-C12-C13-C17  -35.9(8) 
C11-C12-C13-C14  71.1(9) 
C12-C13-C14-C15  -70.0(9) 
C17-C13-C14-C15  37.8(8) 
C13-C14-C15-C16  -0.7(9) 
C14-C15-C16-C11  68.8(8) 
C14-C15-C16-C17  -33.5(8) 
O3-C11-C16-C15  176.9(5) 
C12-C11-C16-C15  -67.8(7) 
O3-C11-C16-C17  -80.5(6) 
C12-C11-C16-C17  34.8(7) 
C12-C13-C17-C16  55.7(7) 
C14-C13-C17-C16  -56.6(7) 
C15-C16-C17-C13  55.3(7) 
C11-C16-C17-C13  -54.8(7) 
C3-C2-N1-O3   178.9(5) 
C1-C2-N1-O3   -3.0(9) 
C3-C2-N1-Pd1  14.3(9) 
C1-C2-N1-Pd1  -167.6(5) 
C5-C4-O1-C9   15.8(8) 
C3-C4-O1-C9   -162.8(5) 
C3-C8-O2-C10  -171.3(6) 
C7-C8-O2-C10  12.1(9) 
C2-N1-O3-C11  129.1(6) 
Pd1-N1-O3-C11  -63.8(5) 
C16-C11-O3-N1  -76.4(6) 
C12-C11-O3-N1  172.1(5) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1       
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X-ray structure data of Pd complex 4.7: 
 
The major diastereomer of Pd complex 
4.7: 
 
 
The minor diastereomer of Pd complex 
4.7:
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Table 4.2.1. Crystal data and structure refinement for Pd complex 4.7. 
Empirical formula     C28 H32 N2 O4 Pd 
Formula weight     566.95 
Temperature      100(2) K 
Wavelength      0.71073 Å 
Crystal system     orthorhombic 
Space group      P 21 21 21 
  Unit cell dimensions   a = 5.8758(11) Å  
      b = 17.966(4) Å  
      c = 23.513(4) Å  
Volume     2482.2(8) Å3 
Z      4 
Density (calculated)    1.517 Mg/m3 
Absorption coefficient   0.785 mm-1 
F(000)      1168 
Crystal size     0.230 x 0.070 x 0.040 mm3 
Theta range for data collection  3.450 to 27.463°. 
Index ranges     -7<=h<=7, -23<=k<=23, -29<=l<=30 
Reflections collected    39216 
Independent reflections   5677 [R(int) = 0.0590] 
Completeness to theta = 25.242°  99.7 %  
Absorption correction    Semi-empirical from equivalents 
Max. and min. transmission   1.00 and 0.800 
Refinement method    Full-matrix least-squares on F2 
Data / restraints / parameters   5677 / 375 / 438 
Goodness-of-fit on F2    1.163 
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Final R indices [I>2sigma(I)]   R1 = 0.0343, wR2 = 0.0650 
R indices (all data)    R1 = 0.0374, wR2 = 0.0660 
Absolute structure parameter   -0.033(15) 
Extinction coefficient    n/a 
Largest diff. peak and hole   0.419 and -0.807 e.Å-3 
 
Table 4.2.2. Atomic coordinates and equivalent isotropic displacement parameters for 4.7.   
U(eq) is defined as one-third of the trace of the orthogonalized Uij tensor. 
Atomic coordinates (x 10
4
) and equivalent  isotropic displacement parameters (Å
2
x 10
3
) 
______________________________________________________________________________  
Atom   x   y   z   U(eq) 
______________________________________________________________________________   
C1   3196(9)  454(2)   7596(2)  24(1) 
C2   2642(10)  489(3)   8182(2)  31(1) 
C3   4161(9)  262(3)   8591(3)  39(1) 
C4   6294(10)  2(3)   8447(2)  40(2) 
C5   6894(10)  -35(3)   7887(2)  32(1) 
C6   5384(9)  187(3)   7450(2)  23(1) 
C7   6187(9)  108(3)   6881(2)  24(1) 
C8   5265(8)  -383(3)  5567(2)  20(1) 
C9   6280(20)  -309(7)  4975(6)  30(2) 
C10   7496(14)  -1047(4)  4870(3)  34(2) 
C11   5680(30)  -1647(8)  4796(8)  40(2) 
C12   4684(16)  -1723(5)  5398(4)  40(2) 
C13   6040(20)  -1169(8)  5755(6)  27(2) 
C14   8332(13)  -1218(5)  5471(3)  33(2) 
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C9A   5520(40)  -1163(17)  5813(11)  31(4) 
C10A   7020(30)  -1564(7)  5385(6)  36(2) 
C11A   5630(50)  -1691(13)  4846(15)  39(3) 
C12A   5310(30)  -897(8)  4618(6)  35(3) 
C13A   6670(40)  -404(11)  5022(12)  30(4) 
C14A   8550(20)  -923(9)  5198(7)  35(3) 
C15   1092(8)  1302(2)  5226(2)  18(1) 
C16   1648(8)  1273(2)  4638(2)  23(1) 
C17   141(9)   1515(3)  4231(2)  24(1) 
C18   -1985(9)  1807(2)  4383(2)  24(1) 
C19   -2556(8)  1843(2)  4948(2)  22(1) 
C20   -1060(8)  1600(2)  5377(2)  18(1) 
C21   -1809(8)  1688(2)  5950(2)  18(1) 
C22   -660(40)  2140(12)  7270(11)  14(4) 
C23   -634(17)  2942(6)  7036(4)  23(2) 
C24   -2101(17)  3373(4)  7461(3)  30(2) 
C25   -760(20)  3439(6)  8012(5)  31(3) 
C26   -756(17)  2630(5)  8251(4)  34(2) 
C27   -2100(30)  2210(8)  7804(7)  29(4) 
C28   -3894(16)  2793(6)  7613(6)  31(2) 
C22A   -1050(60)  2110(17)  7280(17)  25(9) 
C23A   -2160(50)  2019(11)  7861(9)  20(4) 
C24A   -3420(20)  2756(7)  7963(6)  32(3) 
C25A   -1660(30)  3365(12)  8083(8)  43(6) 
C26A   -410(20)  3456(8)  7506(7)  38(3) 
C27A   -1650(20)  2922(8)  7116(6)  24(4) 
C28A   -4070(20)  2964(9)  7349(6)  30(4) 
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O1   1653(6)  671(2)   7232(1)  25(1) 
O2   6318(5)  183(2)   5921(1)  20(1) 
O3   2633(5)  1059(2)  5584(1)  20(1) 
O4   -1941(7)  1607(2)  6905(1)  22(1) 
Pd1   2157(1)  878(1)   6409(1)  16(1) 
N1   5063(6)  289(2)   6428(2)  20(1) 
N2   -696(6)  1489(2)  6399(2)  18(1) 
______________________________________________________________________________  
 
Table 4.2.3. Bond lengths [Å] and angles [°] for 4.7. 
_________________________________________________________________________  
C1-O1  1.307(5) 
C1-C2  1.416(6) 
C1-C6  1.415(7) 
C2-C3  1.374(7) 
C2-H2  0.95 
C3-C4  1.380(8) 
C3-H3  0.95 
C4-C5  1.365(7) 
C4-H4  0.95 
C5-C6  1.415(7) 
C5-H5  0.95 
C6-C7  1.426(7) 
C7-N1  1.295(6) 
C7-H7  0.95 
C8-O2  1.454(5) 
C8-C9  1.519(16) 
C8-C13A   1.52(3) 
C8-C9A   1.52(3) 
C8-C13   1.549(15) 
C8-H8  0.96(5) 
C9-C10   1.525(13) 
C9-H9A   0.99 
C9-H9B   0.99 
C10-C11   1.526(15) 
C10-C14   1.527(10) 
C10-H10   1.00 
C11-C12   1.54(2) 
C11-H11A   0.99 
C11-H11B   0.99 
C12-C13   1.526(17) 
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C12-H12A   0.99 
C12-H12B   0.99 
C13-C14   1.507(13) 
C13-H13   1.00 
C14-H14A   0.99 
C14-H14B   0.99 
C9A-C10A   1.519(18) 
C9A-H9A1   0.99 
C9A-H9A2   0.99 
C10A-C11A   1.524(18) 
C10A-C14A   1.528(13) 
C10A-H10A   1.00 
C11A-C12A   1.54(3) 
C11A-H11C   0.99 
C11A-H11D   0.99 
C12A-C13A   1.52(2) 
C12A-H12C   0.99 
C12A-H12D   0.99 
C13A-C14A   1.507(17) 
C13A-H13A   1.00 
C14A-H14C   0.99 
C14A-H14D   0.99 
C15-O3   1.310(5) 
C15-C20   1.419(6) 
C15-C16   1.421(6) 
C16-C17   1.374(7) 
C16-H16   0.95 
C17-C18   1.401(7) 
C17-H17   0.95 
C18-C19   1.371(6) 
C18-H18   0.95 
C19-C20   1.409(6) 
C19-H19   0.95 
C20-C21   1.425(6) 
C21-N2   1.292(6) 
C21-H21   0.95 
C22-O4   1.49(2) 
C22-C27   1.52(3) 
C22-C23   1.54(3) 
C22-H22   1.00 
C23-C24   1.531(12) 
C23-H23A   0.99 
C23-H23B   0.99 
C24-C25   1.523(14) 
C24-C28   1.524(12) 
C24-H24   1.00 
C25-C26   1.558(15) 
C25-H25A   0.99 
C25-H25B   0.99 
C26-C27   1.517(19) 
C26-H26A   0.99 
C26-H26B   0.99 
C27-C28   1.552(17) 
C27-H27   1.00 
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C28-H28A   0.99 
C28-H28B   0.99 
C22A-O4   1.37(3) 
C22A-C23A   1.52(4) 
C22A-C27A   1.55(3) 
C22A-H22A   1.00 
C23A-C24A   1.54(2) 
C23A-H23C   0.99 
C23A-H23D   0.99 
C24A-C25A   1.531(18) 
C24A-C28A   1.539(16) 
C24A-H24A   1.00 
C25A-C26A   1.55(2) 
C25A-H25C   0.99 
C25A-H25D   0.99 
C26A-C27A   1.513(19) 
C26A-H26C   0.99 
C26A-H26D   0.99 
C27A-C28A   1.527(17) 
C27A-H27A   1.00 
C28A-H28C   0.99 
C28A-H28D   0.99 
O1-Pd1   1.991(3) 
O2-N1   1.413(5) 
O3-Pd1   1.988(3) 
O4-N2   1.412(5) 
Pd1-N2   2.004(3) 
Pd1-N1   2.009(3) 
O1-C1-C2  117.7(5) 
O1-C1-C6  124.9(4) 
C2-C1-C6  117.4(5) 
C3-C2-C1  121.2(6) 
C3-C2-H2  119.4 
C1-C2-H2  119.4 
C2-C3-C4  121.3(6) 
C2-C3-H3  119.3 
C4-C3-H3  119.3 
C5-C4-C3  119.2(5) 
C5-C4-H4  120.4 
C3-C4-H4  120.4 
C4-C5-C6  121.6(6) 
C4-C5-H5  119.2 
C6-C5-H5  119.2 
C1-C6-C5  119.3(5) 
C1-C6-C7  124.2(5) 
C5-C6-C7  116.5(5) 
N1-C7-C6  125.3(5) 
N1-C7-H7  117.3 
C6-C7-H7  117.3 
O2-C8-C9  107.2(6) 
O2-C8-C13A  105.6(9) 
O2-C8-C9A  112.6(12) 
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C13A-C8-C9A 104.1(8) 
O2-C8-C13  110.4(6) 
C9-C8-C13  103.1(6) 
O2-C8-H8  106(3) 
C9-C8-H8  113(3) 
C13A-C8-H8  123(3) 
C9A-C8-H8  106(3) 
C13-C8-H8  117(3) 
C8-C9-C10  104.9(8) 
C8-C9-H9A  110.8 
C10-C9-H9A  110.8 
C8-C9-H9B  110.8 
C10-C9-H9B  110.8 
H9A-C9-H9B  108.8 
C11-C10-C9  107.8(9) 
C11-C10-C14  100.8(10) 
C9-C10-C14  100.1(7) 
C11-C10-H10  115.4 
C9-C10-H10  115.4 
C14-C10-H10  115.4 
C10-C11-C12  103.0(8) 
C10-C11-H11A 111.2 
C12-C11-H11A 111.2 
C10-C11-H11B 111.2 
C12-C11-H11B 111.2 
H11A-C11-H11B 109.1 
C13-C12-C11  104.4(8) 
C13-C12-H12A 110.9 
C11-C12-H12A 110.9 
C13-C12-H12B 110.9 
C11-C12-H12B 110.9 
H12A-C12-H12B 108.9 
C14-C13-C12  100.6(9) 
C14-C13-C8  100.9(9) 
C12-C13-C8  106.5(9) 
C14-C13-H13  115.6 
C12-C13-H13  115.6 
C8-C13-H13  115.6 
C13-C14-C10  96.4(8) 
C13-C14-H14A 112.5 
C10-C14-H14A 112.5 
C13-C14-H14B 112.5 
C10-C14-H14B 112.5 
H14A-C14-H14B 110.0 
C10A-C9A-C8 104.0(14) 
C10A-C9A-H9A1 111.0 
C8-C9A-H9A1 111.0 
C10A-C9A-H9A2 111.0 
C8-C9A-H9A2 111.0 
H9A1-C9A-H9A2 109.0 
C9A-C10A-C11A 108.2(15) 
C9A-C10A-C14A 100.1(13) 
C11A-C10A-C14A 100.9(16) 
C9A-C10A-H10A 115.2 
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C11A-C10A-H10A 115.2 
C14A-C10A-H10A 115.2 
C10A-C11A-C12A 102.5(10) 
C10A-C11A-H11C 111.3 
C12A-C11A-H11C 111.3 
C10A-C11A-H11D 111.3 
C12A-C11A-H11D 111.3 
H11C-C11A-H11D 109.2 
C13A-C12A-C11A 105.1(11) 
C13A-C12A-H12C 110.7 
C11A-C12A-H12C 110.7 
C13A-C12A-H12D 110.7 
C11A-C12A-H12D 110.7 
H12C-C12A-H12D 108.8 
C14A-C13A-C8 100.5(15) 
C14A-C13A-C12A 101.2(13) 
C8-C13A-C12A 104.9(16) 
C14A-C13A-H13A 116.0 
C8-C13A-H13A 116.0 
C12A-C13A-H13A 116.0 
C13A-C14A-C10A 96.4(11) 
C13A-C14A-H14C 112.5 
C10A-C14A-H14C 112.5 
C13A-C14A-H14D 112.5 
C10A-C14A-H14D 112.5 
H14C-C14A-H14D 110.0 
O3-C15-C20  125.5(4) 
O3-C15-C16  116.9(4) 
C20-C15-C16  117.6(4) 
C17-C16-C15  121.2(5) 
C17-C16-H16  119.4 
C15-C16-H16  119.4 
C16-C17-C18  121.1(5) 
C16-C17-H17  119.5 
C18-C17-H17  119.5 
C19-C18-C17  118.8(5) 
C19-C18-H18  120.6 
C17-C18-H18  120.6 
C18-C19-C20  121.9(5) 
C18-C19-H19  119.1 
C20-C19-H19  119.1 
C19-C20-C15  119.5(4) 
C19-C20-C21  116.8(4) 
C15-C20-C21  123.6(4) 
N2-C21-C20  125.9(4) 
N2-C21-H21  117.1 
C20-C21-H21  117.1 
O4-C22-C27  104.2(18) 
O4-C22-C23  113.4(17) 
C27-C22-C23  102.9(9) 
O4-C22-H22  111.9 
C27-C22-H22  111.9 
C23-C22-H22  111.9 
C24-C23-C22  103.5(10) 
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C24-C23-H23A 111.1 
C22-C23-H23A 111.1 
C24-C23-H23B 111.1 
C22-C23-H23B 111.1 
H23A-C23-H23B 109.0 
C25-C24-C28  102.3(8) 
C25-C24-C23  107.7(8) 
C28-C24-C23  101.4(7) 
C25-C24-H24  114.7 
C28-C24-H24  114.7 
C23-C24-H24  114.7 
C24-C25-C26  103.5(7) 
C24-C25-H25A 111.1 
C26-C25-H25A 111.1 
C24-C25-H25B 111.1 
C26-C25-H25B 111.1 
H25A-C25-H25B 109.0 
C27-C26-C25  102.4(8) 
C27-C26-H26A 111.3 
C25-C26-H26A 111.3 
C27-C26-H26B 111.3 
C25-C26-H26B 111.3 
H26A-C26-H26B 109.2 
C26-C27-C22  108.7(15) 
C26-C27-C28  102.6(10) 
C22-C27-C28  101.3(14) 
C26-C27-H27  114.3 
C22-C27-H27  114.3 
C28-C27-H27  114.3 
C24-C28-C27  93.4(9) 
C24-C28-H28A 113.0 
C27-C28-H28A 113.0 
C24-C28-H28B 113.0 
C27-C28-H28B 113.0 
H28A-C28-H28B 110.4 
O4-C22A-C23A 110(3) 
O4-C22A-C27A 112(3) 
C23A-C22A-C27A 103.2(14) 
O4-C22A-H22A 110.4 
C23A-C22A-H22A 110.4 
C27A-C22A-H22A 110.4 
C22A-C23A-C24A 104.7(16) 
C22A-C23A-H23C 110.8 
C24A-C23A-H23C 110.8 
C22A-C23A-H23D 110.8 
C24A-C23A-H23D 110.8 
H23C-C23A-H23D 108.9 
C25A-C24A-C23A 108.6(15) 
C25A-C24A-C28A 99.7(14) 
C23A-C24A-C28A 100.5(13) 
C25A-C24A-H24A 115.3 
C23A-C24A-H24A 115.3 
C28A-C24A-H24A 115.3 
C24A-C25A-C26A 103.4(12) 
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C24A-C25A-H25C 111.1 
C26A-C25A-H25C 111.1 
C24A-C25A-H25D 111.1 
C26A-C25A-H25D 111.1 
H25C-C25A-H25D 109.0 
C27A-C26A-C25A 103.7(11) 
C27A-C26A-H26C 111.0 
C25A-C26A-H26C 111.0 
C27A-C26A-H26D 111.0 
C25A-C26A-H26D 111.0 
H26C-C26A-H26D 109.0 
C26A-C27A-C28A 101.4(11) 
C26A-C27A-C22A 109.7(17) 
C28A-C27A-C22A 99.7(16) 
C26A-C27A-H27A 114.8 
C28A-C27A-H27A 114.8 
C22A-C27A-H27A 114.8 
C27A-C28A-C24A 95.3(11) 
C27A-C28A-H28C 112.7 
C24A-C28A-H28C 112.7 
C27A-C28A-H28D 112.7 
C24A-C28A-H28D 112.7 
H28C-C28A-H28D 110.2 
C1-O1-Pd1  126.1(3) 
N1-O2-C8  110.9(3) 
C15-O3-Pd1  125.7(3) 
C22A-O4-N2  116.4(16) 
N2-O4-C22  108.6(10) 
O3-Pd1-O1  178.55(13) 
O3-Pd1-N2  90.95(15) 
O1-Pd1-N2  89.40(15) 
O3-Pd1-N1  89.27(15) 
O1-Pd1-N1  90.41(16) 
N2-Pd1-N1  178.48(16) 
C7-N1-O2  113.1(3) 
C7-N1-Pd1  125.7(4) 
O2-N1-Pd1  119.8(3) 
C21-N2-O4  112.7(3) 
C21-N2-Pd1  125.7(3) 
O4-N2-Pd1  120.3(3)
__________________________________________________________________  
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Table 4.2.4. Anisotropic displacement parameters for 4.7. 
The anisotropic displacement (Å
2
x 10
3
) factor exponent takes the form: -22[ h2a*2U11 +... + 
2 h k a* b* U
12
 ]  
Atom U11  U22   U33  U23  U13  U12    
C1 30(3)   17(2)  24(2)   3(2)  -6(2)   -7(2) 
C2 37(3)   32(3)  24(2)   2(2)  -3(2)   -9(2) 
C3 52(3)   46(3)  20(2)   7(3)  -5(3)   -19(3) 
C4 42(3)   49(3)  29(3)   16(2)  -16(2)   -17(3) 
C5 33(3)   30(3)  31(3)   9(2)  -12(2)   -9(2) 
C6 31(3)   13(2)  25(3)   3(2)  -4(2)   -7(2) 
C7 26(3)   14(2)  32(3)   1(2)  -5(2)   -5(2) 
C8 15(2)   18(2)  26(3)   -5(2)  -1(2)   0(2) 
C9 35(5)   27(4)  29(4)   -3(3)  2(4)   4(4) 
C10 39(4)   28(3)  34(3)   -7(3)  9(3)   2(3) 
C11 52(4)   24(4)  45(5)   -14(4)  4(4)   -1(4) 
C12 45(4)   24(4)  51(4)   -7(3)  1(4)   -4(3) 
C13 34(5)   14(3)  34(4)   -2(3)  -1(4)   2(4) 
C14 32(4)   23(3)  45(4)   0(3)  -1(3)   7(3) 
C9A 35(7)   20(5)  37(6)   -3(5)  0(6)   4(6) 
C10A 42(5)   23(4)  42(4)   -3(4)  2(4)   6(4) 
C11A 49(6)   25(5)  43(6)   -9(5)  3(5)   -3(5) 
C12A 45(5)   24(5)  36(5)   -3(5)  -1(4)   -2(5) 
C13A 34(6)   28(6)  28(6)   -9(5)  2(5)   -5(5) 
C14A 30(5)   37(5)  36(5)   -7(5)  11(4)   5(5) 
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C15 23(2)   12(2)  18(2)   0(2)  -1(2)   0(2) 
C16 27(3)   18(2)  24(2)   -2(2)  3(2)   -2(2) 
C17 32(3)   23(3)  18(2)   1(2)  -1(2)   -7(2) 
C18 26(2)   20(2)  25(2)   1(2)  -5(2)   -3(2) 
C19 20(3)   18(2)  27(2)   -1(2)  -2(2)   -5(2) 
C20 20(2)   14(2)  21(2)   -1(2)  1(2)   -4(2) 
C21 16(2)   14(2)  24(2)   0(2)  -4(2)   1(2) 
C22 11(6)   16(6)  15(6)   -9(4)  -1(4)   -4(4) 
C23 23(5)   25(4)  21(5)   0(4)  0(4)   3(4) 
C24 33(5)   16(4)  40(5)   1(3)  1(4)   1(4) 
C25 41(7)   18(5)  33(5)   -15(4)  6(5)   -8(5) 
C26 47(5)   31(5)  24(4)   -12(4)  0(4)   -9(4) 
C27 40(6)   18(6)  30(6)   0(5)  0(5)   -11(6) 
C28 20(5)   28(5)  43(7)   -8(5)  9(5)   4(4) 
C22A 25(13)  21(11)  29(12)  3(8)  -3(9)   7(9) 
C23A 28(8)   19(9)  14(7)   -8(6)  4(6)   -5(7) 
C24A 33(7)   32(7)  31(7)   -5(6)  6(6)   -1(5) 
C25A 40(10)  39(9)  51(9)   -26(7)  -3(8)   -7(8) 
C26A 34(8)   24(7)  56(8)   -15(6)  2(7)   -4(6) 
C27A 30(8)   17(6)  27(7)   -2(5)  13(6)   8(6) 
C28A 27(7)   28(8)  33(8)   -4(6)  2(6)   8(6) 
O1 31(2)   25(2)  18(2)   4(1)  3(1)   3(1) 
O2 19(2)   17(2)  23(2)   -6(1)  2(1)   -1(1) 
O3 21(2)   24(2)  16(1)   1(1)  0(1)   5(1) 
O4 26(2)   23(2)  17(2)   -6(1)  6(2)   -1(2) 
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Pd1 18(1)   13(1)  16(1)   1(1)  0(1)   1(1) 
N1 23(2)   14(2)  22(2)   -1(2)  1(2)   0(1) 
N2 21(2)   16(2)  19(2)   -4(2)  3(2)   0(1) 
Table 4.2.5. H coordinates and isotropic displacement parameters for 4.7. 
H coordinates (x10
4
) and isotropic displacement parameters (Å
2
x10
3
) 
________________________________________________________________________  
Atom  x    y    z    U(eq) 
________________________________________________________________________ 
H2  1193   672   8294   37 
H3  3734   285   8980   47 
H4  7332   -150   8734   48 
H5  8363   -214   7788   38 
H7  7669   -93   6830   29 
H9A  7373   111   4960   36 
H9B  5077   -226   4689   36 
H10  8702   -1036   4570   41 
H11A  6361   -2121   4667   48 
H11B  4502   -1489   4521   48 
H12A  3043   -1597   5401   48 
H12B  4880   -2236   5544   48 
H13  6033   -1262   6175   33 
H14A  9014   -1720   5502   40 
H14B  9413   -839   5614   40 
H9A1  6252   -1147   6192   37 
 325 
H9A2  4020   -1411   5848   37 
H10A  7830   -2013   5535   43 
H11C  4152   -1928   4932   47 
H11D  6474   -2005   4571   47 
H12C  5906   -855   4225   42 
H12D  3686   -757   4620   42 
H13A  7153   90   4867   36 
H14C  9476   -722   5515   41 
H14D  9555   -1062   4876   41 
H16  3085   1082   4525   28 
H17  548   1485   3841   29 
H18  -3013   1978   4099   29 
H19  -4000   2038   5052   26 
H21  -3256   1912   6006   22 
H22  912   1956   7358   17 
H23A  934   3142   7023   27 
H23B  -1299   2962   6649   27 
H24  -2726   3853   7314   36 
H25A  -1509   3786   8280   37 
H25B  813   3615   7939   37 
H26A  812   2433   8284   41 
H26B  -1509   2605   8627   41 
H27  -2766   1729   7940   35 
H28A  -4800   2628   7281   37 
H28B  -4910   2954   7925   37 
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H22A  636   2047   7310   30 
H23C  -993   1935   8158   24 
H23D  -3232   1595   7861   24 
H24A  -4717   2730   8237   39 
H25C  -594   3209   8386   52 
H25D  -2412   3835   8198   52 
H26C  -534   3973   7364   45 
H26D  1213   3321   7540   45 
H27A  -1505   3036   6701   29 
H28C  -5103   2595   7171   35 
H28D  -4733   3469   7319   35 
H8  3670(80)  -280(30)  5570(20)  22 
________________________________________________________________________   
Table 4.2.6.  Torsion angles [°] for 4.7. 
_______________________________________________________________________ 
O1-C1-C2-C3   179.2(4) 
C6-C1-C2-C3   -0.9(7) 
C1-C2-C3-C4   0.9(8) 
C2-C3-C4-C5   -0.5(8) 
C3-C4-C5-C6   0.0(8) 
O1-C1-C6-C5   -179.7(4) 
C2-C1-C6-C5   0.4(6) 
O1-C1-C6-C7   -1.0(7) 
C2-C1-C6-C7   179.1(4) 
C4-C5-C6-C1   0.0(7) 
C4-C5-C6-C7   -178.8(5) 
C1-C6-C7-N1   2.1(8) 
C5-C6-C7-N1   -179.1(5) 
O2-C8-C9-C10  117.5(7) 
C13-C8-C9-C10  1.0(8) 
C8-C9-C10-C11  70.1(12) 
C8-C9-C10-C14  -34.7(9) 
C9-C10-C11-C12  -69.8(12) 
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C14-C10-C11-C12  34.5(10) 
C10-C11-C12-C13  -0.7(12) 
C11-C12-C13-C14  -33.9(11) 
C11-C12-C13-C8  70.9(10) 
O2-C8-C13-C14  -80.6(9) 
C9-C8-C13-C14  33.6(8) 
O2-C8-C13-C12  174.8(6) 
C9-C8-C13-C12  -71.0(9) 
C12-C13-C14-C10  54.6(9) 
C8-C13-C14-C10  -54.7(9) 
C11-C10-C14-C13  -55.4(9) 
C9-C10-C14-C13  55.1(9) 
O2-C8-C9A-C10A  -114.6(15) 
C13A-C8-C9A-C10A  -0.6(18) 
C8-C9A-C10A-C11A  -71(2) 
C8-C9A-C10A-C14A  34.5(19) 
C9A-C10A-C11A-C12A 68(3) 
C14A-C10A-C11A-C12A -37(2) 
C10A-C11A-C12A-C13A 4(3) 
O2-C8-C13A-C14A  84.8(11) 
C9A-C8-C13A-C14A  -34.0(14) 
O2-C8-C13A-C12A  -170.5(9) 
C9A-C8-C13A-C12A  70.7(17) 
C11A-C12A-C13A-C14A 31(2) 
C11A-C12A-C13A-C8 -73.1(19) 
C8-C13A-C14A-C10A 54.8(13) 
C12A-C13A-C14A-C10A -52.8(17) 
C9A-C10A-C14A-C13A -55.2(17) 
C11A-C10A-C14A-C13A 55.7(15) 
O3-C15-C16-C17  -180.0(4) 
C20-C15-C16-C17  -0.8(6) 
C15-C16-C17-C18  0.7(7) 
C16-C17-C18-C19  -0.5(7) 
C17-C18-C19-C20  0.5(7) 
C18-C19-C20-C15  -0.6(6) 
C18-C19-C20-C21  178.0(4) 
O3-C15-C20-C19  179.8(4) 
C16-C15-C20-C19  0.8(6) 
O3-C15-C20-C21  1.3(7) 
C16-C15-C20-C21  -177.7(4) 
C19-C20-C21-N2  179.0(4) 
C15-C20-C21-N2  -2.5(7) 
O4-C22-C23-C24  111.2(13) 
C27-C22-C23-C24  -0.7(16) 
C22-C23-C24-C25  71.2(12) 
C22-C23-C24-C28  -35.7(12) 
C28-C24-C25-C26  35.8(10) 
C23-C24-C25-C26  -70.6(10) 
C24-C25-C26-C27  -0.1(12) 
C25-C26-C27-C22  71.8(14) 
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C25-C26-C27-C28  -34.9(13) 
O4-C22-C27-C26  169.9(11) 
C23-C22-C27-C26  -71.5(16) 
O4-C22-C27-C28  -82.5(15) 
C23-C22-C27-C28  36.1(16) 
C25-C24-C28-C27  -55.1(10) 
C23-C24-C28-C27  56.1(10) 
C26-C27-C28-C24  55.5(11) 
C22-C27-C28-C24  -56.9(13) 
O4-C22A-C23A-C24A -116(2) 
C27A-C22A-C23A-C24A 4(3) 
C22A-C23A-C24A-C25A -72(2) 
C22A-C23A-C24A-C28A 32(2) 
C23A-C24A-C25A-C26A 67.8(19) 
C28A-C24A-C25A-C26A -36.8(16) 
C24A-C25A-C26A-C27A 2.5(18) 
C25A-C26A-C27A-C28A 33.3(16) 
C25A-C26A-C27A-C22A -72(2) 
O4-C22A-C27A-C26A -173.8(19) 
C23A-C22A-C27A-C26A 68(2) 
O4-C22A-C27A-C28A 80(2) 
C23A-C22A-C27A-C28A -38(2) 
C26A-C27A-C28A-C24A -55.5(13) 
C22A-C27A-C28A-C24A 57.0(17) 
C25A-C24A-C28A-C27A 56.4(13) 
C23A-C24A-C28A-C27A -54.7(15) 
C2-C1-O1-Pd1  166.7(3) 
C6-C1-O1-Pd1  -13.2(6) 
C9-C8-O2-N1   164.2(5) 
C13A-C8-O2-N1  176.0(8) 
C9A-C8-O2-N1  -71.0(9) 
C13-C8-O2-N1  -84.2(6) 
C20-C15-O3-Pd1  11.5(6) 
C16-C15-O3-Pd1  -169.4(3) 
C23A-C22A-O4-N2  -164.0(13) 
C27A-C22A-O4-N2  82(2) 
C27-C22-O4-N2  -178.6(10) 
C23-C22-O4-N2  70.3(12) 
C6-C7-N1-O2   177.3(4) 
C6-C7-N1-Pd1  11.0(7) 
C8-O2-N1-C7   115.8(4) 
C8-O2-N1-Pd1  -77.0(4) 
C20-C21-N2-O4  -176.3(4) 
C20-C21-N2-Pd1  -9.3(6) 
C22A-O4-N2-C21  -116.4(17) 
C22-O4-N2-C21  -119.2(10) 
C22A-O4-N2-Pd1  75.8(17) 
C22-O4-N2-Pd1  73.0(10) 
_________________________________________________________________________  
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X-ray structure data of Pd complex 4.8: 
 
 
Table 4.3.1.  Crystal data and structure refinement for Pd complex 4.8. 
Empirical formula    C32 H30 N O2 P Pd 
Formula weight    597.94 
Temperature     100(2) K 
Wavelength     1.54184 Å 
Crystal system    triclinic 
Space group     P -1 
  Unit cell dimensions  a = 9.1130(9) Å  
     b = 11.3390(11) Å  
     c = 13.8100(12) Å  
Volume    1282.2(2) Å3 
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Z     2 
Density (calculated)   1.549 Mg/m3 
Absorption coefficient  6.669 mm-1 
F(000)     612 
Crystal size    0.190 x 0.100 x 0.067 mm3 
Theta range for data collection 3.556 to 76.893°. 
Index ranges    -10<=h<=11, -13<=k<=14, -17<=l<=16 
Reflections collected   15182 
Independent reflections  5283 [R(int) = 0.0188] 
Completeness to theta = 67.684° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission  0.689 and 0.459 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  5283 / 0 / 334 
Goodness-of-fit on F2   1.080 
Final R indices [I>2sigma(I)]  R1 = 0.0207, wR2 = 0.0543 
R indices (all data)   R1 = 0.0210, wR2 = 0.0544 
Extinction coefficient   n/a 
Largest diff. peak and hole  0.410 and -0.498 e.Å-3 
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Table 4.3.2. Atomic coordinates and equivalent isotropic displacement parameters for 4.8. 
U(eq) is defined as one-third of  the trace of the orthogonalized Uij tensor. 
Atomic coordinates (x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
______________________________________________________________________________  
Atom  x  y  z  U(eq) 
______________________________________________________________________________  
C1  1077(2) 2475(2) 880(2)  23(1) 
C2  -473(2) 1847(2) 500(2)  27(1) 
C3  -1575(2) 2086(2) -272(2) 28(1) 
C4  -1208(2) 2936(2) -734(2) 31(1) 
C5  282(2)  3536(2) -409(2) 29(1) 
C6  1455(2) 3336(2) 396(1)  22(1) 
C7  2973(2) 4013(2) 657(1)  22(1) 
C8  6810(2) 3970(2) 1752(2) 24(1) 
C9  6656(2) 3549(2) 2683(1) 20(1) 
C10  7949(2) 2778(2) 2873(2) 25(1) 
C11  9450(2) 3787(2) 3414(2) 29(1) 
C12  8837(2) 5011(2) 3417(2) 28(1) 
C13  8290(2) 4953(2) 2246(2) 28(1) 
C14  7288(2) 4811(2) 3644(2) 26(1) 
C15  2792(2) 1125(2) 3454(2) 20(1) 
C16  1629(2) 336(2)  2542(2) 25(1) 
C17  204(2)  -41(2)  2618(2) 30(1) 
C18  -90(2)  380(2)  3597(2) 35(1) 
C19  1048(3) 1171(2) 4507(2) 36(1) 
C20  2498(2) 1543(2) 4442(2) 26(1) 
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C21  5168(2) 81(2)  2627(1) 18(1) 
C22  5045(2) -913(2) 3000(2) 22(1) 
C23  5410(2) -2076(2) 2472(2) 25(1) 
C24  5880(2) -2258(2) 1562(2) 26(1) 
C25  6000(2) -1282(2) 1181(2) 24(1) 
C26  5640(2) -114(2) 1711(1) 20(1) 
C27  5909(2) 2309(2) 4624(1) 19(1) 
C28  6990(2) 1711(2) 5126(1) 21(1) 
C29  7906(2) 2348(2) 6181(2) 25(1) 
C30  7753(2) 3577(2) 6738(2) 26(1) 
C31  6688(2) 4175(2) 6247(2) 27(1) 
C32  5772(2) 3543(2) 5195(2) 23(1) 
N1  4184(2) 3866(1) 1306(1) 20(1) 
O1  2022(2) 2228(1) 1644(1) 28(1) 
O2  5552(2) 4621(1) 1424(1) 25(1) 
Pd1  4381(1) 2810(1) 2240(1) 16(1) 
P1  4615(1) 1597(1) 3260(1) 16(1) 
______________________________________________________________________________ 
 
Table 4.3.3. Bond lengths [Å] and angles [°] for 4.8. 
___________________________________________________________________________ 
C1-O1  1.297(2) 
C1-C2  1.422(3) 
C1-C6  1.426(3) 
C2-C3  1.372(3) 
C2-H2  0.95 
C3-C4  1.389(3) 
C3-H3  0.95 
C4-C5  1.369(3) 
C4-H4  0.95 
C5-C6  1.414(3) 
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C5-H5  0.95 
C6-C7  1.435(3) 
C7-N1  1.285(2) 
C7-H7  0.95 
C8-O2  1.453(2) 
C8-C13   1.537(3) 
C8-C9  1.548(2) 
C8-H8  1.00 
C9-C10   1.528(2) 
C9-C14   1.543(2) 
C9-Pd1   2.0404(17) 
C10-C11   1.565(3) 
C10-H10A   0.99 
C10-H10B   0.99 
C11-C12   1.525(3) 
C11-H11A   0.99 
C11-H11B   0.99 
C12-C13   1.540(3) 
C12-C14   1.544(3) 
C12-H12   1.00 
C13-H13A   0.99 
C13-H13B   0.99 
C14-H14A   0.99 
C14-H14B   0.99 
C15-C20   1.390(3) 
C15-C16   1.397(3) 
C15-P1   1.8282(18) 
C16-C17   1.384(3) 
C16-H16   0.95 
C17-C18   1.379(3) 
C17-H17   0.95 
C18-C19   1.385(4) 
C18-H18   0.95 
C19-C20   1.398(3) 
C19-H19   0.95 
C20-H20   0.95 
C21-C26   1.395(2) 
C21-C22   1.396(2) 
C21-P1   1.8195(17) 
C22-C23   1.387(3) 
C22-H22   0.95 
C23-C24   1.387(3) 
C23-H23   0.95 
C24-C25   1.384(3) 
C24-H24   0.95 
C25-C26   1.390(2) 
C25-H25   0.95 
C26-H26   0.95 
C27-C32   1.392(2) 
C27-C28   1.395(2) 
C27-P1   1.8168(18) 
C28-C29   1.391(3) 
C28-H28   0.95 
C29-C30   1.386(3) 
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C29-H29   0.95 
C30-C31   1.378(3) 
C30-H30   0.95 
C31-C32   1.387(3) 
C31-H31   0.95 
C32-H32   0.95 
N1-O2   1.4099(19) 
N1-Pd1   2.0149(15) 
O1-Pd1   2.0682(13) 
Pd1-P1   2.2549(5) 
O1-C1-C2  117.37(17) 
O1-C1-C6  125.53(17) 
C2-C1-C6  117.09(17) 
C3-C2-C1  121.77(19) 
C3-C2-H2  119.1 
C1-C2-H2  119.1 
C2-C3-C4  121.02(19) 
C2-C3-H3  119.5 
C4-C3-H3  119.5 
C5-C4-C3  118.91(18) 
C5-C4-H4  120.5 
C3-C4-H4  120.5 
C4-C5-C6  122.24(19) 
C4-C5-H5  118.9 
C6-C5-H5  118.9 
C5-C6-C1  118.94(18) 
C5-C6-C7  116.82(17) 
C1-C6-C7  124.24(16) 
N1-C7-C6  124.64(17) 
N1-C7-H7  117.7 
C6-C7-H7  117.7 
O2-C8-C13  106.90(15) 
O2-C8-C9  111.26(14) 
C13-C8-C9  104.40(15) 
O2-C8-H8  111.3 
C13-C8-H8  111.3 
C9-C8-H8  111.3 
C10-C9-C14  101.84(15) 
C10-C9-C8  105.77(14) 
C14-C9-C8  100.28(14) 
C10-C9-Pd1  122.86(13) 
C14-C9-Pd1  119.02(12) 
C8-C9-Pd1  104.21(11) 
C9-C10-C11  104.27(15) 
C9-C10-H10A 110.9 
C11-C10-H10A 110.9 
C9-C10-H10B  110.9 
C11-C10-H10B 110.9 
H10A-C10-H10B 108.9 
C12-C11-C10  102.44(15) 
C12-C11-H11A 111.3 
C10-C11-H11A 111.3 
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C12-C11-H11B 111.3 
C10-C11-H11B 111.3 
H11A-C11-H11B 109.2 
C11-C12-C13  108.04(17) 
C11-C12-C14  101.98(16) 
C13-C12-C14  101.46(16) 
C11-C12-H12  114.6 
C13-C12-H12  114.6 
C14-C12-H12  114.6 
C8-C13-C12  103.13(15) 
C8-C13-H13A 111.1 
C12-C13-H13A 111.1 
C8-C13-H13B  111.1 
C12-C13-H13B 111.1 
H13A-C13-H13B 109.1 
C9-C14-C12  94.81(14) 
C9-C14-H14A 112.8 
C12-C14-H14A 112.8 
C9-C14-H14B  112.8 
C12-C14-H14B 112.8 
H14A-C14-H14B 110.2 
C20-C15-C16  119.27(17) 
C20-C15-P1  123.63(15) 
C16-C15-P1  117.05(14) 
C17-C16-C15  120.57(19) 
C17-C16-H16  119.7 
C15-C16-H16  119.7 
C18-C17-C16  120.1(2) 
C18-C17-H17  119.9 
C16-C17-H17  119.9 
C17-C18-C19  120.00(19) 
C17-C18-H18  120.0 
C19-C18-H18  120.0 
C18-C19-C20  120.3(2) 
C18-C19-H19  119.8 
C20-C19-H19  119.8 
C15-C20-C19  119.7(2) 
C15-C20-H20  120.1 
C19-C20-H20  120.1 
C26-C21-C22  119.32(16) 
C26-C21-P1  119.13(13) 
C22-C21-P1  121.45(13) 
C23-C22-C21  120.17(17) 
C23-C22-H22  119.9 
C21-C22-H22  119.9 
C24-C23-C22  119.94(18) 
C24-C23-H23  120.0 
C22-C23-H23  120.0 
C25-C24-C23  120.47(17) 
C25-C24-H24  119.8 
C23-C24-H24  119.8 
C24-C25-C26  119.72(17) 
C24-C25-H25  120.1 
C26-C25-H25  120.1 
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C25-C26-C21  120.37(17) 
C25-C26-H26  119.8 
C21-C26-H26  119.8 
C32-C27-C28  118.87(16) 
C32-C27-P1  116.00(13) 
C28-C27-P1  125.13(14) 
C29-C28-C27  119.96(17) 
C29-C28-H28  120.0 
C27-C28-H28  120.0 
C30-C29-C28  120.33(17) 
C30-C29-H29  119.8 
C28-C29-H29  119.8 
C31-C30-C29  120.08(18) 
C31-C30-H30  120.0 
C29-C30-H30  120.0 
C30-C31-C32  119.77(18) 
C30-C31-H31  120.1 
C32-C31-H31  120.1 
C31-C32-C27  120.99(17) 
C31-C32-H32  119.5 
C27-C32-H32  119.5 
C7-N1-O2  114.50(14) 
C7-N1-Pd1  129.45(13) 
O2-N1-Pd1  115.92(10) 
C1-O1-Pd1  126.70(12) 
N1-O2-C8  106.50(13) 
N1-Pd1-C9  82.31(7) 
N1-Pd1-O1  88.86(6) 
C9-Pd1-O1  171.17(6) 
N1-Pd1-P1  178.82(4) 
C9-Pd1-P1  97.51(5) 
O1-Pd1-P1  91.31(4) 
C27-P1-C21  107.88(8) 
C27-P1-C15  103.40(8) 
C21-P1-C15  102.57(8) 
C27-P1-Pd1  116.39(6) 
C21-P1-Pd1  112.49(6) 
C15-P1-Pd1  112.86(6) 
______________________________________________________________________________ 
Table 4.3.4. Anisotropic displacement parameters for 4.8. 
The anisotropic displacement (Å2x 103) factor exponent takes the form: -22[ h2 a*2U11 + ...  + 
2 h k a* b* U12 ] 
______________________________________________________________________________  
Atom  U11  U22   U33  U23  U13  U12 
______________________________________________________________________________  
 337 
C1  21(1)   27(1)  22(1)   9(1)  6(1)   7(1) 
C2  25(1)   30(1)  27(1)   11(1)  8(1)   4(1) 
C3  21(1)   34(1)  23(1)   5(1)  5(1)   4(1) 
C4  26(1)   40(1)  23(1)   12(1)  2(1)   8(1) 
C5  32(1)   34(1)  24(1)   15(1)  8(1)   10(1) 
C6  25(1)   24(1)  19(1)   7(1)  8(1)   8(1) 
C7  29(1)   21(1)  19(1)   10(1)  10(1)   8(1) 
C8  24(1)   25(1)  26(1)   12(1)  10(1)   5(1) 
C9  18(1)   21(1)  21(1)   8(1)  6(1)   1(1) 
C10  22(1)   29(1)  27(1)   13(1)  9(1)   4(1) 
C11  21(1)   38(1)  30(1)   16(1)  7(1)   2(1) 
C12  26(1)   29(1)  28(1)   8(1)  8(1)   -3(1) 
C13  26(1)   30(1)  32(1)   14(1)  10(1)   1(1) 
C14  26(1)   26(1)  24(1)   6(1)  8(1)   0(1) 
C15  20(1)   21(1)  27(1)   14(1)  12(1)   9(1) 
C16  23(1)   24(1)  31(1)   13(1)  10(1)   6(1) 
C17  21(1)   30(1)  46(1)   21(1)  9(1)   6(1) 
C18  25(1)   38(1)  61(1)   32(1)  25(1)   14(1) 
C19  40(1)   40(1)  48(1)   26(1)  32(1)   19(1) 
C20  30(1)   28(1)  31(1)   15(1)  16(1)   10(1) 
C21  16(1)   17(1)  20(1)   5(1)  6(1)   3(1) 
C22  23(1)   21(1)  23(1)   9(1)  9(1)   5(1) 
C23  26(1)   20(1)  31(1)   10(1)  10(1)   6(1) 
C24  26(1)   19(1)  29(1)   4(1)  10(1)   8(1) 
C25  23(1)   23(1)  24(1)   4(1)  11(1)   4(1) 
C26  19(1)   19(1)  21(1)   7(1)  7(1)   3(1) 
C27  20(1)   20(1)  19(1)   7(1)  9(1)   4(1) 
 338 
C28  21(1)   22(1)  24(1)   11(1)  9(1)   6(1) 
C29  21(1)   34(1)  25(1)   16(1)  6(1)   5(1) 
C30  26(1)   33(1)  18(1)   9(1)  6(1)   -4(1) 
C31  35(1)   23(1)  22(1)   5(1)  13(1)   4(1) 
C32  28(1)   22(1)  21(1)   10(1)  9(1)   9(1) 
N1  22(1)   19(1)  20(1)   9(1)  8(1)   3(1) 
O1  19(1)   37(1)  33(1)   22(1)  4(1)   2(1) 
O2  23(1)   24(1)  30(1)   16(1)  7(1)   2(1) 
Pd1  17(1)   16(1)  16(1)   7(1)  6(1)   4(1) 
P1  18(1)   16(1)  17(1)   7(1)  8(1)   5(1) 
______________________________________________________________________________  
Table 4.3.5. H coordinates and isotropic displacement parameters for 4.8. 
Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) 
______________________________________________________________________________  
Atom  x   y   z   U(eq) 
H2  -753  1247  790  32 
H3  -2604  1662  -495  33 
H4  -1978  3100  -1266  37 
H5  537  4105  -735  34 
H7  3090  4611  326  26 
H8  6887  3237  1128  28 
H10A  7983  2150  2185  30 
H10B  7808  2327  3354  30 
H11A  9962  3829  4154  35 
H11B  10185  3601  2987  35 
H12  9551  5802  3934  34 
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H13A  8074  5787  2216  34 
H13B  9068  4675  1872  34 
H14A  7415  4714  4346  31 
H14B  6664  5484  3585  31 
H16  1817  56  1863  30 
H17  -574  -591  1995  37 
H18  -1072  127  3646  42 
H19  841  1462  5180  43 
H20  3279  2079  5069  32 
H22  4711  -792  3618  26 
H23  5339  -2748  2732  30 
H24  6121  -3058  1198  31 
H25  6327  -1411  560  28 
H26  5717  555  1448  23 
H28  7100  869  4748  25 
H29  8642  1938  6522  30 
H30  8382  4007  7458  32 
H31  6583  5017  6628  32 
H32  5039  3959  4860  28 
______________________________________________________________________________ 
 
Table 4.3.6. Torsion angles [°] for 4.8. 
___________________________________________________________________________  
O1-C1-C2-C3  177.13(18) 
C6-C1-C2-C3  -2.1(3) 
C1-C2-C3-C4  1.4(3) 
C2-C3-C4-C5  0.3(3) 
C3-C4-C5-C6  -1.2(3) 
C4-C5-C6-C1  0.5(3) 
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C4-C5-C6-C7  179.44(18) 
O1-C1-C6-C5  -178.00(18) 
C2-C1-C6-C5  1.1(3) 
O1-C1-C6-C7  3.1(3) 
C2-C1-C6-C7  -177.75(17) 
C5-C6-C7-N1  -174.45(17) 
C1-C6-C7-N1  4.4(3) 
O2-C8-C9-C10 174.83(14) 
C13-C8-C9-C10 -70.21(18) 
O2-C8-C9-C14 -79.63(17) 
C13-C8-C9-C14 35.33(18) 
O2-C8-C9-Pd1 44.05(16) 
C13-C8-C9-Pd1 159.01(12) 
C14-C9-C10-C11 -32.33(18) 
C8-C9-C10-C11 72.07(18) 
Pd1-C9-C10-C11 -168.84(12) 
C9-C10-C11-C12 -2.63(19) 
C10-C11-C12-C13 -69.68(19) 
C10-C11-C12-C14 36.74(19) 
O2-C8-C13-C12 117.55(16) 
C9-C8-C13-C12 -0.44(19) 
C11-C12-C13-C8 72.05(19) 
C14-C12-C13-C8 -34.73(19) 
C10-C9-C14-C12 53.46(17) 
C8-C9-C14-C12 -55.22(16) 
Pd1-C9-C14-C12 -167.92(13) 
C11-C12-C14-C9 -55.76(17) 
C13-C12-C14-C9 55.71(17) 
C20-C15-C16-C17 -0.8(3) 
P1-C15-C16-C17 -178.59(14) 
C15-C16-C17-C18 1.2(3) 
C16-C17-C18-C19 -0.7(3) 
C17-C18-C19-C20 -0.2(3) 
C16-C15-C20-C19 -0.1(3) 
P1-C15-C20-C19 177.54(15) 
C18-C19-C20-C15 0.6(3) 
C26-C21-C22-C23 0.8(3) 
P1-C21-C22-C23 177.13(14) 
C21-C22-C23-C24 -0.8(3) 
C22-C23-C24-C25 0.5(3) 
C23-C24-C25-C26 -0.3(3) 
C24-C25-C26-C21 0.3(3) 
C22-C21-C26-C25 -0.6(3) 
P1-C21-C26-C25 -176.99(14) 
C32-C27-C28-C29 0.1(3) 
P1-C27-C28-C29 -179.14(14) 
C27-C28-C29-C30 0.0(3) 
C28-C29-C30-C31 0.0(3) 
C29-C30-C31-C32 0.0(3) 
C30-C31-C32-C27 0.0(3) 
C28-C27-C32-C31 0.0(3) 
P1-C27-C32-C31 179.24(15) 
C6-C7-N1-O2 179.04(15) 
C6-C7-N1-Pd1 -5.4(3) 
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C2-C1-O1-Pd1 172.17(13) 
C6-C1-O1-Pd1 -8.7(3) 
C7-N1-O2-C8  -154.96(15) 
Pd1-N1-O2-C8 28.83(16) 
C13-C8-O2-N1 -161.23(14) 
C9-C8-O2-N1  -47.83(18) 
C32-C27-P1-C21 173.02(14) 
C28-C27-P1-C21 -7.77(18) 
C32-C27-P1-C15 -78.81(15) 
C28-C27-P1-C15 100.40(16) 
C32-C27-P1-Pd1 45.52(15) 
C28-C27-P1-Pd1 -135.27(14) 
C26-C21-P1-C27 -119.04(14) 
C22-C21-P1-C27 64.64(16) 
C26-C21-P1-C15 132.22(14) 
C22-C21-P1-C15 -44.11(16) 
C26-C21-P1-Pd1 10.68(15) 
C22-C21-P1-Pd1 -165.64(13) 
C20-C15-P1-C27 13.81(17) 
C16-C15-P1-C27 -168.55(14) 
C20-C15-P1-C21 125.92(16) 
C16-C15-P1-C21 -56.44(15) 
C20-C15-P1-Pd1 -112.79(15) 
C16-C15-P1-Pd1 64.85(14) 
___________________________________________________________________________ 
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X-ray structure data of Pd complex 4.10: 
 
 
Table 4.4.1. Crystal data and structure refinement for Pd complex 4.10. 
Empirical formula    C42 H52 N O2 P Pd 
Formula weight    740.21 
Temperature     100(2) K 
Wavelength     1.54184 Å 
Crystal system    triclinic 
Space group     P -1 
  Unit cell dimensions  a = 9.224(2) Å  = 105.095(3)°. 
     b = 11.291(2) Å  
     c = 18.410(3) Å  
Volume    1818.7(6) Å3 
Z     2 
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Density (calculated)   1.352 Mg/m3 
Absorption coefficient  4.802 mm-1 
F(000)     776 
Crystal size    0.170 x 0.120 x 0.050 mm3 
Theta range for data collection 2.527 to 74.418°. 
Index ranges    -11<=h<=11, -14<=k<=14, -22<=l<=22 
Reflections collected   33905 
Independent reflections  7207 [R(int) = 0.0262] 
Completeness to theta = 67.684° 99.4 %  
Absorption correction   Semi-empirical from equivalents 
Max. and min. transmission  1.00 and 0.813 
Refinement method   Full-matrix least-squares on F2 
Data / restraints / parameters  7207 / 35 / 427 
Goodness-of-fit on F2   1.039 
Final R indices [I>2sigma(I)]  R1 = 0.0236, wR2 = 0.0593 
R indices (all data)   R1 = 0.0238, wR2 = 0.0595 
Extinction coefficient   n/a 
Largest diff. peak and hole  0.506 and -0.653 e.Å-3 
 
Table 4.4.2. Atomic coordinates and equivalent isotropic displacement parameters for 4.10. 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________  
  x   y   z   U(eq) 
______________________________________________________________________________  
C1  1015(2)  3573(2)  2741(1)  19(1) 
C2  1780(2)  4698(2)  3396(1)  18(1) 
C3  608(2)   5627(2)  3497(1)  20(1) 
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C4  -535(2)  5045(2)  3875(1)  24(1) 
C5  70(2)   3815(2)  3910(1)  24(1) 
C6  -143(2)  2974(2)  3088(1)  23(1) 
C7  1753(2)  4178(2)  4092(1)  23(1) 
C8  4083(2)  2642(2)  1993(1)  19(1) 
C9  5424(2)  3082(2)  1808(1)  19(1) 
C10  6099(2)  4317(2)  2117(1)  20(1) 
C11  7348(2)  4618(2)  1817(1)  24(1) 
C12  7914(2)  3774(2)  1280(1)  25(1) 
C13  7291(2)  2538(2)  991(1)   22(1) 
C14  6057(2)  2235(2)  1259(1)  22(1) 
C15  8042(2)  1596(2)  445(1)   26(1) 
C16  7045(2)  399(2)   67(1)   33(1) 
C17  9448(3)  1314(2)  907(1)   42(1) 
C18  8415(3)  2117(2)  -205(1)  43(1) 
C19  6135(2)  7652(2)  3993(1)  22(1) 
C20  6821(2)  7687(2)  3379(1)  27(1) 
C21  8308(2)  8095(2)  3506(1)  34(1) 
C22  9111(2)  8471(2)  4247(2)  38(1) 
C23  8453(2)  8444(2)  4858(1)  36(1) 
C24  6963(2)  8038(2)  4737(1)  28(1) 
C25  3273(2)  8107(2)  3306(1)  18(1) 
C26  2181(2)  7618(2)  2661(1)  21(1) 
C27  1470(2)  8388(2)  2269(1)  24(1) 
C28  1848(2)  9649(2)  2513(1)  26(1) 
C29  2950(2)  10147(2)  3149(1)  25(1) 
C30  3663(2)  9381(2)  3542(1)  21(1) 
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C31  3731(2)  7433(2)  4755(1)  19(1) 
C32  4150(2)  6630(2)  5199(1)  25(1) 
C33  3943(2)  6881(2)  5950(1)  28(1) 
C34  3314(2)  7934(2)  6269(1)  25(1) 
C35  2872(2)  8726(2)  5831(1)  24(1) 
C36  3082(2)  8482(2)  5076(1)  19(1) 
C37  2098(6)  4870(4)  841(2)   50(1) 
C38  3244(4)  4446(3)  316(2)   46(1) 
C39  2621(5)  3330(3)  -322(2)  45(1) 
C40  3735(4)  2746(3)  -788(2)  40(1) 
C41  3093(4)  1712(3)  -1492(2)  45(1) 
C42  4396(6)  1026(5)  -1817(3)  53(2) 
C37A  2575(13)  4886(8)  853(5)   44(3) 
C38A  2756(10)  3602(8)  287(4)   47(2) 
C39A  2228(11)  3503(8)  -534(5)  48(2) 
C40A  2509(9)  2365(7)  -1114(5)  45(2) 
C41A  4126(9)  2163(8)  -1160(5)  50(2) 
C42A  4061(14)  947(9)   -1859(6)  40(3) 
N1  3319(2)  3308(1)  2442(1)  18(1) 
O1  2041(1)  2664(1)  2532(1)  21(1) 
O2  5676(1)  5166(1)  2645(1)  24(1) 
P1  4186(1)  7062(1)  3798(1)  16(1) 
Pd1  3744(1)  5074(1)  3088(1)  15(1) 
______________________________________________________________________________ 
 
Table 4.4.3. Bond lengths [Å] and angles [°] for 4.10. 
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________________________________________________________________________ 
C1-O1  1.451(2) 
C1-C6  1.544(2) 
C1-C2  1.550(2) 
C1-H1  1.0000 
C2-C3  1.541(2) 
C2-C7  1.546(2) 
C2-Pd1   2.0412(17) 
C3-C4  1.560(2) 
C3-H3A   0.99 
C3-H3B   0.99 
C4-C5  1.534(3) 
C4-H4A   0.99 
C4-H4B   0.99 
C5-C6  1.539(2) 
C5-C7  1.546(3) 
C5-H5  1.00 
C6-H6A   0.99 
C6-H6B   0.99 
C7-H7A   0.99 
C7-H7B   0.99 
C8-N1  1.288(2) 
C8-C9  1.435(3) 
C8-H8  0.95 
C9-C14   1.420(2) 
C9-C10   1.430(2) 
C10-O2   1.300(2) 
C10-C11   1.420(3) 
C11-C12   1.372(3) 
C11-H11   0.95 
C12-C13   1.413(3) 
C12-H12   0.95 
C13-C14   1.375(3) 
C13-C15   1.536(2) 
C14-H14   0.95 
C15-C17   1.527(3) 
C15-C16   1.530(3) 
C15-C18   1.542(3) 
C16-H16A   0.98 
C16-H16B   0.98 
C16-H16C   0.98 
C17-H17A   0.98 
C17-H17B   0.98 
C17-H17C   0.98 
C18-H18A   0.98 
C18-H18B   0.98 
C18-H18C   0.98 
C19-C20   1.391(3) 
C19-C24   1.403(3) 
C19-P1   1.8323(19) 
C20-C21   1.388(3) 
C20-H20   0.95 
C21-C22   1.391(3) 
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C21-H21   0.95 
C22-C23   1.369(4) 
C22-H22   0.95 
C23-C24   1.390(3) 
C23-H23   0.95 
C24-H24   0.95 
C25-C26   1.396(2) 
C25-C30   1.400(2) 
C25-P1   1.8244(18) 
C26-C27   1.391(3) 
C26-H26   0.95 
C27-C28   1.385(3) 
C27-H27   0.95 
C28-C29   1.392(3) 
C28-H28   0.95 
C29-C30   1.390(3) 
C29-H29   0.95 
C30-H30   0.95 
C31-C36   1.389(2) 
C31-C32   1.399(2) 
C31-P1   1.8237(18) 
C32-C33   1.385(3) 
C32-H32   0.95 
C33-C34   1.381(3) 
C33-H33   0.95 
C34-C35   1.387(3) 
C34-H34   0.95 
C35-C36   1.392(3) 
C35-H35   0.95 
C36-H36   0.95 
C37-C38   1.556(5) 
C37-H37A   0.98 
C37-H37B   0.98 
C37-H37C   0.98 
C38-C39   1.497(5) 
C38-H38A   0.99 
C38-H38B   0.99 
C39-C40   1.510(5) 
C39-H39A   0.99 
C39-H39B   0.99 
C40-C41   1.514(4) 
C40-H40A   0.99 
C40-H40B   0.99 
C41-C42   1.576(5) 
C41-H41A   0.99 
C41-H41B   0.99 
C42-H42A   0.98 
C42-H42B   0.98 
C42-H42C   0.98 
C37A-C38A   1.584(8) 
C37A-H37D   0.98 
C37A-H37E   0.98 
C37A-H37F   0.98 
C38A-C39A   1.484(8) 
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C38A-H38C   0.99 
C38A-H38D   0.99 
C39A-C40A   1.506(8) 
C39A-H39C   0.99 
C39A-H39D   0.99 
C40A-C41A   1.532(8) 
C40A-H40C   0.99 
C40A-H40D   0.99 
C41A-C42A   1.609(8) 
C41A-H41C   0.99 
C41A-H41D   0.99 
C42A-H42D   0.98 
C42A-H42E   0.98 
C42A-H42F   0.98 
N1-O1   1.4102(18) 
N1-Pd1   2.0206(14) 
O2-Pd1   2.0844(13) 
P1-Pd1   2.2637(5) 
O1-C1-C6  106.74(14) 
O1-C1-C2  111.21(14) 
C6-C1-C2  104.94(13) 
O1-C1-H1  111.2 
C6-C1-H1  111.2 
C2-C1-H1  111.2 
C3-C2-C7  101.55(14) 
C3-C2-C1  105.11(14) 
C7-C2-C1  100.16(13) 
C3-C2-Pd1  122.89(12) 
C7-C2-Pd1  119.90(12) 
C1-C2-Pd1  104.16(11) 
C2-C3-C4  104.33(14) 
C2-C3-H3A  110.9 
C4-C3-H3A  110.9 
C2-C3-H3B  110.9 
C4-C3-H3B  110.9 
H3A-C3-H3B  108.9 
C5-C4-C3  102.69(14) 
C5-C4-H4A  111.2 
C3-C4-H4A  111.2 
C5-C4-H4B  111.2 
C3-C4-H4B  111.2 
H4A-C4-H4B  109.1 
C4-C5-C6  108.03(15) 
C4-C5-C7  101.72(14) 
C6-C5-C7  101.92(14) 
C4-C5-H5  114.6 
C6-C5-H5  114.6 
C7-C5-H5  114.6 
C5-C6-C1  102.64(14) 
C5-C6-H6A  111.2 
C1-C6-H6A  111.2 
C5-C6-H6B  111.2 
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C1-C6-H6B  111.2 
H6A-C6-H6B  109.2 
C5-C7-C2  95.03(13) 
C5-C7-H7A  112.7 
C2-C7-H7A  112.7 
C5-C7-H7B  112.7 
C2-C7-H7B  112.7 
H7A-C7-H7B  110.2 
N1-C8-C9  124.70(15) 
N1-C8-H8  117.6 
C9-C8-H8  117.6 
C14-C9-C10  119.52(16) 
C14-C9-C8  116.65(15) 
C10-C9-C8  123.77(16) 
O2-C10-C11  118.20(16) 
O2-C10-C9  125.85(16) 
C11-C10-C9  115.95(16) 
C12-C11-C10  122.58(17) 
C12-C11-H11  118.7 
C10-C11-H11  118.7 
C11-C12-C13  122.01(17) 
C11-C12-H12  119.0 
C13-C12-H12  119.0 
C14-C13-C12  116.34(16) 
C14-C13-C15  123.35(17) 
C12-C13-C15  120.20(17) 
C13-C14-C9  123.52(16) 
C13-C14-H14  118.2 
C9-C14-H14  118.2 
C17-C15-C16  109.26(18) 
C17-C15-C13  108.05(15) 
C16-C15-C13  111.99(16) 
C17-C15-C18  110.30(19) 
C16-C15-C18  106.82(17) 
C13-C15-C18  110.42(17) 
C15-C16-H16A 109.5 
C15-C16-H16B 109.5 
H16A-C16-H16B 109.5 
C15-C16-H16C 109.5 
H16A-C16-H16C 109.5 
H16B-C16-H16C 109.5 
C15-C17-H17A 109.5 
C15-C17-H17B 109.5 
H17A-C17-H17B 109.5 
C15-C17-H17C 109.5 
H17A-C17-H17C 109.5 
H17B-C17-H17C 109.5 
C15-C18-H18A 109.5 
C15-C18-H18B 109.5 
H18A-C18-H18B 109.5 
C15-C18-H18C 109.5 
H18A-C18-H18C 109.5 
H18B-C18-H18C 109.5 
C20-C19-C24  119.14(18) 
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C20-C19-P1  118.52(14) 
C24-C19-P1  122.32(16) 
C21-C20-C19  120.0(2) 
C21-C20-H20  120.0 
C19-C20-H20  120.0 
C20-C21-C22  120.0(2) 
C20-C21-H21  120.0 
C22-C21-H21  120.0 
C23-C22-C21  120.7(2) 
C23-C22-H22  119.6 
C21-C22-H22  119.6 
C22-C23-C24  119.7(2) 
C22-C23-H23  120.2 
C24-C23-H23  120.2 
C23-C24-C19  120.5(2) 
C23-C24-H24  119.8 
C19-C24-H24  119.8 
C26-C25-C30  118.97(16) 
C26-C25-P1  118.93(13) 
C30-C25-P1  122.07(13) 
C27-C26-C25  120.44(16) 
C27-C26-H26  119.8 
C25-C26-H26  119.8 
C28-C27-C26  120.21(17) 
C28-C27-H27  119.9 
C26-C27-H27  119.9 
C27-C28-C29  119.91(17) 
C27-C28-H28  120.0 
C29-C28-H28  120.0 
C30-C29-C28  120.08(17) 
C30-C29-H29  120.0 
C28-C29-H29  120.0 
C29-C30-C25  120.38(16) 
C29-C30-H30  119.8 
C25-C30-H30  119.8 
C36-C31-C32  118.91(16) 
C36-C31-P1  124.32(13) 
C32-C31-P1  116.66(14) 
C33-C32-C31  120.83(17) 
C33-C32-H32  119.6 
C31-C32-H32  119.6 
C34-C33-C32  119.94(17) 
C34-C33-H33  120.0 
C32-C33-H33  120.0 
C33-C34-C35  119.79(17) 
C33-C34-H34  120.1 
C35-C34-H34  120.1 
C34-C35-C36  120.54(17) 
C34-C35-H35  119.7 
C36-C35-H35  119.7 
C31-C36-C35  119.98(16) 
C31-C36-H36  120.0 
C35-C36-H36  120.0 
C38-C37-H37A 109.5 
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C38-C37-H37B 109.5 
H37A-C37-H37B 109.5 
C38-C37-H37C 109.5 
H37A-C37-H37C 109.5 
H37B-C37-H37C 109.5 
C39-C38-C37  110.9(3) 
C39-C38-H38A 109.5 
C37-C38-H38A 109.5 
C39-C38-H38B 109.5 
C37-C38-H38B 109.5 
H38A-C38-H38B 108.1 
C38-C39-C40  114.1(3) 
C38-C39-H39A 108.7 
C40-C39-H39A 108.7 
C38-C39-H39B 108.7 
C40-C39-H39B 108.7 
H39A-C39-H39B 107.6 
C39-C40-C41  114.9(3) 
C39-C40-H40A 108.5 
C41-C40-H40A 108.5 
C39-C40-H40B 108.5 
C41-C40-H40B 108.5 
H40A-C40-H40B 107.5 
C40-C41-C42  108.7(3) 
C40-C41-H41A 109.9 
C42-C41-H41A 109.9 
C40-C41-H41B 109.9 
C42-C41-H41B 109.9 
H41A-C41-H41B 108.3 
C41-C42-H42A 109.5 
C41-C42-H42B 109.5 
H42A-C42-H42B 109.5 
C41-C42-H42C 109.5 
H42A-C42-H42C 109.5 
H42B-C42-H42C 109.5 
C38A-C37A-H37D 109.5 
C38A-C37A-H37E 109.5 
H37D-C37A-H37E 109.5 
C38A-C37A-H37F 109.5 
H37D-C37A-H37F 109.5 
H37E-C37A-H37F 109.5 
C39A-C38A-C37A 114.7(7) 
C39A-C38A-H38C 108.6 
C37A-C38A-H38C 108.6 
C39A-C38A-H38D 108.6 
C37A-C38A-H38D 108.6 
H38C-C38A-H38D 107.6 
C38A-C39A-C40A 117.8(8) 
C38A-C39A-H39C 107.8 
C40A-C39A-H39C 107.8 
C38A-C39A-H39D 107.8 
C40A-C39A-H39D 107.8 
H39C-C39A-H39D 107.2 
C39A-C40A-C41A 116.7(7) 
 352 
C39A-C40A-H40C 108.1 
C41A-C40A-H40C 108.1 
C39A-C40A-H40D 108.1 
C41A-C40A-H40D 108.1 
H40C-C40A-H40D 107.3 
C40A-C41A-C42A 104.9(7) 
C40A-C41A-H41C 110.8 
C42A-C41A-H41C 110.8 
C40A-C41A-H41D 110.8 
C42A-C41A-H41D 110.8 
H41C-C41A-H41D 108.8 
C41A-C42A-H42D 109.5 
C41A-C42A-H42E 109.5 
H42D-C42A-H42E 109.5 
C41A-C42A-H42F 109.5 
H42D-C42A-H42F 109.5 
H42E-C42A-H42F 109.5 
C8-N1-O1  114.02(13) 
C8-N1-Pd1  130.19(12) 
O1-N1-Pd1  115.61(10) 
N1-O1-C1  106.60(12) 
C10-O2-Pd1  126.78(11) 
C31-P1-C25  106.97(8) 
C31-P1-C19  102.01(8) 
C25-P1-C19  103.34(8) 
C31-P1-Pd1  117.55(6) 
C25-P1-Pd1  112.13(6) 
C19-P1-Pd1  113.45(6) 
N1-Pd1-C2  82.32(6) 
N1-Pd1-O2  88.15(5) 
C2-Pd1-O2  170.43(6) 
N1-Pd1-P1  178.95(4) 
C2-Pd1-P1  97.30(5) 
O2-Pd1-P1  92.21(4) 
_________________________________________________________________________ 
 
Table 4.4.4. Anisotropic displacement parameters for 4.10.   
The anisotropic displacement (Å
2
x 10
3
) factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 
h k a* b* U
12
 ] 
______________________________________________________________________________  
Atom  U
11 
 U
22
   U
33
  U
23 
 U
13 
 U
12
 
______________________________________________________________________________  
C1  20(1)   17(1)  18(1)   1(1)  4(1)   2(1) 
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C2  18(1)   15(1)  18(1)   2(1)  2(1)   1(1) 
C3  19(1)   18(1)  21(1)   1(1)  4(1)   3(1) 
C4  23(1)   24(1)  22(1)   0(1)  7(1)   2(1) 
C5  26(1)   26(1)  19(1)   5(1)  6(1)   0(1) 
C6  24(1)   20(1)  23(1)   2(1)  7(1)   -1(1) 
C7  25(1)   23(1)  20(1)   5(1)  3(1)   1(1) 
C8  23(1)   13(1)  18(1)   0(1)  1(1)   2(1) 
C9  20(1)   18(1)  18(1)   2(1)  2(1)   3(1) 
C10  18(1)   19(1)  19(1)   1(1)  1(1)   4(1) 
C11  21(1)   21(1)  26(1)   1(1)  3(1)   -1(1) 
C12  20(1)   28(1)  23(1)   3(1)  5(1)   1(1) 
C13  22(1)   24(1)  17(1)   0(1)  3(1)   5(1) 
C14  23(1)   18(1)  19(1)   0(1)  2(1)   3(1) 
C15  24(1)   30(1)  20(1)   -5(1)  7(1)   3(1) 
C16  28(1)   32(1)  30(1)   -8(1)  8(1)   4(1) 
C17  30(1)   50(1)  32(1)   -15(1)  1(1)   16(1) 
C18  53(2)   44(1)  31(1)   0(1)  21(1)   -1(1) 
C19  17(1)   13(1)  33(1)   2(1)  1(1)   4(1) 
C20  23(1)   15(1)  40(1)   1(1)  6(1)   2(1) 
C21  27(1)   20(1)  56(1)   6(1)  16(1)   6(1) 
C22  20(1)   19(1)  68(2)   6(1)  -5(1)   3(1) 
C23  26(1)   24(1)  50(1)   8(1)  -10(1)   0(1) 
C24  25(1)   17(1)  38(1)   4(1)  -5(1)   2(1) 
C25  17(1)   17(1)  19(1)   4(1)  4(1)   2(1) 
C26  21(1)   18(1)  22(1)   3(1)  3(1)   -1(1) 
C27  22(1)   27(1)  23(1)   8(1)  0(1)   1(1) 
C28  28(1)   26(1)  26(1)   12(1)  5(1)   7(1) 
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C29  30(1)   16(1)  28(1)   7(1)  7(1)   3(1) 
C30  22(1)   17(1)  22(1)   3(1)  2(1)   1(1) 
C31  17(1)   16(1)  19(1)   1(1)  -2(1)   1(1) 
C32  29(1)   18(1)  25(1)   2(1)  -2(1)   7(1) 
C33  32(1)   25(1)  24(1)   9(1)  -4(1)   1(1) 
C34  25(1)   27(1)  20(1)   3(1)  1(1)   -5(1) 
C35  22(1)   20(1)  26(1)   1(1)  5(1)   0(1) 
C36  16(1)   16(1)  24(1)   3(1)  0(1)   1(1) 
N1  18(1)   15(1)  19(1)   2(1)  3(1)   0(1) 
O1  21(1)   14(1)  26(1)   1(1)  8(1)   -1(1) 
O2  20(1)   17(1)  28(1)   -4(1)  8(1)   0(1) 
P1  16(1)   12(1)  19(1)   0(1)  0(1)   2(1) 
Pd1  15(1)   11(1)  16(1)   0(1)  2(1)   2(1) 
______________________________________________________________________________  
 
Table 4.4.5. H coordinates and isotropic displacement parameters for 4.10. 
Hydrogen coordinates (x10
4
) and isotropic displacement parameters (Å
2
x10
3
) 
______________________________________________________________________________  
Atom   x    y    z    U(eq) 
______________________________________________________________________________  
H1   540   3834   2287   23 
H3A   136   5727   2997   24 
H3B   1053   6441   3831   24 
H4A   -571   5571   4393   29 
H4B   -1535   4913   3559   29 
H5   -311   3429   4282   28 
H6A   -1154   2972   2807   27 
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H6B   52   2119   3085   27 
H7A   2333   3459   4074   27 
H7B   2072   4811   4586   27 
H8   3733   1800   1769   23 
H11   7811   5437   1994   29 
H12   8749   4028   1097   30 
H14   5602   1415   1067   26 
H16A   6867   -9   458   49 
H16B   7526   -146   -309   49 
H16C   6102   586   -189   49 
H17A   10101   2076   1140   64 
H17B   9952   721   569   64 
H17C   9193   965   1310   64 
H18A   7506   2304   -493   65 
H18B   8891   1506   -549   65 
H18C   9086   2871   12   65 
H20   6272   7432   2872   33 
H21   8778   8118   3086   41 
H22   10129   8749   4330   46 
H23   9010   8700   5363   43 
H24   6503   8022   5161   34 
H26   1922   6753   2488   25 
H27   722   8048   1833   29 
H28   1357   10173   2246   31 
H29   3215   11011   3314   30 
H30   4418   9724   3974   25 
H32   4582   5904   4982   30 
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H33   4233   6329   6246   33 
H34   3184   8114   6787   30 
H35   2423   9442   6048   28 
H36   2781   9032   4781   23 
H37A   1195   5029   535   75 
H37B   2509   5626   1238   75 
H37C   1868   4223   1082   75 
H38A   3528   5122   100   55 
H38B   4142   4256   622   55 
H39A   1813   3562   -666   54 
H39B   2189   2710   -104   54 
H40A   4476   2423   -456   48 
H40B   4256   3394   -950   48 
H41A   2524   2049   -1883   54 
H41B   2418   1127   -1357   54 
H42A   5129   1629   -1883   79 
H42B   4009   433   -2312   79 
H42C   4861   590   -1459   79 
H37D   3256   5526   786   66 
H37E   2799   4832   1382   66 
H37F   1559   5094   743   66 
H38C   3812   3454   359   57 
H38D   2209   2942   426   57 
H39C   2688   4226   -651   58 
H39D   1150   3565   -608   58 
H40C   1999   2393   -1625   53 
H40D   2049   1639   -1000   53 
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H41C   4652   2036   -677   59 
H41D   4636   2879   -1262   59 
H42D   3038   583   -2038   60 
H42E   4667   349   -1686   60 
H42F   4440   1168   -2278   60 
______________________________________________________________________________  
Table 4.4.6. Torsion angles [°] for 4.10. 
_____________________________________________________________________________  
O1-C1-C2-C3   174.59(13) 
C6-C1-C2-C3   -70.37(17) 
O1-C1-C2-C7   -80.39(16) 
C6-C1-C2-C7   34.64(17) 
O1-C1-C2-Pd1  44.19(15) 
C6-C1-C2-Pd1  159.22(12) 
C7-C2-C3-C4   -32.15(16) 
C1-C2-C3-C4   71.84(16) 
Pd1-C2-C3-C4  -169.72(11) 
C2-C3-C4-C5   -2.78(17) 
C3-C4-C5-C6   -69.99(17) 
C3-C4-C5-C7   36.83(16) 
C4-C5-C6-C1   71.79(18) 
C7-C5-C6-C1   -34.88(17) 
O1-C1-C6-C5   118.11(15) 
C2-C1-C6-C5   0.00(18) 
C4-C5-C7-C2   -55.83(15) 
C6-C5-C7-C2   55.69(16) 
C3-C2-C7-C5   53.42(15) 
C1-C2-C7-C5   -54.45(15) 
Pd1-C2-C7-C5  -167.39(12) 
N1-C8-C9-C14  -175.60(17) 
N1-C8-C9-C10  1.7(3) 
C14-C9-C10-O2  -176.78(16) 
C8-C9-C10-O2  6.0(3) 
C14-C9-C10-C11  2.7(2) 
C8-C9-C10-C11  -174.49(16) 
O2-C10-C11-C12  177.50(17) 
C9-C10-C11-C12  -2.1(3) 
C10-C11-C12-C13  -0.3(3) 
C11-C12-C13-C14  2.0(3) 
C11-C12-C13-C15  -174.48(18) 
C12-C13-C14-C9  -1.2(3) 
C15-C13-C14-C9  175.12(17) 
C10-C9-C14-C13  -1.2(3) 
C8-C9-C14-C13  176.25(17) 
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C14-C13-C15-C17  -104.5(2) 
C12-C13-C15-C17  71.7(2) 
C14-C13-C15-C16  15.9(3) 
C12-C13-C15-C16  -167.88(18) 
C14-C13-C15-C18  134.8(2) 
C12-C13-C15-C18  -49.0(2) 
C24-C19-C20-C21  0.3(3) 
P1-C19-C20-C21  -178.11(14) 
C19-C20-C21-C22  -0.1(3) 
C20-C21-C22-C23  0.0(3) 
C21-C22-C23-C24  -0.1(3) 
C22-C23-C24-C19  0.3(3) 
C20-C19-C24-C23  -0.4(3) 
P1-C19-C24-C23  177.96(15) 
C30-C25-C26-C27  -1.4(3) 
P1-C25-C26-C27  -179.56(14) 
C25-C26-C27-C28  0.5(3) 
C26-C27-C28-C29  0.4(3) 
C27-C28-C29-C30  -0.4(3) 
C28-C29-C30-C25  -0.4(3) 
C26-C25-C30-C29  1.3(3) 
P1-C25-C30-C29  179.44(14) 
C36-C31-C32-C33  -0.9(3) 
P1-C31-C32-C33  175.56(15) 
C31-C32-C33-C34  0.1(3) 
C32-C33-C34-C35  1.0(3) 
C33-C34-C35-C36  -1.2(3) 
C32-C31-C36-C35  0.7(3) 
P1-C31-C36-C35  -175.48(13) 
C34-C35-C36-C31  0.3(3) 
C37-C38-C39-C40  -171.3(3) 
C38-C39-C40-C41  -173.0(3) 
C39-C40-C41-C42  -168.5(4) 
C37A-C38A-C39A-C40A 173.6(9) 
C38A-C39A-C40A-C41A -64.2(12) 
C39A-C40A-C41A-C42A -176.2(8) 
C9-C8-N1-O1   179.88(15) 
C9-C8-N1-Pd1  -5.3(3) 
C8-N1-O1-C1   -154.98(14) 
Pd1-N1-O1-C1  29.39(14) 
C6-C1-O1-N1   -162.26(13) 
C2-C1-O1-N1   -48.34(16) 
C11-C10-O2-Pd1  171.35(12) 
C9-C10-O2-Pd1  -9.1(3) 
C36-C31-P1-C25  -12.27(17) 
C32-C31-P1-C25  171.49(13) 
C36-C31-P1-C19  95.88(16) 
C32-C31-P1-C19  -80.36(15) 
C36-C31-P1-Pd1  -139.38(13) 
C32-C31-P1-Pd1  44.38(15) 
C26-C25-P1-C31  -116.28(14) 
C30-C25-P1-C31  65.58(16) 
C26-C25-P1-C19  136.50(14) 
C30-C25-P1-C19  -41.64(17) 
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C26-C25-P1-Pd1  13.96(16) 
C30-C25-P1-Pd1  -164.18(13) 
C20-C19-P1-C31  -171.08(14) 
C24-C19-P1-C31  10.57(17) 
C20-C19-P1-C25  -60.16(16) 
C24-C19-P1-C25  121.49(15) 
C20-C19-P1-Pd1  61.50(15) 
C24-C19-P1-Pd1  -116.85(14) 
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CHAPTER 5:  TRANSITION-METALS CATALYZED 
ALKYLATION OF AROMATIC C−H BONDS WITH SIMPLE 
OLEFINS 
5.1 Introduction 
Carbon−carbon bond (C−C) formation is at the forefront of modern organic 
synthesis.
1
 Alkylation reactions, the couplings between a nucleophile and an alkylating 
agent, clearly constitute one highly important C−C bond-forming reaction and have been 
widely employed in synthesizing compounds for various purposes. Scheme 1 depicts two 
most representative alkylation reactions: electrophilic aromatic alkylation
2
 and enolate 
alkylation.
3
 Conventionally, both transformations mainly rely on using highly reactive 
alkylating agents, e.g. alkyl halides and sulfonates, etc. While efficient, these 
transformations inevitably are concerned about the cost and generation of stoichiometric 
byproducts. 
Scheme 5.1. Two representative alkylation reactions. 
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With the advancement of transition-metal chemistry during the last three decades, 
catalytic carbon−hydrogen bond (C−H) functionalization has become an important tool 
for synthesizing complex molecules. One intriguing question emerged: can the alkylation 
reactions be achieved through the addition of a C−H bond across an unactivated alkene? 
Comparing to the traditional alkylation reagents, a number of attractive features can be 
envisioned using alkenes: 1) the alkylation reaction would be byproduct-free;
4
 2) olefins 
are generally much cheaper and more readily available than the corresponding alkyl 
halides;
5
 3) the reactivity of alkenes is orthogonal to many functional groups; 4) using 
olefins can streamline syntheses, whereas many primary alkyl halides or sulfonates are 
ultimately synthesized from olefins.
6
 
Herein, this review will focus on transition metal-catalyzed C−H alkylation using 
alkenes as the coupling partner. As an overview of this field, three general mechanistic 
pathways are possible for this transformation (Scheme 2). Type A pathway is mediated 
by a metal−hydride intermediate. In this type, a low-valent transition metal first inserts 
into a C−H bond to give a metal-hydride intermediate, which then undergoes olefin 
migratory insertion followed by reductive elimination to afford the alkylation product. 
The reductive elimination step is generally considered as the most challenging step for 
Type A transformations, where it is often the rate-determining step and therefore controls 
the regioselectivity of the olefin insertion.
7
  
Type B is a pathway involving metalation and net protonation. A carbon−metal 
bond is formed through an electrophilic metallation of the C−H bond, e.g. concerted 
metalation deprotonation (CMD). Instead of forming a hydride intermediate, the 
hydrogen leaves as a proton equivalent. The resulting carbon−metal bond can undergo 
migratory insertion into the olefin, and the newly generated carbon−metal bond then 
directly or indirectly gets protonated to offer the alkylation product. Clearly, type A and 
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type B are closely related pathways, and sometimes, are difficult to differentiate through 
experiments. In this review, we discuss both pathway types in the section of “alkylation 
via C−H activation”. 
Scheme 5.2. Three pathways for the alkylation of aromatic C−H bonds.  
 
Type C involves activation of the alkenes by a π -acidic transition-metal. In this 
pathway, the alkene becomes more electrophilic, which can be attacked by an electron-
rich carbon nucleophile, followed by a proton transfer, to give the alkylation product.
3b
 
This type of reactions will be summarized in the section of “alkylation via olefin 
activation”. Besides the above three major pathways, other mechanisms are also possible, 
and will be discussed on a case-by-case basis.  
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5.2 Background 
The addition of arene C−H bonds across olefins, also known as hydroarylation, 
has been studied extensively over the past four decades. A number of regio- and 
enantioselective hydroarylation methods have been established with various transition-
metal catalysts, including Ru, Rh, Ni, Re, Mn, Co, Fe and rare earth metal complexes. 
Chelation-controlled alkylation has dominated the field since the seminal discovery by 
Lewis
8
 and Murai.
9
 Alkylation of simple arenes, such as benzene, has also been disclosed 
with homogeneous catalysts (e.g. the Ir
10
 and Ru
11
 systems), although the efficiency 
remains to be further improved.
12
 Besides regular arenes, heteroarenes can also be 
alkylated with olefins, with both early (e.g. Sc, Y, Ti, and Zr systems) and late transition 
metals.
7
 While still in its early stage, the hydroarylation methodology has already been 
utilized in late-stage functionalization, polymer synthesis/modification, and total 
synthesis. This section is organized based on the nature of the metal catalysts used. This 
chapter will focus on Ru and Rh-catalyzed alkylation of aromatic C−H bonds. 
 
5.3 TM-Catalyzed Alkylation of Aromatic C−H Bonds 
5.3.1 RUTHENIUM CATALYSIS 
5.3.1.1 Chelation controlled 
In 1986, Lewis reported the first Ru-catalyzed ortho-selective C−H alkylation of 
phenols with ethylene using complex 5.1 (Scheme 5.3).
8
 The phosphite ligand was 
critical for the success of this reaction, to install a directing group in situ from phenoxide 
to assist insertion of the ruthenium into the ortho C−H bonds. Interestingly, when 
propylene reacted with complex 5.2, the branched product was found as the dominating 
product. Complex 5.2 also reacted with styrene, albeit giving a polymeric product 5.3 
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(Scheme 5.4). Other olefins did not react. While the reaction mechanism remains unclear, 
the metal-hydride pathway (Type A, Scheme 5.2) is less likely due to the formation of 
branched products with propene and the lack of evidence for a Ru−H species. Thus, the 
authors proposed a Type B like mechanism. The significance of this seminal work 
includes 1) the first use of a temporary directing group to control site-selectivity of C−H 
functionalization, and 2) the first controlled ortho C−H alkylation with olefins, which is 
distinct from the classical Friedel−Craft reaction. (For an analogous Rh-catalyzed ortho-
alkylation of phenols, see Scheme 5.38). 
Scheme 5.3. Ru-catalyzed ortho-selective C−H alkylation of phenols with ethylene. 
 
Scheme 5.4. Ru-catalyzed C−H alkylation of phenols with styrene. 
 
In 1993, the Ru-catalyzed ortho-alkylation of aromatic ketones with olefins, 
reported by Murai and coworkers, represents another milestone in the field.
9
 Many 
aromatic and heteroaromatic ketones were successfully alkylated (Scheme 5.5). When 2-
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acetylnaphthalene was used as the substrate, the alkylation occurred site-selectively at the 
C1 position. The chelation effect is crucial, and ketones that cannot generate strongly 
chelated five-membered metallocycles, e.g. 1-indanone, do not react. A range of 
unisomerizable olefins can be used as the coupling partner, giving linear, anti-
Markovnikov addition products.
13
 
Scheme 5.5. Ru-catalyzed ortho-alkylation of aromatic ketones with olefins. 
 
The proposed mechanism is illustrated in Scheme 5.6, which is a Type A 
mechanism. The reaction was initiated by a ketone-assisted oxidative addition into the 
ortho C−H bond, giving a ruthenium−hydride complex (5.5). Subsequent migratory 
insertion into the olefin, followed by reductive elimination, provides the alkylation 
product.  
As depicted in Scheme 5.7, deuterium scrambling was observed between the 
starting materials and products when using d5-acetophenone, which supports the 
proposed metal−hydride-involved mechanism. In 1998, the DFT study by Koga and 
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Morokuma indicated that the Ru−H species, generated via oxidative addition of Ru(0) 
into the ortho C−H bond, was a feasible intermediate in the catalytic cycle.14 The 
chelation effect is critical for decreasing the activation energy for the C−H activation 
step. Later, a detailed DFT study by Matsubara, Morokuma and coworkers revealed that 
reductive elimination is the rate determining step.
15
 
Scheme 5.6. Proposed mechanism for Ru-catalyzed ortho-alkylation of aromatic ketones. 
 
Scheme 5.7. The deuterium scrambling experiment for Ru alkylation. 
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After Murai’s seminal work, Grigg and coworkers in 1997 successfully extended 
the scope of the ketone substrates to heterocycles, such as pyridine- and indole-based 
ketones (Scheme 5.8).
16
 High site-selectivity was observed using 3-acetylpyridine, with a 
small amount of bis-alkylated products. Chemo- and site-selective alkylation of the 
pyridine ring instead of the phenyl ring can be achieved. 
Scheme 5.8. Ru-catalyzed alkylation of heterocycles with silylated olefins. 
 
The Ru-catalyzed alkylation of aromatic ketones containing 9-ferrocenyl groups 
was developed by Du and co-workers in 2001 (Scheme 5.9).
17
 The alkylation with 
various terminal olefins gave a good to excellent yield. The alkylation occurred 
chemoselectively at the none-ferrocenyl side, presumably due to its electronic properties. 
In 1996, Murai and coworkers developed the first Ru-catalyzed ortho-alkylation 
of aromatic imines with simple olefins (Scheme 5.10),
18
 in which Ru3(CO)12 was used as 
the pre-catalyst. For certain substrates, a few alkenylation products were observed. The 
alkylation conditions for imine and ketone directing groups are orthogonal to each other, 
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with chemoselective alkylations achieved by properly choosing the corresponding Ru 
precatalysts (Scheme 5.11).
19
 
Scheme 5.9. Ru-catalyzed alkylation of aromatic ketones containing 9-ferrocenyl groups. 
 
Scheme 5.10. Ru-catalyzed ortho-alkylation of aromatic imines with simple olefins. 
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Scheme 5.11. Ru-catalyzed chemoselective alkylations with simple olefins. 
In 2001, the Whittlesey group prepared four new Ru complexes for C–H alkylation, but 
unfortunately, none of them shown improved reactivity from the RuH2(CO)(PPh3)3 
complex.
20
 Meanwhile, the Leitner group successfully developed a room temperature 
alkylation with an in situ generated Ru catalyst (Scheme 5.12).
21
 In 2005, Stabo-Etienne 
and coworkers prepared and isolated the RuH2(H2)2(PCyp3)2 complex, which was 
confirmed by neutron diffraction analysis (Scheme 5.13).
22
 With this newly prepared Ru 
complex, the alkylation of acetophenone can reach 90% conversion within 35 minutes at 
room temperature, which previously required 10 hours using the Murai’s pre-catalyst 
with heat. 
Scheme 5.12. Room temperature alkylation with an in situ generated Ru catalyst. 
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Scheme 5.13. Room temperature alkylation with a fully characterized Ru catalyst. 
 
In 2006, the Darses and Genet group utilized the [Ru(p-cymene)Cl2]2 as a 
versatile catalyst for both ketone and imine directed alkylations.
23
 By combining the Ru 
pre-catalyst with a reductant, sodium formate, many aromatic ketones and imines were 
successfully alkylated (Scheme 5.14). According to the kinetic studies, a 1:3 
ruthenium/phosphine ratio gave the best result. Later in 2008, the alkylation with styrenes 
was achieved with an electron-poor phosphine ligand, P(4-CF3C6H4)3, in which linear 
products were the major isomer.
24
 
Scheme 5.14. A versatile Ru catalyst for alkylations of both aromatic ketones and imines. 
 
To investigate the role of the formate salt, complexes 5.7 and 5.8 were 
synthesized as shown in Scheme 5.15.
25
 Complex 5.8 exhibits higher reactivity for 
alkylation reaction, as the rapid decarboxylation of the formate intermediate gives a 
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monohydride ruthenium complex 5.9, which can form 5.10 through ligand exchange with 
PPh3. Complex 5.10 can form the known dihydride ruthenium complex 5.11.  
Scheme 5.15. Mechanistic study of formate salt in Ru-catalyzed alkylation. 
 
In 2009, the Darses group found that using isopropanol as a solvent could lower 
the temperature of the Ru-catalyzed alkylation reaction.
26
 Either the pre-made or in situ 
generated catalyst can be used, affording the desired products in high yield (Scheme 
5.16). Since the ketone can be reduced by the metal hydride species, acetone was 
introduced as a co-solvent and hydride acceptor to suppress the reduction. One year later, 
the tandem oxidation of benzylic alcohols to the corresponding ketones, and then 
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alkylation was achieved by the same group, using the less expensive RuCl3 species as a 
precatalyst.
27
 
Scheme 5.16. Ru-catalyzed alkylation with isopropanol to lower the temperature. 
 
Scheme 5.17. Ru-catalyzed room temperature C−H alkylation of aromatic ketones. 
 
In 2010, Murai, Kakiuchi, and coworkers reported a Ru-catalyzed room 
temperature C−H alkylation of aromatic ketones.28 When treating RuH2(CO)(PPh3)3 with 
vinyl silane in benzene-d6 at 90
 
ºC for 1.5 h, a mixture of four Ru complexes was formed 
(Scheme 5.17). Using the mixture of Ru complexes, the alkylation can be carried out at 
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room temperature in excellent yield, or even with low catalyst loadings (0.1 mol%, 994 
turnovers at 120
o
C) in excellent yields (Scheme 5.18). 
Scheme 5.18. Reactivity in alkylation with new Ru catalysts. 
 
Scheme 5.19. Ru-catalyzed alkylation with various functional groups.  
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Besides aryl ketones and imines, other types of substrates have also been 
employed for the Murai-type reaction. Functional groups, such as oxazolines
29
, nitriles
30
, 
hydrazones
31
, esters
32
, and aldehydes
33
, can effectively assist chelation for the ortho-
alkylation reactions (Scheme 5.19).  
Scheme 5.20. Ru-catalyzed alkylation of 2-phenylpyridine derivatives. 
 
In 2008, Ackermann and coworkers reported a Ru-catalyzed alkylation of 2-
phenylpyridine derivatives.
34
 The highly strained methylenecyclopropanes were used as 
the alkylation reagent without ring opening (Scheme 5.20). A cis-product was obtained 
and confirmed by X-ray crystallography. A mechanism similar to Type A, involving a 
ruthenium−hydride intermediate, was proposed for this transformation. 
Later in 2013, Ackermann extended the Ru-catalyzed alkylation scope to simple 
olefins by using pyridine, pyrazole, indole, and imidazoline as the directing groups 
(Scheme 5.21).
35
 Inspired by the role of carbonate ligands in Ru-mediated 
deprotonation/metalation pathways, the Ackermann group came up with a bulky 
carboxylate additive, KCO2Mes. This additive was found to be crucial for this C–H 
alkylation reaction during the deprontation of the C–H bond. Noteworthy, this reaction 
can tolerate water as cosolvent.  
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Scheme 5.21. Ru-catalyzed alkylation using heterocycles as the directing groups. 
 
In 2009, through merging the olefin redox isomerization and ortho C−H 
alkylation transformations, the Martín-Matute group reported a Ru-catalyzed ortho-
alkylation/tautomerization reaction of allylic and homoallylic alcohols (Scheme 5.22).
36
 
Aryl group with various electronic properties can be tolerated. High mono-alkylation 
selectivity can be achieved for most substrates. 
Scheme 5.22. Ru-catalyzed alkylation/tautomerization reaction of allylic and homoallylic 
alcohols. 
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In 1999, Uchimaru reported one example of N-methyl aniline reacting with 
styrene to give an ortho-alkylated product with Ru catalysis (Scheme 5.23).
37
 In this 
reaction, the branched product was obtained, which is due to the benzylic stabilization of 
the Ru-complex. When an alkyne was applied, hydroamination became the major 
reaction pathway. The mechanism for this reaction is still not clear. 
Scheme 5.23. One example on Ru-catalyzed alkylation of N-methyl aniline. 
 
 
5.3.1.2 Non-chelation control 
In 2003, Gunnoe and coworkers reported a Ru-catalyzed C−H alkylation of 
simple benzene (Scheme 5.24).
11
 The hydridotris(pyrazolyl)borate (TAB) ligand was 
used to form Ru catalyst 13, which can catalyze the alkylation of benzene with ethylene 
gas in 51 turnovers over 4 h. The 1.6:1 linear to branched ratio was observed using 
propene as the alkylation reagent with 14 turnovers after 19 h. Later DFT study by the 
Goddard group suggests the rate-determining step of the reaction is the olefin migratory 
insertion.
38
 As the ethylene pressure increased, there was a resulting decrease in the 
reaction rate. The proposed catalytic cycle (Scheme 5.25) starts with ligand exchange 
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with ethylene, followed by insertion of the olefin with the C–Ru bond, and finally C−H 
bond activation of the benzene to release of the product. 
Scheme 5.24. Ru-catalyzed C−H alkylation of simple benzene. 
 
Scheme 5.25. Proposed mechanism for Ru-catalyzed C−H alkylation of simple benzene. 
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When 1-hexene was used as the alkylation reagent, the linear product was 
obtained as the major product with benzene as the substrate. The regioselectivity 
indicates the 2,1-insertion is slightly favored and can be explained by the steric 
interaction between the substituent groups of the olefin with the pyrazolyl rings on the 
catalyst. When ethylbenzene was used, the meta- and para-selective products were 
obtained, which is a unique difference from typical Friedel-Crafts reactions (Scheme 
5.26). 
Scheme 5.26. Ru-catalyzed C−H alkylation of simple benzene with 1-hexene. 
 
In the same year, Gunnoe, Petersen, and coworkers extended the Ru-catalyzed 
alkylation to heteroaromatic substrates.
39
 Catalysts 5.17 and 5.18 containing the 
corresponding heteroaryl ligands, were used for the alkylation of furans and thiophenes 
(Scheme 5.27). A DFT study by Goddard and coworker suggested a similar reaction 
pathway as the previous arene alkylation.
40
 
Later in 2007, Gunnoe, Cundari, and coworkers, discovered evidence for a -
bond metathesis mechanism.
41
 The observance of electron-poor arenes affording higher 
alkylation yields (Scheme 5.28) suggested that the electrophilic aromatic substitution 
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C−H bond cleavage mechanism could be excluded. The Hammett plot was obtained with 
a positive -value, suggesting a preference for a -bond metathesis mechanism in the 
C−H activation step.  
Scheme 5.27. Ru-catalyzed alkylation of heteroaromatic substrates. 
 
Scheme 5.28. Mechanistic study on Ru-catalyzed alkylation of simple arenes.  
 
In the same year, Gunnoe and co-workers studied the effect of ancillary ligands 
on the Ru catalyst in the reaction.
42
 The CO ligand was found to promote catalyst 
decomposition through the formation of CO-bridged multinuclear complexes. Following 
this observation in 2008, Gunnoe, Cundari and coworkers, developed catalyst 5.19, which 
contains a bicyclic phosphite ligand (Scheme 5.29). Using this catalyst the hydroarylation 
reaction can be achieved at lower temperatures.
43
 Catalyst 5.19 exhibited enhanced 
stability compared to the CO-based catalyst. On the other hand, given that the rate-
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determining step was found to be the C−H cleavage step, a highly reactive cationic 
catalyst (5.20) was developed by Gunnoe, Cundari and coworkers, which can achieve 
565 TON after 131 h.
44
 It’s likely the e-deficient nature of the ligand significantly, 
increased the binding affinity of benzene, which consequently promoted the C−H 
activation. 
Scheme 5.29. Ru-catalyzed alkylation of simple arenes with high TON.  
 
5.3.1.3 Application of Ruthenium-Catalyzed Arene C−H Bond Alkylation 
The Ru-catalyzed arene C–H alkylation has been applied in polymer synthesis, 
Weber and coworkers reported a step-growth copolymerization between an acetophenone 
and a 1,7-silyldiene in 1995 (Scheme 5.30).
45
 This reaction is sensitive to the electronic 
properties of acetophenone, where electron rich arenes gave polymers of a higher 
molecular weight. 
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Scheme 5.30. Ru-catalyzed step-growth copolymerization with acetophenone. 
 
Scheme 5.31. Ru-catalyzed copolymerization with in situ generated catalyst.  
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Weber and coworkers further developed a new catalyst for the copolymerization 
reactions.
46
 Complex 5.22 prepared from complex 5.21 with styrene was able to provide 
much higher molecular weight polymers than using complex 5.21 for the 
copolymerization, as shown in Scheme 5.31.
47
 The spectral and thermal properties of 
these polymers have been studied and reported. It has also been used for post-
functionalization of a silicon-based polymer (Scheme 5.32).
48
 In addition, this method 
has been employed to derivatize diterpenoid natural products (Scheme 5.33).
49
 
Scheme 5.32. Ru-catalyzed a post-functionalization with a silicon-based polymer. 
 
Scheme 5.33. Ru-catalyzed derivatization of diterpenoid natural products. 
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5.3.2 RHODIUM CATALYSIS 
5.3.2.1 Electron-Rich Benzene Rings and Heterocycles 
In 1992, Brunet and coworkers discovered an unexpected Rh-catalyzed 
hydroarylation of norbornene with aniline or diphenylamine.
50
 The catalyst 5.24 was 
prepared by reacting lithium anilide with [Rh(PEt3)2Cl]2 using aniline as a solvent. 
Attempts to use 5.24 to catalyze the designed hydroamination of norbornene resulted in 
only 15% yield. However, the ortho-alkylation product was isolated in 30% yield 
(Scheme 5.34). Similarly to the sp
3
 nitrogen assisted C–H alkylation with Ru catalyst (see 
Scheme 5.23), this mechanism has not been fully understood. 
Scheme 5.34. Rh-catalyzed hydroarylation of norbornene with aniline or diphenylamine. 
 
In 2000, Miura and coworkers reported a multi-alkylation reaction of aryl boronic 
acids with norbornene.
51
 Norbornene has previously been shown to couple well with 
arenes; however, in this case, its unique bicyclic structure allows further alkylations to 
provide mono-, di-, tri-, and tetrasubstituted products (Scheme 5.35). Mechanistic 
insights were gained through a deuterium experiment, in which the deuteriums of the 
starting material were transferred to the C2-position of the norbornyl group (5.25) 
(Scheme 5.36). 
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Scheme 5.35. Rh-catalyzed multi-alkylation of aryl boronic acids. 
 
Scheme 5.36. Deuterium labeling in Rh-catalyzed multi-alkylation. 
 
The proposed mechanism is depicted in Scheme 5.37, beginning with 
transmetalation of the ArB(OH)2 with the rhodium catalyst to generate an aryl-rhodium 
species 5.26. Migratory insertion into norbornene through an exo-fashion affords alkyl-
rhodium species 5.27. Sequential C−H bond cleavage then reductive elimination results 
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in intermediate 5.29, which can repeat the insertion and reductive elimination to give 
multi alkylated arenes 5.30, 5.31 and 5.32. 
Scheme 5.37. Proposed mechanism for Rh-catalyzed multi-alkylation. 
 
In 2006, the Cole-Hamilton group reported a Rh-catalyzed ortho-alkylation of 
phenols and anilines (Scheme 5.38).
52
 The alkylation of phenols was similar to the Ru-
catalyzed reaction by Lewis, using a phosphinite additive to form a covalent bond 
temporarily with phenol or aniline through transesterification (Scheme 5.3). Thus, the 
directing group was installed and later removed in situ. Other metals such as Ru and Pd 
were also examined but were found less effective than Rh. Ethylene was the only alkene 
used in these studies. 
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Scheme 5.38. Rh-catalyzed ortho-alkylation of phenols and anilines. 
 
Scheme 5.39. Rh-catalyzed alkylation of aromatic ketones with new Rh catalyst.   
 
In 1999, Brookhart and coworkers developed an aromatic ketone-directed ortho-
alkylation with simple olefins using a Rh(I) catalyst (Scheme 5.39).
53
 Linear products 
were obtained exclusively, and bulky terminal olefins were found to react faster and give 
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higher yields. When isomerizable olefins were used, the alkylation gave a moderate 
conversion, and isomerization to internal olefins was observed. 
A deuterium study on this transformation suggested that all the C–H bonds on 
arenes could be activated by the Rh catalyst (Scheme 5.40); however, only the ortho-
positions favor reductive elimination. This effect can be explained by the chelation effect 
of the ketone, blocking open coordination sites on the Rh catalyst, forcing -hydride 
elimination. The increased steric demands of this intermediate should have a higher 
tendency to undergo reductive elimination.  
Scheme 5.40. Deuterium study on alkylation with Cp
*
Rh catalyst. 
 
In 2000, Jun and coworkers developed a Rh-catalyzed dialkylation of 
benzaldehydes, in which both the ipso-position of the aldehyde and the ortho-position of 
the arene are alkylated with olefins (Scheme 5.41).
54
 Through the examination of the 
reaction intermediates, the aldehyde C–H bond was proposed to be activated first. The 
resulting ketone can subsequently condense with benzylamine to give an imine 
intermediate, which should assist the ortho-alkylation.  
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Scheme 5.41. Rh-catalyzed ipso- and ortho-dialkylation of benzaldehydes. 
 
Scheme 5.42. Rh-catalyzed alkylation of aromatic ketimines with internal olefins. 
 
 
 397 
Later, in 2002, the Jun group developed a chelation-assisted alkylation of 
aromatic ketimines with olefins using Rh catalysis (Scheme 5.42).
55
 Isomerizable 1-
alkenes and -dienes (5.33) can afford the desired products in high yields, which were 
problematic in the previous Ru-based systems (Section 5.10). Notably, internal olefins 
also provided linear products, stemming from a facile isomerization of the alkene -bond 
to the terminal position. In 2004, a microwave-assisted alkylation of aromatic imines was 
achieved by the same group.
56 
Scheme 5.43. The proposed mechanism of Rh-catalyzed alkylation of aromatic 
ketimines. 
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The catalytic cycle was proposed to begin with dissociation of PPh3 and 
coordination with the nitrogen of the ketimine to give 5.34. The subsequent oxidative 
addition of the C−H bond would give Rh-hydride intermediate 5.35, which upon ligand 
exchange with an olefin, hydride migratory insertion, and reductive elimination affords 
the ortho-alkylated product (Scheme 5.43). Supported by H/D scrambling experiment, 
the reductive elimination was proposed as the rate-determining step. 
Scheme 5.44. Rh-catalyzed alkylation of aromatic ketones with catalytic benzylamine. 
 
The imine moiety was found to play an important role in the ortho C–H alkylation 
reaction, likely due to its strong coordination ability. Given that imines can be reversibly 
formed from ketones and amines, a catalytic amount of amine, in principle, is needed to 
generate an imine intermediate in situ, which can ultimately enable a general ortho C–H 
alkylation of ketones. Indeed, Jun and coworkers found when 50 mol% of benzylamine 
was used, the aromatic ketones can be efficiently alkylated at the ortho-position (Scheme 
5.44).   
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Scheme 5.45. Rh catalysis using recyclable self-assembly-supported (SAS) system. 
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In 2005, Jun and coworkers further developed a recyclable self-assembly-
supported (SAS) system for the ortho-alkylation of aromatic imines.
57
 The illustrative 
preparation of the SAS system is shown in Scheme 5.45. An interesting feature of this 
system is that it operates under homogeneous conditions at high temperature while it 
remained heterogeneous at room temperature. Such a property allowed the catalyst (5.37) 
to be easily recycled and reused for 8 cycles of the alkylation reaction without any loss of 
reactivity.  
Scheme 5.46. Rh-catalyzed alkylation of aromatic aldimines and ketimines with olefins. 
 
In 2001, Lim and coworkers reported a Rh-catalyzed alkylation of aromatic 
aldimines and ketimines with olefins.
58
 Using electron-rich PCy3 as the ligand, the bis-
alkylation became the major reaction pathway. The reaction exhibits complete selectivity 
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for anti-Markovnikov addition. Using isomerizable alkenes as substrates gave lower 
yields (Scheme 5.46).  
In 2005, Lim and coworkers further studied the Rh-catalyzed alkylation of 
terephthaldimine with olefins,
59
 in which the 2,6-dialkylated product (5.38) was the major 
product instead of the 2,5-dialkylated isomer (5.39). When 2-alkylated substrate was 
used, the alkylation still occurred at the C6 position, which suggested the electron-
donating alkyl substituent likely enhanced the coordination ability of the adjacent 
ketimine (Scheme 5.47). 
Scheme 5.47. Rh-catalyzed alkylation of terephthaldimine with olefins. 
 
In 2007, Shibata and coworkers investigated the Rh-catalyzed alkylation of 
aromatic ketones with diynes and enynes, in which a tandem transformation occurred 
resulting in a monocyclic product (Scheme 5.48).
60
 When a chiral bidentate ligand (e.g. 
BINAP) was used, high enantioselectivity was obtained. A similar transformation was 
reported by Tanaka and coworkers in 2008 using (R)-H8-BINAP as the chiral ligand.
61
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Scheme 5.48. Rh-catalyzed alkylation of aromatic ketones with diynes and enynes. 
 
In 1994, Kim and coworkers described a Rh-catalyzed alkylation of 2-
phenylpyridines with olefins (Scheme 5.49).
62
 The linear products were obtained as the 
major isomers, suggesting a Rh-hydride involved mechanism. Using isomerizable olefins 
as the alkylation reagents resulted in lower yields. By adding a methyl group at the 3-
postition of the pyridine ring, the mono-alkylated product was obtained exclusively.  
Further investigations by the Kim group, showed that when styrene-type olefins 
were applied, the linear product was major; however, a minor branched product was also 
obtained due to the added stability of the 2-alkyl rhodium species at the benzylic position 
(Scheme 5.50).
63
  
The ligand effects were also tested and found that phosphine ligands with a large 
cone angle such as PCy3 gave higher reaction yields. The atroposelective alkylation 
reaction was reported in 2000 by Murai and coworkers.
64
 The best result was obtained by 
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replacing PCy3 with the chiral ligands, (R),(S)-PPFOMe, axial chirality was induced 49% 
ee, albeit in low yield (Scheme 5.51). 
Scheme 5.49. Rh-catalyzed alkylation of 2-phenylpyridines with olefins. 
 
Scheme 5.50. Rh-catalyzed alkylation of 2-phenylpyridines with styrene. 
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Scheme 5.51. Rh-catalyzed atroposelective alkylation with pyridine DG. 
 
In 2001, Bergman, Ellman, and co-workers, reported an intramolecular C–H 
alkylation of heteroarenes, such as imidazoles and benzimidazoles.
65
 PCy3 proved to an 
optimal ligand. The 2-position of the imidazole ring was selectively alkylated to form 
five- and six-membered rings (Scheme 5.52). In 2003, a microwave-assisted alkylation 
with an enhanced reaction rate was accomplished by the same team.
66
 
Scheme 5.52. Rh-catalyzed intramolecular C–H alkylation of heteroarenes. 
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Scheme 5.53. Mechanistic study of the intramolecular alkylation of heterocycles. 
 
Scheme 5.54. Rh-catalyzed intermolecular C–H alkylation of heteroarenes. 
 
In 2002, Bergman, Ellman, and coworkers reported a mechanistic study of the 
previous intramolecular alkylation of heterocycles (Scheme 5.53).
67
 The crystal structure 
of a carbene species 5.41 was obtained as strong evidence to support the proposed 
carbene insertion mechanism. The reaction goes through C−H activation to form a 
carbene then insertion into olefin and reductive elimination to give the final product. 
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According to the DFT calculation, the rate-determining step is the carbene insertion to the 
alkene. 
In the same year, Bergman, Ellman, and coworker, realized an intermolecular 
alkylation of heterocycles with olefins (Scheme 5.54).
68
 Lutidinium chloride was found 
to be an effective additive. On the other hand, using phosphonium salt, HClP(t-Bu)2Et, as 
a ligand without additives, the temperature for this reaction could drop to 75 °C.
69
 
Scheme 5.55. Proposed mechanism for intermolecular alkylation of heterocycles. 
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The role of HClPCy3 can be explained by the proposed mechanism shown in 
Scheme 5.55. After the C–H activation, intermediate 5.42 oxidatively adds into HCl to 
form a Rh(III) hydride 5.43, which inserts into the olefin to give complex 5.44. After 
alkyl migration and -hydride elimination, the product 5.46 is released, and a potential 
catalyst 5.47 could react with substrates through proton transfer to form complex 5.43. 
In 2004, Bergman, Ellman, and coworker extended the Rh-catalyzed alkylation 
chemistry to 4,4-dimethyl-2-oxazolines (Scheme 5.56).
70
 A broad range of alkenes can be 
coupled to give linear products in good to high yields. When only phosphine ligands were 
used in the reaction, no product formation was found, which suggested the PCy3·HCl salt 
was necessary. In some cases, the reaction temperature can be as low as 45
 
°C, and the 
isomerizable alkenes, such as 1-hexene, also worked well. 
Scheme 5.56. Rh-catalyzed alkylation of 4,4-dimethyl-2-oxazolines with olefins. 
 
In 2006, Bergman, Ellman, and co-workers extended the heteroarenes scope to 
3,4-dihydroquinazoline (Scheme 5.57).
71
 Both the intermolecular and intramolecular C–
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H alkylations with alkenes were demonstrated. For the intermolecular case, kinetic 
monitoring of the reaction revealed that the substrate first underwent C–H alkylation to 
give the alkylated 3,4-dihydroquinazoline, which was then converted to the 
corresponding quinazoline products through transfer hydrogenation. Thus, one equivalent 
of olefin was consumed as the oxidant. The intramolecular version can provide a fused 
five-membered ring, which fits the framework of some natural products, such as 
Vasicoline (see Scheme 5.67). In the same year, the experimental and computational 
studies on the mechanism were reported by the same groups.
71
  
Scheme 5.57. Rh-catalyzed alkylation of 3,4-dihydroquinazoline with simple olefins. 
 
According to DFT calculations (Scheme 5.58), the C−H activation was initiated 
by coordination of the Rh catalyst with the sp
2
 nitrogen on imidazoline 5.48. Intermediate 
5.48 can go through ligand exchange to give complex 5.50, which can undergo oxidative 
addition to providing Rh-hydride species 5.52. Upon migratory insertion into the C=N 
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double bond, an NHC-Rh complex 5.54 is formed, which can be isolated. This pathway is 
also supported by deuterium studies. Furthermore, the computational results were 
consistent with the experimental results obtained from kinetic studies. 
Scheme 5.58. DFT calculations on Rh-catalyzed alkylation of 3,4-dihydroquinazoline. 
 
Scheme 5.59. Rh-catalyzed alkylation of quinolines and pyridines with olefins. 
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In 2007, Bergman, Ellman, and coworkers developed the Rh-catalyzed alkylation 
of quinolines and pyridines with olefins (Scheme 5.59).
72
 Mono-substitution at the C2 
position of the pyridine proved to be critical. In most cases, the linear addition products 
were the exclusive product formed. Interestingly, when quinoline was used, both linear 
and branched products were observed in 80% and 14% yield respectively from alkylation 
with 1-haxene. The cyclic alkene was also found to be suitable coupling partner. 
Scheme 5.60. Rh-catalyzed  annulation of aromatic imines using Wilkinson's catalyst. 
 
In 2001, Bergman, Ellman, and co-workers also developed a Rh-catalyzed  
annulation of aromatic imines via directed C−H activation with Wilkinson's catalyst 
(Scheme 5.60).
73
 This method provides rapid access to functionalized heterocycles such 
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as indane, tetralane, dihydrobenzofuran, and dihydroindole derivatives. By changing the 
heteroatom and length of the tether, five- or six-membered rings can be prepared in good 
yield. The tethers containing heteroatoms are more effectively cyclized in an exo-fashion 
to provide five-membered rings while all-carbon tethers favored endo-cyclization.  
An enantioselective imine-directed alkylation was reported by the same team in 
2004, using chiral phosphoramidites ligands (5.55 and 5.56, as shown in Scheme 5.61).
74
 
Lowering the reaction temperature helped the enantioselectivity. The enantioselective 
alkylation of aromatic imines with nitrogen-containing linkers or oxygen-containing 
linkers was also achieved.
75
 These methods provide efficient access to many biologically 
active chiral indanes, dihydrobenzofurans, and dihydropyrrole indole. Application of this 
method in natural product synthesis will be mentioned in Scheme 5.68. 
Scheme 5.61. Rh-catalyzed enantioselective alkylation using chiral ligands. 
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In 2007, Bergman, Ellman, and coworkers realized a Rh-catalyzed asymmetric 
alkylation using chiral aromatic imines (Scheme 5.62).
76
 The C–H alkylation can take 
place in a diastereoselective fashion with a chiral primary amine group. Upon imine 
hydrolysis, enantioenriched aryl aldehydes can be obtained in moderate ee. The screening 
of the chiral amines revealed that 7-fluoro-aminoindane provided the highest selectivity. 
This regio- and the enantioselective reaction can also be achieved with a catalytic amount 
of chiral amines with precondensed achiral imines, in which the imine exchange reaction 
is accelerated by Sc(OTf)3.  
Scheme 5.62. Rh-catalyzed asymmetric alkylation using chiral aromatic imines. 
 
In 2012, Chang, Jung, and coworkers developed a Rh-catalyzed alkylation of 2,2'-
bipyridines and 2,2'-bisquinolines with olefins.
77
 A broad range of simple olefins was 
used as alkylation reagents to give the bis-alkylated products for 2,2’-bipyridine (Scheme 
5.63). Rh(acac)3 was found to be the most suitable pre-catalyst in this reaction. 
 413 
Scheme 5.63. Rh-catalyzed alkylation of 2,2'-bipyridines and 2,2'-bisquinolines. 
 
Scheme 5.64. The proposed mechanism of Rh-catalyzed alkylation of 2,2'-bipyridines. 
 
 
 414 
According to the DFT studies, the proposed mechanism of the first hydroarylation 
cycle is shown in Scheme 5.64. The reductive elimination was proposed to be the rate-
determining step, and the NHC ligand can help rollover of the bipyridine, due to the 
strong trans-effect. The catalytic cycle was initiated with formation of complex 5.57, and 
dissociation of one pyridinyl group from the bipyridine to give 5.58. The C−H activation 
occurred to give Rh-hydride 5.59, which can undergo migratory insertion with the olefin 
and reductive elimination to give complex 5.61. This intermediate can re-enter the 
catalytic cycle to give the bis-alkylated product. 
In 2012, Shibata and coworker reported two examples of a Rh(III)-catalyzed 
intramolecular alkylation of 2-aryl-3-vinylpyridines to give the 9-methyl-4-azafluorenes 
in moderate yields (Scheme 5.65).
78
  Neither [Cp
*
RhCl2]2 nor Cu(OAc)2 was effective by 
itself, and the true catalyst was proposed to be a rhodium acetate. The role of the copper 
salt may be to provide acetate because other metal acetate salts can also produce the 
product. A Type B mechanism was proposed for this reaction. 
Scheme 5.65. Rh-catalyzed intramolecular alkylation of 2-aryl-3-vinylpyridines. 
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5.3.2.2 Application of Rhodium-Catalyzed Arene C−H Bond Alkylation 
In 2003, Bergman, Ellman, and coworker disclosed the Rh-catalyzed synthesis of 
a tricyclic mescaline analog through an intramolecular alkylation.
79
 Mescaline was 
discovered in 1896 and had been used as a prototypical compound for structure–activity 
relationship screening for treating central nervous system disorders. Utilizing the 
alkylation methodology, this drug was prepared in six steps with 38% overall yield 
(Scheme 5.66). 
Scheme 5.66. Rh-catalyzed synthesis of a tricyclic mescaline analog. 
 
In 2006, the same team further extended the Rh-catalyzed alkylation method to 
the total synthesis of vasicoline.
71
 Vasicoline, a member of the quinazoline natural 
product family, has been isolated from various plants and microbial sources, which 
exhibits interesting antimalarial, anti-inflammatory, and antitumor activity. The natural 
product was synthesized in 7 linear steps with 10% overall yield from commercial 
materials. The key reaction involves an intramolecular C−H alkylation at the C2 position 
of the alkene-tethered 3,4-dihydroquinazoline (Scheme 5.67). 
  
 416 
Scheme 5.67. Rh-catalyzed alkylation in the total synthesis of Vasicoline. 
 
Scheme 5.68. Rh-catalyzed enantioselective synthesis of a protein kinase C inhibitor. 
 
 
 417 
In the same year, the same team reported a Rh-catalyzed enantioselective 
synthesis of a protein kinase C inhibitor for isozyme  with a C−H bond alkylation 
strategy (Scheme 5.68).
80
 The dihydropyrole indole core is a common motif found in 
biologically active compounds, which can be rapidly constructed using the imine-directed 
ortho-alkylation method. Good yield and high ee can be obtained using a 
phosphoramidite ligand. 
Scheme 5.69. Rh-catalyzed a concise synthesis of potent bicyclic bisaryl imidazoles. 
 
In 2007, Bergman, Ellman, and coworkers developed a Rh-catalyzed concise 
synthesis of a number of potent bicyclic bisaryl imidazoles that serve as potent inhibitors 
of c-Jun N-terminal kinase (5.62-5.64), which can potentially treat neurodegenerative 
diseases (Scheme 5.69).
81
 The inhibitor 5.63 was prepared in 10 steps, in which the key 
step involved an intramolecular alkylation giving 50% yield and 90% ee.  Notably, this 
methodology allows for diversification of these molecules and compound 5.64 was found 
to be the most potent inhibitor. 
 418 
In 2007, Jun and coworkers reported a Rh-catalyzed alkylation of aromatic 
ketimines with a polybutadiene species.
82
 The modification of polybutadiene with a high 
ratio of vinyl-internal olefin groups exhibited a low conversion rate, due to steric 
congestion of the polymer substrate (Scheme 5.70). Isomerization of the backbone double 
bonds was observed. 
Scheme 5.70. Rh-catalyzed alkylation of aromatic ketimines with polybutadiene. 
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